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General introduction | 11
A cigarette is a legal but lethal consumer product 
The fact that cigarette smoking is related to developing (lung) cancer 1 and 
cardiovascular and pulmonary diseases 2 has been reported since 1950s. Smoke 
toxicants entering the smoker’s lungs cause pulmonary damage, leading to 
inflammation and a compromised immune state. The initiation of smoking-induced 
damage is followed by remodeling and repair mechanisms in all compartments of 
the respiratory system, from the single-cell alveolar walls to the large conducting 
airways 3. The repetition of damage, inflammation, remodeling and repair after each 
cigarette smoked lead to lung destruction (emphysema and fibrosis). Furthermore, 
some smoking-derived chemicals induce DNA damage and, if not repaired, this may 
lead to cancer in the oral and nasal cavities, and the airways. Moreover, many smoke 
chemicals, either as parent compounds or after being metabolized, are transferred 
across the lung epithelium, taken up into the blood and distributed in the smoker’s 
body. Throughout the whole body, smoke toxicants or their metabolites can cause 
damage of cells and tissues after each cigarette consumed. All these processes 
together lead to the risk of developing tobacco-related diseases, i.e. cardiovascular 
diseases, cancers, chronic respiratory diseases, reproduction failure and adverse 
immune responses 4. In 2018, one in every 4 men and one in every 20 women was 
a daily smoker and more than 8 million deaths are attributable to tobacco smoking 
worldwide every year 5,6, which is 1 person every 4 seconds. There is scientific and 
public consensus about the fact that smoking leads to tobacco-related diseases 7 as 
can also be read in the preamble of the World Health Organization (WHO) Framework 
Convention on Tobacco Control (FCTC): “…the scientific evidence unequivocally 
established that the consumption and exposure to tobacco smoke cause death, disease 
and disability, and that there is a time lag between the exposure to smoking and the uses 
of other tobacco products, and the onset of tobacco-related diseases”. 
Smoking a cigarette 
When a cigarette is lit on one side and a puff is drawn from the other side, smoke 
goes from the burning tip through the tobacco and the filter into the mouth of the 
smoker. During this transfer, the hot smoke distills compounds, such as nicotine 
and flavors, from the tobacco filler and delivers them to the smoker to satisfy their 
craving. Simultaneously, the smoker is exposed to toxic chemicals present in the 
smoke. Smoking a cigarette is a delicate process in which smoke is cooled down by 
filter ventilation to prevent inhaling hot smoke. During smoking, the combination of 
fuel (the tobacco), fire and oxygen in the air generates a combustion process that 
can reach temperatures up to 950 °C 8-10. During puffing by the smoker, two zones 
inside the burning cigarette can be distinguished: a combustion zone and a pyrolysis 
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zone (Figure 2). Inside the combustion zone, oxygen reacts with carbon-containing 
plant material of the tobacco, thereby producing chemicals such as carbon dioxide 
and nitric oxides, together with a large number of incomplete oxidation products. 
Downstream of the combustion zone is the cooler pyrolysis zone where oxygen is 
scarce and other smoke chemicals such as acrolein and acetaldehyde are produced. 
Various volatile organic compounds (VOCs) such as carbon monoxide (CO) and 
benzene are produced both by (incomplete) combustion and pyrolysis 8,11. In addition, 
in the absence of puffing, tobacco is further oxidized and pyrolysed during a self-
sustaining smoldering process, but at much lower temperatures than during burning 8.
Figure 1. The burning cigarette (adapted from Baker et al 8). 
The hot super-saturated vapor generated in the combustion and pyrolysis zones 
extracts and distils chemicals such as nicotine from the remaining tobacco filler. It 
also cools within the tobacco rod when transported towards the mouth-end, which 
leads to condensation of chemicals after puffing 11,12. During each puff and inter-
puff smoldering the tobacco rod will become shorter, and the balance between 
the various chemical and physico-chemical processes changes. Cigarette design 
features, particularly ventilation, influence the burning, pyrolysis, distillation and 
condensation processes inside the cigarette as well as the dilution of the smoke 
before it enters the mouth of the consumer (Figure 2). Hence, the produced cigarette 
smoke is a complex and dynamic mixture consisting of gases, (semi-)volatiles and 
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liquid droplets (particulate phase) with particles ranging between 0.1 and <1 µm in 
diameter which are able to penetrate deep into the lungs 10. 
Figure 2. The modern cigarette (adapted from Thielen et al. 10)
Cigarette smoke
After combustion, pyrolysis, distillation, condensation and dilution of tobacco, the 
tobacco smoke contains over 6,000 chemicals distributed between the gas- and 
particulate phase depending on their physical (e.g. volatility) and chemical properties 
4,12,13. Classes of compounds include, but are not limited to, neutral gases, carbon 
and nitrogen oxides, amides, imides, lactames, carboxylic acids, lactones, esters, 
aldehydes, ketones, alcohols, phenols, amines, N-nitrosamines, N-heterocyclics, 
aliphatic hydrocarbons, monocyclic and polycyclic aromatic hydrocarbons (PAHs), 
nitriles, anhydrides, carbohydrates, ethers, nitro compounds and metals 4. The 
gaseous phase consists mainly of nitrogen, but also contains combustion products 
such as CO, carbon dioxide, nitric oxide, and VOCs 10,14. Particulate phase consists 
of PAHs, tobacco-specific nitrosamines (TSNAs), metals and water 10,14. It is often 
referred to as ‘tar’ and quantified without the water content. Semi-volatiles are 
partitioned between the particulate and gaseous phases. Cigarette smoke has been 
extensively studied with the use of smoking machines to characterize and quantify its 
chemical composition. The first comprehensive list of biologically and toxicologically 
relevant substances in mainstream smoke was the so-called ‘Hoffman list’ 15. Counts 
et al., Talhout et al., Fowles and Dybing and the WHO reported additional toxicants 
to the growing list of cigarette smoke toxicants 16-19. Different factors (i.e. smoking 
behavior, tobacco blend, and filter paper) influence the puffing and smoldering of the 
cigarette and thus the formed chemical emissions 13. In other words, taking a small 
or short puff may not only lead to inhaling less smoke per puff per cigarette, but 
also to a (slightly) different chemical composition than that of a larger or longer puff. 
Additionally, smokers may use their smoking behavior to interact with the cigarette 
brands differing in tobacco blend, filter paper and ventilation 20. 
14 | Chapter 1
Smoking behavior
The traditional view on why people smoke tobacco is the smoker’s nicotine intake to 
satisfy his or her mental and behavioral needs 21. Smoking behavior is a multifaceted 
process and comprises the actual act of smoking, puffing, depth of inhalation, and 
the frequency of smoking (i.e. cigarettes per day (CPD)). Puffing, i.e. drawing smoke 
from the cigarette into the mouth, mouth holding and inhalation contribute to the 
exposure of the smoker to smoke constituents 22. After puffing, the smoke remains 
in the mouth because the soft palate at the back of the mouth remains closed 23. 
After a period of mouth-holding, the smoker relaxes the soft palate and inhales the 
smoke. Together with additional ‘fresh’ air, the smoke is drawn deeply into the alveoli 
compartment where gaseous chemicals are transported across the blood lung barrier 
23. Puff volume and inhalation volume are separate but linked parameters. A smoker 
may take a large puff with no, or minimal, subsequent inhalation. The converse is 
also possible, i.e. a small puff volume followed by a large inhalation volume 24. 
When a person inhales nicotine distilled from cigarette smoke, it moves in less than 
20 seconds to the brain after entering the arterial blood circulation. Once nicotine 
diffuses into brain tissue, it binds to nicotinic acetylcholine receptors (nAChR). 
Particularly binding to the dopaminergic nerves in the ventral tegmental area, 
which stimulates the release of dopamine in the shell of the nucleus accumbens, 
is an important mechanism in drug-induced reward (‘brain’s reward system’) 25. The 
stimulation of the brain’s mesolimbic reward circuit creates a nicotine dependency 
and contributes to addiction and thus the difficulty of quitting smoking. It has been 
suggested that there is a threshold for daily nicotine to initiate and sustain addiction of 
4 to 6 mg for adults, and probably even lower for adolescents 26. There are indications 
that experienced smokers can control and adapt or change their smoking behavior to 
modulate their nicotine intake 27. In addition to activating the brain by nicotine taken 
up by the lungs and transported by blood, also direct activation of the brain by nicotine 
in the oral and nasal cavity can play an important role. Several studies showed that 
nerves in the olfactory area of the nasal cavity, as well as the trigeminal nerve, are 
activated by nicotine 28-30. The brain’s response towards such activations takes only a 
few seconds. A high dose of nicotine can cause an experience of burning and stinging 
pain by the smoker due to strong activation of the trigeminal nerve, which may limit 
the smoker’s puffing because the nicotine intake exceeds the threshold for stinging 
or burning. In addition to nicotine, also flavors in the tobacco smoke, such as menthol, 
activate nerves in the olfactory region, contributing to the smokers experience of the 
smoked tobacco product 31. Furthermore, for example menthol may even influence 
the nicotine-modulation of the trigeminal nerve during, or shortly after puffing 28. 
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In addition to the variety in cigarette brands as source for varying nicotine intake, two 
individuals may smoke the same cigarette brand but can be exposed to different levels 
of nicotine 32. Ergo, by modulating the nicotine intake by changing their way of smoking, 
smokers (unconsciously) control the quantity and relative chemical composition 
of inhaled cigarette smoke, and influence their own exposure to smoke toxicants. 
Puffing topography 
Smoking or puffing topography is a term that relates to the physical characteristics of 
smoking behavior or, more simply phrased, how a person smokes his or her cigarette. 
Detailed examination of puffing topography involves quantitatively measuring the 
puffing by the smoker: number of puffs per cigarette, puff duration (s), puff volume (mL) 
and inter-puff interval (time between successive puffs, (s)) 32-35. Consecutively, puff 
flow (mL/s), total cigarette volume (mL) and cigarette burn time (s) can be calculated. 
Puff flow is puff volume divided by puff duration. Total cigarette volume is the product 
puff volume and number of puffs per cigarette. Daily puffing volume is the product of 
total cigarette volume and CPD. Cigarette burn time is the sum of the durations of all 
the puffs from a particular cigarette, a parameter not often used in previous studies 36.
Measuring puffing topography 
Human puffing topography is often recorded by the use of a flowmeter-device 
between the cigarette and the mouth of the smoker. Basically, the flowmeter captures 
pressure differences as smoke is inhaled from the cigarette and this pressure is 
converted into a flowrate via calibrated software. The software records the selected 
puff topography variables using flow onset, rate and offset measurements. In 
addition to desktop devices, portable devices were introduced to make it possible to 
measure naturalistic smoking behavior outside the lab. Whether the use of a puffing 
topography device influences human smoking behavior, is previously  examined by 
observational video recordings of the sessions 37 and by comparing smoking with 
and without mouthpiece 32. In these studies, smokers were video recorded while 
smoking with and without topography device and puff duration, time between puffs, 
puff frequency and total cigarette duration were distilled from the video recordings 
and compared to the topography device measurements. Results showed similar 
puffing parameters indicating that smokers did not change their puffing behavior 
when using the device 37.
Puffing topography differences between individual characteristics
Puffing topography is widely studied, and considerable intra-individual and inter-
individual differences between smokers have been observed. In studies published 
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since 2000 the puff volume ranged from 30.8 mL 32 to 85.1 mL 38 with a duration of 
0.9 s 32 to 3 s 39. On average, smokers take between 8 40 and 20 puffs 41 per cigarette, 
with a puff interval between 9 42 and 45 s 38. The variation in puff parameters is 
influenced by several factors as gender, race/ethnicity, nicotine dependence, 
psychological factors and genetic background. For instance, gender seems to be 
relevant since women take significantly smaller puffs (37.6 mL/puff vs. 45.8 mL/puff) 
of significantly shorter duration (1.33 s/puff vs. 1.48 s/puff) resulting in significantly 
more puffs per cigarette (14 vs. 12) than men 43. Age seems not to have a large 
influence on puffing topography 44. Nicotine dependence seems to be involved since 
cigarette volume and maximum puff volume are increased in combination with a 
more stable puffing profile, for those scoring high in the Fagerström Test for Nicotine 
Dependence (i.e. standard instrument for assessing the intensity of physical addiction 
to nicotine) 45,46. Several studies have shown that the brand smoked (e.g. percentage 
of filter ventilation) as determined with smoking machines), flavor (menthol), time 
of the day of smoking, and smoking location is of influence on smoking topography 
39. Limitations to interpret the published data until now are that studies differ in 
their study design, for instance, allowing the consumption of multiple cigarettes in 
one study session 37, or multiple sessions allowing just one cigarette 45,47. Another 
limitation is that most studies determine the average puffing parameters per 
cigarette. However, it has been shown that during the act of smoking a cigarette the 
puff characteristics change, resulting in a changed chemical puff content over the 
course of smoking one cigarette 48. Xie et al , for instance, showed that nicotine per 
puff increases when puff number increases (in case of a stable puff volume per puff) 
49. Since studies predict nicotine exposure levels and other smoke constituents by 
puff parameters 36,40,50-56 it is important to study smoking topography under natural 
smoking circumstances to assess reliably smoking associated chemical exposures.
Puffing parameters influence chemical smoke content
The puffing topography of a smoker influences the composition of cigarette smoke 
as it has impact on the burning temperature, the oxygen supply and consecutively 
the burning, pyrolysis, distillation and condensation of chemicals inside the cigarette. 
The air stream during puffing influences the heat and mass transfer and thus the 
tobacco consumed: the higher the puff flow, the higher the temperature. The 
smoldering period – the duration between puffs (inter-puff interval) – influences 
the temperature loss. As the smoke moves along the tobacco rod, the smoke 
particles tend to coagulate, resulting in a higher average particle diameter, and a 
smaller number of particles. The faster the particles move down the tobacco rod, 
the less time they have for coagulation and the smaller the average particle size 
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will be 57. Thus, also the level/number and the characteristics of the chemicals 
formed and the distribution between the particulate and gas phase depend on the 
puffing parameters. The smoke constituent yields  generated in the first puffs are 
generally lower than in later puffs, due to the time required to form the coal and 
more extensive filtration and condensation of smoke by the tobacco rod 58.  In the 
final puffs of a cigarette, higher smoke yields are also generated due to the shorter 
filtration-condensation path that the smoke passes, and re-distillation of smoke 
filtered and condensated in earlier puffs 59.  More intense smoking regimes change 
the thermal process of burning cigarettes, resulting in relative increases or decreases 
of the chemical compositions 16,60,61. However, it is difficult to measure the exact 
influence of a single puffing parameter because, for example, when the puff duration 
changes, but not the volume, the puff flow will change as well. 
Cigarette characteristics
At the time (1950s) it was discovered that smoking was related to development of 
tobacco-related diseases, unfiltered cigarettes were smoked. The public’s awareness 
and concern of the harmful effects of smoking rose. Manufacturers responded 
by introducing the first filter cigarette and claimed reduced tar yields. Because 
of the reduced inhaled tar in the smoke the filtered cigarettes were marketed as 
less harmful than the unfiltered cigarettes 62. Throughout the years, manufacturers 
kept developing their product. The five biggest tobacco industry companies, Philip 
Morris International, British American Tobacco, Imperial Brands, Japan Tobacco 
International, and China Tobacco, all manufacture a variety of cigarette brands and 
develop unique cigarette brands by engineering a combination of tobacco filler 
and cigarette design features. Cigarette characteristics are used to increase the 
attractiveness to consumers by reducing negative experiences (e.g. throat irritation), 
increasing positive experiences (e.g. optimized draw resistance and mouth feel), 
appealing to new users and specific target groups, and fostering the perception of 
less personal risk (e.g. ‘light’ cigarette) 19,20. 
As stated in the preamble of the WHO FCTC, ”…cigarettes and some other products 
containing tobacco are highly engineered so as to create and maintain dependence, 
and that the many compounds they contain, and the smoke they produce are 
pharmacologically active, toxic, mutagenic and carcinogenic, ….”. Tobacco filler 
related aspects are the tobacco type, blend, amount and type of additives used and 
filler weight. Cigarette design features are cigarette paper, filter type, cigarette rod 
dimensions (e.g. circumference and length) and the well-known filter (and paper) 
ventilation 63. By increasing ventilation in the cigarette, for example by adding 
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ventilation holes in the filter, ‘low tar’ cigarettes were introduced to the consumer 
markets. This change in cigarette design parallels the increase in adenocarcinoma, a 
typical form of tobacco-related lung cancer 64. 
There are three main filter types; cellulose acetate (mainly used), pure cellulose or 
in combination with carbon. The combination of the filter material, paper porosity 
and draw resistance add to filter efficiency, which is the percentage of incoming 
smoke components removed by the filter. When a higher suction is needed to draw 
smoke through the filter (as reflected in the filter pressure drop), filtration efficiency 
increases due to a reduction in airflow through the cigarette.
Cigarette design features influence smoke content
The combination of the different cigarette design features affects smoke emissions. 
For example, cigarette smokers became more aware of the harmful effects of 
smoking in the 1960s. Subsequently, the tobacco industry introduced a ‘healthier 
alternative’: the ‘light’-cigarette. These light-cigarettes have filters with visible and/
or microscopically small ventilation holes through which additional air is drawn 
when taking a puff. The high ventilation leads to dilution of smoke and lower tar, 
nicotine and CO (TNCO) yields when machine smoked according to ISO. This is used 
by the manufacturer to define as a regular, medium-, low- or ultra-low tar cigarette 
13,65. Because the smoke entering the smokers’ mouth is diluted, smokers perceived 
the light-cigarette as milder and less irritating to the throat, which enhances the 
misperception of consuming a less harmful product (i.e. reduced TNCO-intake). 
However, it is discussed that the smoker will adapt his or her smoking behavior 
consciously or unconsciously (compensatory smoking behavior) 64,66,67 to gain the 
nicotine to which they are accustomed. If they smoke a cigarette with (more) filter 
vents, the puff volume might be greater and the concentration of nicotine and 
other toxicants per puff will change 68. An increased puffing intensity resulted in 
an increase in the concentration of tar and nicotine yields because ventilation and 
tar reduction depend on how fast and large the puff is 69,70. In order to handle the 
higher puff volume smokers’ inhale more deeply; they also take more and/or longer 
puffs or even smoke more CPD 34,64. Smokers may also cover some of the ventilation 
holes, consciously or unconsciously, with their fingers and mouth while they are 
smoking. Nowadays, all commercial cigarettes have a certain amount of filter vents 
located at the filter tip. The amount of additional air drawn in varies from 10 to 
83 % and depends on the number, the size and the position of the filter vents 64. 
In addition, from machine smoking experiments is known that as filter ventilation 
increases, the cigarette is burned down less rapidly because of a decreased airflow 
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through the burning tip and a drop in temperature. This results in more incomplete 
combustion, more puffs and thus formation of different toxicants as has been 
shown using smoking machines 64. Another effect of filter ventilation is the increase 
of particle size, due to increased water content, condensation and coagulation of 
smoke compounds. The slower burn rate of the cigarette and increased residence 
time of the smoke allows particles to absorb more water, constituents and gases 64,71. 
Filter vents appear to have a synergistic effect on the formation of smoke toxicants, 
which supports the hypothesis of a causal relationship between filter ventilation and 
increased risk for developing tobacco-related diseases 71. 
Cigarette emissions and smoking machines
The interaction between the variable puffing topography across smokers and the 
design features of the product makes that emissions of cigarettes under real-life 
conditions are hard to predict and thus difficult to control from a regulatory point of 
view. Generally, smoking machines are used to measure cigarette smoke emissions 
under standardized conditions in order to guard the consistency of cigarettes, for 
inter-brand comparison of emissions and for research, e.g., for cigarette toxicity 
testing or identification of smoke constituents. Cigarettes are usually machine 
smoked according to a particular puffing regime followed by measuring the 
chemical emissions in the mainstream smoke. Moreover, standardized machine 
smoking regimes were introduced to provide information in the relative ranking of 
cigarettes in terms of TNCO yields. The Federal Trade Commission (FTC) opted a 
standard method in 1966, followed by comparable methods such as the CORESTA 
(Cooperation Centre for Scientific Research Relative to Tobacco) Recommended 
Method in 1969 72 and the DIN method in 1978 73,74. The different methods were 
harmonized by agreeing on one method, ISO 3308, which was introduced by the 
International Standardisation Organisation (ISO) in 1991 75. The puffing parameters 
are a 35 mL puff taken for 2 s every minute. The ISO 3308 regime was, for instance, 
taken up in the Tobacco Products Directive (TPD). The TPD describes the regulatory 
standard in the European Union where brands that generate emissions >10 
mg of tar, >1 mg of nicotine or >10 mg of CO are prohibited, based on machine 
smoking according to the ISO regime 76. However, the ISO 3308 regime is widely 
acknowledged to be irrelevant for purposes of setting regulatory restrictions as it 
does not reflect and underestimates human smoking behavior and thus human health 
77. The standard settings of ISO 3308 originate from the mid 1960’s when cigarette 
designs differed strongly from nowadays cigarettes. Later on, a more intensive set of 
puffing parameters for smoking machines was introduced by Health Canada as the 
Health Canada Intense (HCI) regime; a 55 mL puff is taken for two seconds twice 
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a minute. In addition, any filter ventilation holes of the cigarette are taped, thereby 
preventing dilution of the smoke. Smoking machine yields of cigarette emissions (i.e. 
TNCO) generated with HCI are one average 2-3 times higher than yields generated 
with an ISO regime, due to the combination of the intense puffing parameters and 
the blocked filter ventilation 10,77,78. More importantly, the difference between ISO 
vs HCI yields increases as ventilation increases. There is an ongoing dispute to what 
extend emissions generated by smoking machines can be used for risk assessment 
and regulation of smoke emissions. 
Exposure to smoke toxicants
The amount of toxicants the smoker is exposed to depends on different factors; 
the number of cigarettes smoked, the toxicants’ yields delivered per cigarette that is 
associated with the puffing behavior and lastly the inhalation process. The number 
of cigarettes smoked per day can be determined by self-report or by asking smokers 
to collect their cigarette butts. The range of toxicants that smokers are exposed to, 
due to these individual differences in puffing topography, is not completely defined. 
As a surrogate, smoking machine data using different smoking machines regimes 
can be used to estimate toxicant yields delivered per cigarette. Different regimes 
can represent the least and most intense smoker, and/or the protocol resulting in 
the lowest and highest yields. This can be done for smokers either in general or for 
an individual smoker specifically. The latter is however not commonly used due to 
the wide variety in human smoking topography and that it is not feasible in practical 
terms. Another approach to estimate exposure to smoke is the measurement of 
smoke chemicals, or their metabolites, in human body fluids such as saliva, blood 
and urine. As cigarette smoke first enters the mouth, saliva might be used to 
estimate mouth-level exposure to nicotine or smoke toxicants. Researchers were 
able to determine cotinine, the metabolite of nicotine, in saliva 79-81 of smokers and 
proposed it as a good and non-invasive exposure marker of cigarette smoke 81. Oral 
mucosa cells obtained from mouth rinses or brushes can be a source for biomarkers 
of tobacco smoke exposure and molecular changes that are potentially related to 
cancer 82. Blood reflects uptake of smoke toxicants into the circulation and therefore 
blood and urine levels of nicotine, cotinine and other smoke toxicants and their 
metabolites can be used to estimate the uptake due to smoking 83-88. Lastly, exhaled 
breath might also be used as biomarker of exposure because after inhalation, the 
smoker exhales the smoke 89. Due to the intermittent exposure to smoke by lighting 
several cigarettes throughout the day, sampling randomly during a day does not 
inform on peak exposure, acute exposure nor exposure due to smoking a single 
cigarette. There is still a gap in knowledge about how individual smoking behavior 
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determines smoke toxicant yields, and the subsequent bodily exposure of these 
smoke toxicants. To accurately determine the relation between the internal dose 
of the smoker and their personal smoking behavior, smoke toxicants formed and 
released under puffing parameter conditions should be measured. 
Hazard and risk assessment
Risk assessment describes the overall process of hazard identification, hazard 
characterization, exposure characterization, and risk evaluation. First, hazards, 
which is anything that could be potentially damaging, and risk factors are identified. 
Then, the risk is analyzed and evaluated, which is the chance that someone will 
experience the damaging effects upon exposure to the hazard. Risk assessment can 
be used to inform stakeholders, improve information for the public and may lead 
to regulation. This principle of risk assessment also applies to the assessment of 
cigarette smoking-related risks to cause harm and develop diseases. This can be a 
total risk or a risk to develop a specific disease, and can be based on single toxicants 
or whole smoke. However, the complexity of the mixture of thousands of chemicals 
with different concentrations in mainstream smoke, combined with the dynamics of 
the formation of the smoke that depends on the smoker’s behavior and the cigarette 
design complicate risk assessment of cigarette smoke. In addition to using smoke 
condensate or mainstream smoke, during the last two decades attempts have been 
made to assess the risk attributed to various chemical and toxicological classes of 
smoke constituents.  The main data sources for risk assessment are articles listing 
smoke constituents, particularly the Hoffmann list 15,90,91. This list formed the basis of 
Health Canada’s monitoring for tobacco constituents 92. Another list was published by 
Counts et al. consisting of 44 individual smoke toxicants according to three machine 
smoking regimes in 48 Philip Morris brands, overlapping with the Hoffmann list 16. 
There is also overlap with the list of Rodgman et al. that contains 162 tobacco and/or 
tobacco smoke components, each of which was classified as biologically adverse 93. 
One of the first risk assessments concerning smoke toxicants was done by Vorhees 
and Dodson and was supported by the Massachusetts Department of Public 
Health Tobacco Control Program 94. They used yield data for smoke constituents 
in 25 brands of conventional cigarettes to calculate cancer risks due to 71 smoke 
toxicants. Fowles and Dybing provided a hazard prioritization index of 158 toxicants, 
including 41 carcinogens, based on machine smoking ISO data 17. They calculated 
the cancer risk index (CRI) by multiplying the cancer potency factors (CPFs) with 
yield levels derived from machine smoking cigarettes according to the ISO 3308 
regime. The non-cancer risk index was calculated by dividing the ISO yield levels 
with reference exposure levels (RELs) 17. This research was already part of the year 
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2000-report for the New Zealand Ministry of Health 95. Pankow et al. 2007 focused 
on different types of cigarettes (‘regular’, ‘light’, and ‘ultralight’) and calculated the 
lung cancer risk for 13 smoke toxicants in 26 brands (‘regular’, ‘light’, and  ‘ultralight’) 
and eight potentially reduced exposure tobacco products (PREP) 96. Data originated 
from the Massachusetts Benchmark Study that used the Massachusetts smoking 
machine regime. Cancer risks were calculated for an assumed smoking dose of 
one pack-year (=7300 cigarettes), a body weight of 70 kg, and a 70-year lifetime. 
Moreover, a cumulative risk (accumulation of risk factors) was computed with an 
additive model of the US Environmental Protection Agency. The sum of the risks 
calculated by Fowles and Dybing was lower than the risks based on epidemiology 
data. Therefore, the WHO technical report 951 97 revised the method of Fowles and 
Dybing 17 in that yields derived from machine smoking according to HCI were used 
16, after normalization per milligram of nicotine. Using normalized levels of toxicants 
per mg nicotine included reduces the misleading differences between levels of 
toxicants expressed per cigarette due to differences in smoking behavior. Talhout 
et al. updated the Hoffmann list to identify ‘constituents of concern’ by generating 
a database consisting of 542 smoke toxicant levels with an extensive literature 
search 18. A human inhalation risk value for 98 compounds was found, based on 
carcinogenicity, cardiovascular and pulmonary disease endpoints, which can be 
used for regulatory purposes. In 2014, WHO Study Group on Tobacco Product 
Regulation (TobReg) updated their priority list to 38 toxicants and suggested that 
their list should be used for monitoring and regulating the contents and emissions 
of cigarettes, as required by Article 9 of the WHO FCTC 98,99. The US Food & Drug 
Administration (FDA) has published a list of 106 “harmful or potentially harmful” 
tobacco and tobacco smoke components (HPHC) and has updated it over time as 
toxicological knowledge and analytical techniques have advanced 100,101. Marano et al. 
addressed numerical increases and decreases in HPHC yields between two or more 
tobacco products 102. They considered that HCI regime yields are representative for 
human smoking and the default assumption of 100% absorption should be used. 
This is a conservative approach because part of the volatiles are exhaled. USEPA 
environmental site risk assessment methodology, with minor adjustments, was 
demonstrated to be suitable as risk assessment method for tobacco products. Some 
risk assessment approaches focused on nicotine 103,104 or specific smoke toxicants 
103,105-109, while others focused on specific endpoints, for example lung related disease 
110, or on smokers’ characteristics, for example, ethnicity 108. 
Limitations are the number of smoke toxicants with actual measured yields in 
smoke and gaps in the potency values. The first study using exposure data more 
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representative to human smoking was the study of Watanabe et al. 111. They 
performed a probabilistic risk assessment (Monte Carlo method), probability 
distributions of incremental lifetime cancer risk (ILCR)) accounting for uncertainty 
and variability in the way people smoke cigarettes and differentiates between 
‘regular’ and ‘light’ cigarettes and the number of cigarettes per day. The focus was 
on benzo[a]pyrene, N-nitrosonornicotine and nicotine-derived nitrosamine ketone 
emissions measured under human smoking conditions from Djordjevic et al. (2000) 
112. The incremental lifetime cancer risk (ILCR) for male regular smokers was similar to 
that for female regular smokers and the same trend was seen for ‘light’ smokers. The 
advantage of incorporating uncertainty and variability in yields and among smoking 
behaviors is the more robust estimate of toxicant hazards and risk. Others tried 
to estimate human exposure by measuring compounds such as nicotine in spent 
butts 113 or by using computer models 114. Pack et al. aimed to estimate the uptake 
of the 38 toxicants on the WHO TobReg list based on human-smoked toxicant 
yields in 361 Korean smokers 113. Nicotine determined in spent cigarette butts 
(part-filter method (PFM) was compared with the measures of smoking machine 
experiments (8 regimes). Smokers’ systemic uptake of the 38 toxicants was derived 
by considering loss mechanisms, such as mouth spill (MS) (e.g. smoke escaping 
from mouth) and respiratory retention (RR), adopted from published results for 
conventional cigarettes. Consequently, a comprehensive risk was assessed followed 
by a Korean specific priority list of toxicants. Corley et al. had another approach; 
machine-smoking data was used as intake in a model to predict specific respiratory 
tissue exposure 114. Exposure conditions were calculated based on human body 
weight, cardiac output, puffing behavior (puffs/cig), and yield per cigarette and per 
puff, volume and concentration of the oral cavity. 
In summary, a variety of lists with hazardous compounds and approaches have 
been used to assess the hazard and/or risk of tobacco smoke, or classes of smoke 
constituents. Many studies focused on the particles phase of the smoke, which 
contains many of the heavy metals, nitrosamines, polycyclic aromatic hydrocarbons 
(PAHs) and many other chemicals with low boiling or sublimation points. Other 
focused on the volatile constituents of mainstream tobacco smoke. In the WHO 
TobReg study it has been shown that machine smoke yields of individual compounds 
within the class of volatile aldehydes correlate with each other 97. A similar observation 
is reported for VOCs. However, it is unclear whether this also applies for actual 
exposure of smokers. Moreover, more in general, all risk assessments suffer from 
inadequate exposure assessment. Although cigarette per day and smoking machine 
yields generate exposure assessment data that to some extend can be used for risk 
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assessment, better quantification of exposure of tobacco smoke constituents under 
standardized testing conditions would serve regulatory measures. Since in Fowles 
and Dybing 17, WHO TobReg technical report 951 97 and others initially assessed 
that aldehydes and other VOCs pose the highest risk to cigarette smokers based 
on smoking machine data, quantification of actual exposure of human smokers 
contributes to better risk assessment to support product regulation in the future. 
WHO Framework Convention on Tobacco Control and tobacco regulation
It is estimated that during the last century, tobacco consumption was the cause 
of death of approximately 100 million people worldwide. With the growing world 
population and the ‘highly engineered cigarette products’ it is estimated that almost 
1 billion people will die due to tobacco consumption in the 21st century  115. In the 
last decade of the 20st century, the WHO took the initiative to regulate tobacco 
products based on an international treaty. The WHO FCTC entered into force as 
a response to the global tobacco epidemic in 2005 116. The Parties that signed the 
Convention are legally bound to the treaty’s provisions that are described in 38 
articles. The first sentence in the preamble of the treaty reads “.. that the spread of 
the tobacco epidemic is a global problem with serious consequences for public health 
that calls for the widest possible international cooperation and the participation of all 
countries in an effective, appropriate and comprehensive international response”. The 
core articles 6 to 14 state the price, tax measures, and non-price measures to reduce 
the demand for tobacco. The non-price measures include protection from exposure 
to tobacco smoke, regulation of tobacco products and disclosures, packaging and 
labelling of tobacco products, education, communication, training, and public 
awareness, tobacco advertising, promotion and sponsorship, and demand reduction 
measures concerning tobacco dependence and cessation. Preventing initiation 
of tobacco product use, promoting cessation of tobacco use, and protecting the 
public from exposure to second hand smoke are the most effective approaches 
to reduce tobacco related morbidity and mortality. Article 9 and 10 of the treaty 
include regulations of the content and disclosures of tobacco products, from a harm 
reduction perspective 116. Harm reduction consists of a package of measures that 
prevents the harmful effects of legal or illegal human behavior without necessarily 
changing the behavior itself. Harm reduction includes interventions, programs 
and policy measures that aim to reduce health, social and economic damage of, 
for example, drug use to individuals, communities and reduce societies (EMCDDA 
2010). A tobacco product may be harm reducing if it lowers total tobacco related 
mortality and morbidity even though use of that product may involve continued 
exposure to tobacco related chemicals 65. Health professionals have divided opinions 
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on the harm reduction perspective: 1) it is unclear whether dose-response curves 
are linear and thus whether yield reduction is proportional to harm reduction. 2) It 
is not possible to sufficiently translate reduced yields to reduced exposure, or even 
reduced risk. 3) The harm reduction principle might distract from quitting smoking. 
4) It might tempt to initiate smoking because ‘it is less harmful’. 
Critics of harm reduction find that tolerating risky or illegal behavior sends a signal 
to the community that such behavior is acceptable. Furthermore, they find that 
some of the proposed measures by the advocates of harm reduction do not limit the 
long-term damage. Consequently, the focus should also, or mainly, be on lowering 
attractiveness, addictiveness and toxicity of tobacco products.  
The WHO study group on Tobacco Product Regulation proposed mandated lowering 
of toxicants in cigarette smoke 117. Such a strategy for regulation is based on product 
performance measures with the goal of reducing toxicant levels in mainstream 
cigarette smoke measured under standardized conditions. This is a challenge 
for which scientific data based on toxicological testing are needed to support 
regulatory approaches. Particularly the use of smoking machine data retrieved 
under ‘standardized conditions’ for regulatory purposes is often criticized. Part of 
the critiques is that such measures are costly and technical, which can be solved 
by having the tobacco industry pay for it. The other part of the critique is that the 
standardized conditions of smoking machines cannot be linked to the risks of human 
smokers from a scientific and biologically relevant perspective.
Aim of this thesis
Throughout the years, risk assessment approaches are mainly based on machine 
smoking data and the assumption that human exposure to smoke toxicants is 
controlled by the smokers’ need for nicotine. The IARC-WHO working group even 
recommended using the ratio between the concentrations of toxicants and nicotine 
in tobacco smoke for regulation purposes. Furthermore, machine-smoking yields are 
used to compare different brands and to classify cigarettes based on their nicotine 
delivery under standardized machine testing conditions. However, in such studies 
it remains partly unclear how the emission generated by smoking machines should 
be linked to cigarette emission during human smoking and how predictive such 
emissions are for actual uptake in the human body. In parallel, in human volunteer 
studies biomarkers of exposure are used to show actual uptake of tobacco smoke 
toxicants. Such studies often show substantially elevated concentrations of 
(biomarkers of) toxicants in smokers’ blood compared to those in the blood of non-
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smokers, indicating an increased health risk. However, such studies not always 
investigate how the actual exposure doses depend on individual smoking behaviors 
and individual variations in smoking topography. Moreover, the influence of human 
smoking behavior on blood concentration of smoke toxicants, in combination with 
the yields of the used products, is scarcely investigated. Additionally, hardly any 
studies focus on the actual exposure dose of toxicants in the lungs of smokers. To 
assure the relevance of using machine-smoking data in risk assessment and product 
regulation, better knowledge regarding how such laboratory data reflect actual 
human exposure to smoke toxicants is warranted. This is especially needed and 
relevant for highly ventilated cigarettes of which it is sometimes assumed that the 
nicotine exposure is very low, even below the threshold of initiation or sustaining 
of nicotine addiction (daily dose of less than ~5mg) as suggested by Benowitz and 
Henningfield in 1994 26. Therefore, the aim of this thesis is to:
Relate, for the purpose of risk assessment and cigarette product regulation, the emissions 
of nicotine, carbon monoxide, and volatile organic compounds produced with smoking 
machines to emissions produced during human smoking, as well as to the actual uptake 
in the body of smokers, taking into account the smokers’ daily use of cigarettes and their 
personal puffing topography. 
In order to provide scientific support for risk assessment, product classification and 
regulation, the following research questions have been postulated.
Research Question 1 – Do smokers have characteristic puffing topography profiles?
Research Question 2 – How do the puffing regimes ISO 3308 and HCI used as 
settings for smoking machines relate to puffing topography of human smokers?
Research Question 3 – Is the nicotine delivery of ‘very low yield’  cigarettes above 
the threshold to initiate and sustain nicotine addiction as postulated by Benowitz 
and Henningfield (1994) 26? 
Research Question 4 – Does the individual nicotine systemic uptake change when a 
different type of cigarette is smoked and are smokers using their puffing topography 
to (partially) compensate for differences in nicotine yields of the cigarettes?
Research Question 5 – Is the uptake of CO or other volatile toxicants in tobacco 
smoke linked to the nicotine uptake during smoking ventilated cigarettes?
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Research Question 6 – Can toxicant yields of cigarettes produced with a smoking 
machine be used for human risk assessment purposes, or are there alternatives such 
as exhaled breath?
Research Question 7 – What are the contributions of (variations of) human puffing 
topography and (differences between) toxicant smoke yields to the risk of smokers?
In Chapter 2, first the focus is on the variation in smoke constituents yields between 
brands. A smoking machine is used with four standardized settings to allow 
comparisons of yields aldehydes generated during smoking of 11 cigarette brands of 
the Dutch market. Second, the focus is particularly on the potential use of nicotine 
yields of the same brands and tested under the same conditions to normalize the 
yields of smoke constituents. Special attention is given to highly ventilated cigarettes. 
Chapter 3 focuses on VOCs such as benzene and toluene. The influence of high filter 
ventilation on smoke VOCs generated by a smoking machine is further investigated. 
The machine-derived data are compared with data of a human study in which the 
smoke constituents are measured in (headspace of) blood and in exhaled breath.
In Chapter 4, human puffing topography is addressed and the device used in 
this study that measures human smoking topography (the number of puffs, puff 
frequency and puff volume) is critically evaluated. 
Chapter 5 further elaborates on the findings about the role of filter ventilation on 
the yields produced by smoking machines under ISO 3308 standardized conditions 
relative to HCI conditions and human puffing. Particularly the link between filter 
ventilation, smoking topography and nicotine uptake by the smoker is investigated. 
In Chapter 6 - the general discussion - a summary of the results is given and the 
research questions are addressed.
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Tobacco filler
Tobacco is a natural product, grown in many parts of the world, and subject 
to weather influences. This leads to crop and year variation therefore multiple 
crop years are used in blended cigarettes to maintain the cigarette taste or 
intendent slowly change the cigarette. The blends itself are a combination 
of types of tobacco differing in curing, density and burn properties. Burley 
tobacco is air cured, has a high filling power and burns excellent, bright (or 
Virginia) tobacco is flue cured, has a moderate filling power and a variable 
burn, and oriental tobacco is air cured, has a low filling power and a slow burn. 
Reconstituted tobacco consists of scraps and stems and it allows manufacturers 
to make the most efficient use of their tobacco with little waste. The expanded 
tobacco is a combination of the three before mentioned tobacco sorts, and 
treated to reduce the weight of the cigarettes by increasing the filling power 
and burn rate of tobacco without losing taste. A balanced tobacco weight or 
density ensures the physical stability of the cigarette; however, a reduced 
tobacco density reduces smoke yields. Blending is done to achieve specific pH, 
taste, burning characteristics and nicotine content 13. The recipe for the type 
of tobacco blend significantly affects the pH, nicotine content and toxicity of 
the smoke and are therefore closely kept trade secrets of the manufactory 
industry. The pH strongly influences the concentration of so-called free-
base nicotine in tobacco smoke, whereas the nitrate content influences the 
carcinogenic potential of smoke 65. The uncharged, volatile form of nicotine, 
free-base nicotine, is formed at a specific pH. The higher the pH of the smoke, 
the more free-base nicotine is formed, inhaled and leads to higher levels of 
nicotine that reach the brain 118. Tobacco blends with high carbohydrate or 
sugar-content generate more acidic smoke and therefore lower free base 
nicotine concentrations 119. Subsequently, smokers will inhale more deeply 
to satisfy their nicotine-need, or smoke more frequently 77,120. Moreover, 
combustion of sugars in tobacco leads to the production of acetaldehyde 
121, which increases the firing potential of dopaminergic nerves in the ventral 
tegmental area, and thus adds to the addictive potential of the cigarette 122.
Additives are substances added for specific technological purposes in the 
manufacture or to advance appealing of tobacco products 123. 1) Flavorings 
impart a specific taste, flavor or aroma to a product and give the tobacco 
brand its unique sensory characteristics. Moreover, it makes the cigarette 
attractive, may increase the consumption rate and thus enhances addiction 
20. Since May 2016, characterizing flavors are prohibited and since May 2020, 
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menthol is not allowed anymore in the European Union. 2) Humectants 
increase the moisture-holding capacity of the tobacco and fillers contribute 
to the volume of the product without contributing significantly to odor, taste 
or flavor. 3) Preservatives protect the product from deterioration caused by 
microorganisms, and binders and strengtheners make it possible to maintain 
the physical state of the product. Lastly, 4) solvents are used to dissolve or 
dilute ingredients, without altering their function, in order to facilitate their 
handling and application. The different additives are used in small amounts, 
not expected to give short-term effects, but their combustion products can be 
toxic, transforming the smoke in an even more complex chemical mixture. For 
example, the total particulate matter (gross tar), CO and carbonyl compounds, 
especially formaldehyde, increased in smoke when additives were added 124,125. 
Additives that make products more toxic in unburnt form, or after combustion, 
those resulting in a characteristic flavor or encouraging deeper and longer 
inhalation, increasing the amount of nicotine that gets into the body, are 
further assessed in order to take regulatory decisions (e.g. limit). Since 2014, 
the Tobacco Product Directive (TPD) 2014/40/EU prohibits tobacco products 
containing additives that attribute to carcinogenic, mutagenic and reproductive 
toxicity in unburnt form or that increase overall toxicity of the tobacco product 
76. Especially, the latter is difficult to prove. Moreover, manufacturers are 
obliged to disclose ingredients of tobacco products on the European market 
to the EU common entry gate (EU-CEG) 126.
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Abstract
The WHO study group on tobacco product regulation (TobReg) advised regulating and 
lowering toxicant levels in cigarette smoke. Aldehydes are one of the chemical classes 
on the TobReg smoke toxicants priority list. To provide insight in factors determining 
aldehyde yields, the levels of 12 aldehydes in mainstream cigarette smoke of 11 
Dutch brands were quantified. Variations in smoking behavior and cigarette design 
affecting human exposure to aldehydes were studied by using four different machine 
testing protocols. Machine smoking was based on the International Standardization 
Organization (ISO) and Health Canada Intense (HCI) regime, both with and without 
taping the filter vents. The 11 cigarette brands differed in (i) design and blend 
characteristics; (ii) tar, nicotine, and carbon monoxide (TNCO) levels; (iii) popularity; 
and (iv) manufacturer. Cigarette smoke was trapped on a Cambridge filter pad and 
carboxen cartridge. After being dissolved in methanol/CS2 and derivatization with 
DNPH, the aldehyde yields were determined using HPLC-DAD. Using an intense 
smoking regime (increased puff volume, shorter puff interval) significantly increased 
aldehyde yields, following the pattern: ISO < ISO-taped < HCI-untaped < HCI. For all 
of the regimes, acetaldehyde and acrolein yields were strongly correlated (r = 0.804). 
The difference in TNCO and aldehyde levels between regular and highly ventilated 
low-TNCO cigarettes (as measured using ISO) diminished when smoking intensely; 
this effect is stronger when combined with taping filter vents. The highly ventilated 
low-TNCO brands showed six times more aldehyde production per mg nicotine for 
the intense smoking regimes. In conclusion, acetaldehyde and acrolein can be used 
as representatives for the class of volatile aldehydes for the different brands and 
smoking regimes. The aldehyde-to-nicotine ratio increased when highly ventilated 
cigarettes were smoked intensely, similar to real smokers. Thus, a smoker of highly 
ventilated low-TNCO cigarettes has an increased potential for higher aldehyde 
exposures compared to a smoker of regular cigarettes.
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Introduction
During the Framework Convention on Tobacco Control (FCTC), parties started to 
develop guidelines for the regulation of contents and emissions of tobacco products 
in order to reduce tobacco-related morbidity and mortality1. As part of this, the 
WHO Study Group on Tobacco Product Regulation (TobReg) advised regulating 
and lowering toxicant yields in cigarette smoke2. Due to the complex composition 
of cigarette smoke and the wide variety of tobacco-related diseases, TobReg 
proposed beginning regulation with a limited set of high-priority toxic emissions. 
To this end, priority lists of smoke toxicants were compiled based on toxicity indices 
in combination with other information of products. This indicates that regulation 
is feasible, for example the considerable differences in emission levels between 
brands under similar smoking conditions2-6. One of the chemical classes identified 
by TobReg, as well as others, as priority due to their impact on human health is 
the volatile aldehydes1,2,4,7,8. In order to study their adverse health effects, modelled 
human exposures to cigarette-derived aldehydes were compared to No Observed 
Adverse Effect Levels (NOAELs) or Lowest Observed Adverse Effect Levels (LOAELs) 
derived from animal experimental data, which was translated to human risks using 
safety factors. Risk assessors concluded that exposure to individual aldehydes 
leads to adverse acute and chronic health effects6,9-11. Burns et al. showed that 
for all brand characteristics and human smoking behaviors2, the chemical class of 
aldehydes present in cigarette smoke may be represented by only three compounds, 
i.e. acetaldehyde, formaldehyde and acrolein. These three were selected because 
of similarities in structures, precursors or mechanisms of formation2. It is suggested 
to express the toxicant yields per mg of nicotine, since smokers titrate the nicotine 
need. 
Since smoking behavior varies between individuals, it is important to study the 
influence of smoking behavior on individual exposure to cigarette mainstream 
smoke (MSS) constituents. Machine smoking with standardized settings for puff 
volume, puff duration and interpuff intervals can be used to create a range of 
mimicked smoking intensities that cover exposure for all human smokers. For this 
purpose, the International Organization for Standardization (ISO) smoking regime 
(puff volume 35mL, puff duration 2s, puff interval 60s) and Health Canada Intense 
(HCI), (puff volume 55mL, puff duration 2s, puff interval 30s) smoking regimes are 
often applied. In addition to the Health Canada Intense smoking regime being more 
intense, another difference with the ISO smoking regime is that the cigarette filters 
are taped to block filter vents. Industry uses cigarette filter ventilation and cigarette 
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paper porosity as a major design feature, resulting in reduced yields of tar, nicotine, 
and carbon monoxide (CO) as measured using the ISO regime12. This is explained by 
the dilution of the emissions produced in the burning tip, with ambient air invading 
via filter vents before the emissions are collected at the mouth end. The influence 
of cigarette filter ventilation is determined by combining the smoking regimes 
and blocking filter vents with tape13,14. It has been shown that machine-smoked 
cigarettes produce significantly lower yields per puff and per cigarette when ISO 
regimes are applied rather than HCI conditions15. On the one hand, filter ventilation 
is responsible for large differences in aldehyde yields under machine smoking 
conditions16, explained by a changed burning process17,18. On the other hand, due 
to the increased puff parameters, additional smoke is produced. The combination 
of filter ventilation and puff parameters is investigated in four smoking conditions.
The industry aims at increasing product elasticity to facilitate the ability of smokers 
to extract desirable levels of nicotine19. A good example is the low-TNCO cigarette 
which smokers unconsciously manipulate in such a way that they extract enough 
nicotine to satisfy their needs20-22. In addition to smoking behavior and filter 
ventilation, other brand characteristics also influence smoke constituent yields, 
such as aldehyde yields. A cigarette brand is unique because of agricultural practices, 
plant characteristics, tobacco blending and cigarette design23. The curing process 
and the type and blend of tobacco, i.e. Virginia/Bright, Oriental, and Burley tobacco, 
are important contributors to the aldehyde yields in cigarette smoke3,16. Natural 
sugars in tobacco leaves are thought to be a significant source of aldehydes11,24. In 
addition, sugar is added by the manufacturer to improve the flavor and taste of the 
smoke25-27. It has already been shown that lowering sugar content is promising for 
reducing aldehydes in smoke11,28. 
The objectives of the present study are:
1. to quantify aldehyde levels in cigarette MSS for four different smoking regimes 
and 11 different brands;
2. to study whether acrolein, acetaldehyde and formaldehyde levels correlate 
well with the other aldehyde levels, and are thus representative of the class of 
volatile aldehydes;
3. to quantify TNCO levels for quality assurance purposes and to be able to 
estimate nicotine exposure;
4. to estimate the influence of the smoking regime, especially filter ventilation, 
and brand characteristics on the aldehyde yields in cigarette smoke;
5. to estimate the aldehyde exposure of a smoker for different brands and smoking 
regimes.
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Experimental procedures
Eleven cigarette brands, available on the Dutch market in 2015, were selected based 
on different TNCO levels, popularity, tobacco blend, and cigarette manufacturer 
(Table 1). According to the website of the tobacco company, the selected cigarettes 
in the main study typically contain the three main tobacco types in different ratios: 
Virginia/Bright, Burley and Oriental. All brands used were bought at a tobacconist 
and have the same batch code on the package. Cigarettes were conditioned and 
marked as described in ISO 3402:1999 and ISO 438729,30. In addition, two reference 
cigarettes 3R4F and 1R5F, with a high and low TNCO level respectively, were 
purchased from the College of Agriculture Reference Cigarette Program, University 
of Kentucky (Lexington, KY 40546, USA).
Study design
Cigarettes were machine-smoked on a 20-port linear smoking machine (Cerulean 
SM450, Milton Keynes, UK), according to the ISO and HCI smoking regimes as 
described by ISO 3308:2012 and WHO TobLabNet SOP 0131,32. The ISO smoking 
regime is based on a 35mL puff volume, 2s puff duration, 60s puff interval and no 
vent blocking. The HCI smoking regime is described as 55mL puff volume, 2s puff 
duration and 30s puff interval. A 100% vent blocking is achieved by taping the vents 
with 19mm width Scotch Magic TM tape (cat no: 810, 3M, USA). Two extra smoking 
regime variations on the conventional methods were included: the ISO method with 
filter vent blocking by taping (ISO-taped) and the HCI method without taping the 
filter vents (HCI-untaped).  
Aldehyde measurements
The 85.2mmol/L 2,4-dinitrophenylhydrazine hydrochloride (DNPH) reagent was 
composed of hydrochloride, phosphoric acid (85%) (Merck) and acetonitrile (>99%) 
(Biosolve). Calibration standards were made for formaldehyde-DNPH (97%) (Sigma-
Aldrich), acetaldehyde-DNPH (Sigma-Aldrich), acrolein-DNPH (Sigma-Aldrich), 
including 0, 0.1, 0.2, 0.5, 1.0 and 2.0µg/mL, and aldehyde/ketone-DNPH mix (ERA-
020, Sigma-Aldrich) including 0, 0.15, 0.45, 0.90 1.80 and 3.0µg/mL.
For the aldehyde measurement, cigarette smoke was trapped on a holder containing 
a Cambridge filter pad (CFP) and a CX 572 20/45 cartridge (cat no: 11072-U, Sigma) 
300mg in a 3mL SPE tube (cat no:57241, Sigma). Extraction was done as described 
in the WHO SOP0833. In short, CFP and carboxen were extracted by 10mL carbon 
disulfide/methanol (20/80) while shaken for 10minutes at 120rpm. 0.5mL was taken 
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to derivate with 0.2 mL DNPH solution for 10minutes followed by dilution with 4.3mL 
ethanol. The aldehydes were quantified by HPLC LC-10Ai (Shimadzu), including 
SIL-20AC autosampler and a SPD-M20A photo diode array detector, quantified at 
wavelength 360nm, and verification of identity wavelength scan was done between 
250 and 450nm. As mobile phase, a gradient of water (A) and acetonitrile (B) was 
used, starting with A55% and B 45%, after 25minutes changed to B 100%, with a 
change back to A 55% and 45% after 31minutes, ending the run at 45minutes. The 
individual aldehydes were measured in five replicates per cigarette brand, using four 
smoking conditions. Aldehydes of interest were acetaldehyde, acrolein, formaldehyde, 
acetone, propionaldehyde, crotonaldehyde, butyraldehyde, benzaldehyde, 
isovaleraldehyde, hexaldehyde and 2,5-dimethylbenzaldehyde, with o-, m- and 
p-tolualdehyde combined. The latter compound has been determined as a single 
compound since the chromatographic method did not separate the three isomers. 
TNCO measurements
TNCO in cigarette smoke was measured under the same conditions as the aldehyde 
measurements. A 44-mm diameter CFP (product no: 9703-9654, Whatman, GE 
Healthcare UK Limited) was used to trap the mainstream cigarette smoke constituents 
and was immediately extracted with isopropanol (>99.8%) (CAS 67-63-0, Merck), 
containing heptadecane (99.6%) (CAS 629-78-7, Sigma-Aldrich) as internal standard 
for nicotine (Art18142, Across). Ethanol (Merck) was used as an internal standard 
for water. Smoke extracts were analyzed by GC flame ionization and thermal 
conductivity detectors, with the use of WCOT Fused Silica coated with CP-WAX 51 
for Amines 25m x 0.25mm ID (part CP7405, Agilent Technologies) and PoraBond Q, 
25m x 0.32m ID, 5µm (part CP7351I5, Agilent Technologies). Tar, nicotine and CO 
concentrations were determined as described in ISO 4387:2000, ISO 10315:2014 
and ISO 8454:2007, with as modification for the tar and nicotine measurements 
one cigarette per CFP and for the CO measurements three cigarettes per smoking 
session, five and three replicates for four smoking conditions respectively34-36.
Filter ventilation
Filter tip ventilation is the percentage of smoke that is diluted by air when a smoker 
takes a puff. The KC-3 apparatus (Borgwaldt-KC, Richmond, Virginia, USA) was used 
to measure the filter tip ventilation at a flow rate of 17.5 mL/s for five cigarettes per 
brand37. 
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Statistical analysis
Aldehyde yields in cigarette smoke were calculated as µg per cigarette, and TNCO as 
mg per cigarette. Mean yields and standard deviations were given for all components 
per cigarette brand and smoking condition. To compare the degree of variation 
between samples, the coefficient of variance was calculated for TNCO. Values 
for smoke components were compared using ANOVA statistics. For comparison 
between brands within each single smoking condition, one-way ANOVA was used. 
For comparison between brands and smoking conditions, two-way ANOVA was 
used, with brands and smoking condition as factors. Differences were considered 
significantly different when p<0.05. Correlations were determined between the 
individual aldehydes as the Pearson correlation coefficient.
Results
Aldehyde levels in cigarette mainstream smoke 
The smoke emissions of several aldehydes from different cigarette brands were 
measured using the machine smoking regimes ISO and HCI, both with and 
without the ventilation holes taped (Figure 1, Table S2). The different brands, the 
manufacturer, the claimed and measured TNCO values, and the tobacco blend are 
listed in Table 1. For both regimes, fewer puffs were taken per cigarette when the 
ventilation holes were taped, but the number of puffs per cigarette increased when 
ISO is compared to HCI. 
Significantly different yields of individual aldehyde emissions were produced for 
both different cigarette brand characteristics and different smoking conditions 
(p<1E-09 in all cases) (Table S3). Within one of the four smoking conditions, taking 
the cigarette brands as the only variable into account, the individual aldehydes show 
significant differences in yield when compared to each other (p<0.02). 
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Tar (mg/cigarette) Nicotine (mg/cigarette) Carbon monoxide (mg/cigarette) Venti-
lation
Puff number






































































Camel filter JT International Mainly Virginia and 





Dark tobaccos from 
Syria/Turkey (strong 
distinctive aroma)
10 12.02 14.71 25.28 28.94 0.8 0.89 0.87 2.03 1.89 10 9.71 13.74 20.89 25.32 22.90 6.52 5.7 8.7 7.78
Dunhill red British American 
Tobacco
Mainly Virginia 10 10.64 12.52 22.21 28.62 0.9 0.8 0.79 1.84 1.79 10 9.99 13.78 20.99 24.75 18.88 6.18 5.82 8.12 7.52
Lucky Strike red British American 
Tobacco
Virginia, Burley, 






Oriental tobacco 10 10.69 14.01 24.21 39.3 0.8 0.83 0.83 1.85 1.86 10 9.59 15.31 20.71 23.72 26.54 6.74 6.14 9.16 8.68
Kent surround British American 
Tobacco
Virginia, Burley, 
Oriental tobacco 4 5.8 10.28 12.36 22.84 0.4 0.54 0.71 1.27 1.51 5 6.7 12.41 17.59 24.19 77.38 6.68 5.66 10.46 8.16
L&M red Philip Morris Virginia, Burley, 
Oriental tobacco 10 8.36 16.22 23.05 34.01 0.8 0.78 0.94 1.88 2.02 10 9.17 13.84 21.85 28.07 37.80 8.28 7.32 11.14 9.14
Marlboro Red Philip Morris Virginia, Burley, 
Oriental tobacco 10 10.37 15.4 25.01 34.03 0.8 0.8 0.9 1.93 1.97 10 8.51 15.12 20.7 26.27 42.72 7.92 6.94 10.92 8.9
Marlboro 
Menthol
Philip Morris Virginia, Burley, 
Oriental tobacco 10 10.94 17.36 24.53 33.83 0.8 0.8 0.84 1.65 1.72 10 9.85 17.68 21.28 29.4 32.66 8.08 7.18 10.32 8.7
Marlboro gold Philip Morris Virginia, Burley, 
Oriental tobacco 8 8.63 12.69 19.37 20.32 0.6 0.67 0.77 1.64 1.67 9 8.25 13.97 19.41 25.45 33.50 6.76 6.24 9.32 8.2
Philip Morris 
One
Philip Morris Virginia, Burley, 
















Maryland, Oriental 1.67 2.56 8.34 6.98 21.11 0.16 0.27 0.45 0.72 1.01 2.95 3.6 17.27 17.45 36.97 70.00 7 4.92 10.1 6.7
CV < 0.012 0.006 0.004 0.005 0.007 0.001 0.001 0.001 0.002 0.003 0.001 0.001 0.001 0.003 0.001 0.001
$=failed measurement
Table 1: Dutch cigarette brands and reference cigarettes with manufacturer, TNCO values and 
tobacco blend. Tobacco blends as mentioned on the websites of the tobacco company. Dutch 
market cigarette brands and reference cigarettes 1R5F and 3R4F, with claimed yields of TNCO 
on the package (measured with ISO), and the mean measured TNCO and puff number when 
machine-smoked following the ISO or HCI regime, both with and without taped filter. The 
tip ventilation is shown as a percentage. Tar and nicotine content were from five replicates, 
while for CO three replicates of three cigarettes are shown (mg/cigarette). The coefficient 
of variance (CV) for all brands is smaller than the mentioned percentage within the smoking 
condition.
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Tar (mg/cigarette) Nicotine (mg/cigarette) Carbon monoxide (mg/cigarette) Venti-
lation
Puff number






































































Camel filter JT International Mainly Virginia and 





Dark tobaccos from 
Syria/Turkey (strong 
distinctive aroma)
10 12.02 14.71 25.28 28.94 0.8 0.89 0.87 2.03 1.89 10 9.71 13.74 20.89 25.32 22.90 6.52 5.7 8.7 7.78
Dunhill red British American 
Tobacco
Mainly Virginia 10 10.64 12.52 22.21 28.62 0.9 0.8 0.79 1.84 1.79 10 9.99 13.78 20.99 24.75 18.88 6.18 5.82 8.12 7.52
Lucky Strike red British American 
Tobacco
Virginia, Burley, 






Oriental tobacco 10 10.69 14.01 24.21 39.3 0.8 0.83 0.83 1.85 1.86 10 9.59 15.31 20.71 23.72 26.54 6.74 6.14 9.16 8.68
Kent surround British American 
Tobacco
Virginia, Burley, 
Oriental tobacco 4 5.8 10.28 12.36 22.84 0.4 0.54 0.71 1.27 1.51 5 6.7 12.41 17.59 24.19 77.38 6.68 5.66 10.46 8.16
L&M red Philip Morris Virginia, Burley, 
Oriental tobacco 10 8.36 16.22 23.05 34.01 0.8 0.78 0.94 1.88 2.02 10 9.17 13.84 21.85 28.07 37.80 8.28 7.32 11.14 9.14
Marlboro Red Philip Morris Virginia, Burley, 
Oriental tobacco 10 10.37 15.4 25.01 34.03 0.8 0.8 0.9 1.93 1.97 10 8.51 15.12 20.7 26.27 42.72 7.92 6.94 10.92 8.9
Marlboro 
Menthol
Philip Morris Virginia, Burley, 
Oriental tobacco 10 10.94 17.36 24.53 33.83 0.8 0.8 0.84 1.65 1.72 10 9.85 17.68 21.28 29.4 32.66 8.08 7.18 10.32 8.7
Marlboro gold Philip Morris Virginia, Burley, 
Oriental tobacco 8 8.63 12.69 19.37 20.32 0.6 0.67 0.77 1.64 1.67 9 8.25 13.97 19.41 25.45 33.50 6.76 6.24 9.32 8.2
Philip Morris 
One
Philip Morris Virginia, Burley, 
















Maryland, Oriental 1.67 2.56 8.34 6.98 21.11 0.16 0.27 0.45 0.72 1.01 2.95 3.6 17.27 17.45 36.97 70.00 7 4.92 10.1 6.7
CV < 0.012 0.006 0.004 0.005 0.007 0.001 0.001 0.001 0.002 0.003 0.001 0.001 0.001 0.003 0.001 0.001
$=failed measurement
Table 1: Dutch cigarette brands and reference cigarettes with manufacturer, TNCO values and 
tobacco blend. Tobacco blends as mentioned on the websites of the tobacco company. Dutch 
market cigarette brands and reference cigarettes 1R5F and 3R4F, with claimed yields of TNCO 
on the package (measured with ISO), and the mean measured TNCO and puff number when 
machine-smoked following the ISO or HCI regime, both with and without taped filter. The 
tip ventilation is shown as a percentage. Tar and nicotine content were from five replicates, 
while for CO three replicates of three cigarettes are shown (mg/cigarette). The coefficient 
of variance (CV) for all brands is smaller than the mentioned percentage within the smoking 
condition.
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Figure 1: The radar chart shows cigarette smoke emissions of formaldehyde, acrolein, 
acetaldehyde and crotonaldehyde (mean µg/cigarette) of 13 different cigarette brands when 
machine-smoked according to the four different smoking conditions (n=5).
Aldehyde yields significantly increased when the smoking regime was intensified 
(increasing puff volume and puff interval) (Table S3). Nearly all cigarette smoke 
emissions of aldehydes showed the same pattern, as illustrated in Figure 1: ISO< 
ISO-taped < HCI-untaped < HCI. Apart from the highly ventilated cigarettes 
Philip Morris One and 1R5F, this pattern is not observed for formaldehyde. While 
differences between ISO on the one hand and ISO-taped, HCI-untaped, and HCI on 
the other are clearly noticeable, differences between ISO-taped, HCI-untaped and 
HCI are not so clear. To a lesser extent, this is also the case for acetaldehyde, where 
differences between HCI-untaped, and HCI are absent for most brands. 
The other individual aldehydes show comparable increases in yield due to intensifying 
the smoking regime or taping the filter vents (Table S2). There were exceptions for 
acetone when ISO-taped, and for hexaldehyde and o-, m-, p-tolualdehyde for HCI.
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In summary, the individual aldehyde yields increase as a result of the smoking regime 
and the filter vents being taped.
Figure 2: Correlation plots show the comparison of acetaldehyde vs. formaldehyde (top left), 
acrolein vs. formaldehyde (top right), acrolein vs. acetaldehyde (bottom left), crotonaldehyde 
vs. formaldehyde (bottom right) (mean µg/cig). The replicates (n=5) of the 13 cigarette brands 
are represented by dots in four different colors representing the four different smoking 
conditions. ISO regime is orange, ISO-taped is red, HCI-untaped is green and HCI is blue.
Correlation between aldehyde levels
Additionally, the relation between the different aldehydes that are present in the 
cigarette smoke was investigated (Table 2, Figure 2). It was found that the different 
aldehydes produced in different cigarette brands correlate well within a particular 
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smoking regime (Figure 2, Table S3). More specifically, acetaldehyde and acrolein 
show a strong correlation (r=0.804) with each other and with the other aldehydes. 
The weakest correlation is seen for formaldehyde, with acetaldehyde (p=0.614) and 
acrolein (p=0.57), and even lower with the other aldehydes (Figure 2, Table S4).
Table 2: Correlation coefficients of individual aldehyde emissions produced by 13 cigarette 
























































































Formaldehyde - 0.614 0.576 0.438 0.530 0.553 0.566 0.506 0.507 0.594 0.579 0.591
Acetaldehyde 0.614 - 0.804 0.775 0.868 0.831 0.909 0.818 0.874 0.786 0.698 0.849 0.0
Acrolein 0.576 0.804 - 0.807 0.921 0.896 0.886 0.734 0.850 0.744 0.564 0.768 0.1
Acetone 0.438 0.775 0.807 - 0.863 0.832 0.851 0.740 0.847 0.669 0.500 0.780 0.2
Propanal 0.530 0.868 0.921 0.863 - 0.965 0.977 0.902 0.968 0.840 0.678 0.880 0.3
Crotonalde-
hyde 0.553 0.831 0.896 0.832 0.965 - 0.958 0.903 0.964 0.803 0.666 0.908 0.4
Butyraldehyde 0.566 0.909 0.886 0.851 0.977 0.958 - 0.927 0.977 0.857 0.751 0.923 0.5
Benzaldehyde 0.506 0.818 0.734 0.740 0.902 0.903 0.927 - 0.935 0.816 0.770 0.911 0.6
Isovaleralde-
hyde 0.507 0.874 0.850 0.847 0.968 0.964 0.977 0.935 - 0.842 0.704 0.923 0.7
o-m-p-tolual-
dehyde 0.594 0.786 0.744 0.669 0.840 0.803 0.857 0.816 0.842 - 0.875 0.798 0.8




0.591 0.849 0.768 0.780 0.880 0.908 0.923 0.911 0.923 0.798 0.741 - 1.0
TNCO levels in cigarette mainstream smoke
The same experimental set-up was used to measure TNCO yields in the smoke of the 
different brands (Table 1, Table S1). The yields of TNCO measured with ISO differed 
with a maximum of 20% from the claimed TNCO levels printed on the cigarette 
package. In addition to the standard ISO regime, taping the cigarette filter resulted 
in an increase in TNCO yields (ISO-taped). The yields of tar increased between 
18 - 939%, nicotine yields between 0 - 148%, and CO between 32 - 731% (ISO 
vs. ISO-taped). When smoked with a higher puff volume and more frequent puffs 
using HCI-untaped , the TNCO yields at least doubled, compared to ISO. Using HCI 
resulted in higher tar and CO yields, respectively; varying between 5 - 413% and 9 - 
264%, compared to the HCI-untaped emissions. For nicotine, no clear increase was 
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detected, with some brands even showing a decrease in nicotine values when HCI 
was used (HCI-untaped vs. HCI). 
Influence of smoking protocol and brand characteristics, especially filter 
ventilation.
The filter tip ventilation differs between the brands in the range of 18.9 to 77.4%. 
Taping the filter vents, thereby eliminating the tip filter ventilation to 0%, as well as 
increasing puff volume and having a smaller puff interval, both lead to an increase in 
aldehyde yields in cigarette smoke. More specifically, for most aldehydes, the impact 
of an intense smoking regime is at least two times larger compared to taping filter 
vents, except in the low-TNCO cigarettes, as shown in Figure 1. The low-TNCO 
brands Kent, Marlboro Gold, Philip Morris One and 1R5F have filter tip ventilation 
in the range of 33.5 to 77.4%. It is only for these highly ventilated low-TNCO 
cigarettes that closing ventilation holes for the ISO regime (ISO-taped) leads to a 
more increased aldehyde yield than using an intense smoking regime (HCI). For the 
most intense smoking condition (HCI with taped ventilation holes), the aldehyde 
yields even reached the levels of the other brands. This was observed in the cases 
of acrolein, acetaldehyde, acetone, crotonaldehyde, propionaldehyde, benzaldehyde 
and 2,5-methylbenzaldehyde (Figure 1, Appendix B).
Toxicants per nicotine ratio per brand
The difference in aldehyde yields per mg of nicotine per cigarette for the different 
cigarette brands under different smoking conditions is shown in Figure 3. The acrolein 
and acetaldehyde per nicotine ratio is larger in low-TNCO cigarettes. This trend 
observed for acetaldehyde, acrolein, formaldehyde, crotonaldehyde, butyraldehyde 
and acetone (Figure 3) is also seen for the other aldehydes (not shown in Figure 
3; propanal, butanal, isovaleraldehyde, o-, m-, p-tolualdehyde, hexanal and 2,5 
dimethylbenzaldehyde)). When smoking intensely (HCI), regular cigarettes (0.5-1.0 
mg/cig according to the standard ISO regime), have comparable yields of aldehyde 
per mg of nicotine produced. In this case, taping has no increasing effect on the 
aldehyde production per mg of nicotine. The highest yields of aldehydes produced 
per mg of nicotine in smoke were measured in taped cigarettes when smoked with 
the ISO regime (ISO-taped). The largest difference is seen in low-TNCO cigarettes 
(ISO nicotine around 0.2mg/cig). In these low-TNCO cigarettes, up to six times more 
aldehyde production per mg nicotine is measured when comparing the least intense 
(ISO regime) with the most intense regime (HCI). 
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Figure 3: Toxicant-to-nicotine ratio. Acetaldehyde, acrolein, formaldehyde, crotonaldehyde, 
butyraldehyde and acetone yields divided by nicotine (mg/cig) measured using the four 
smoking conditions. On the X-axis, the nicotine (mg/cig) yields measured using the ISO 
method is shown to differentiate between the brands.
Discussion
Aldehydes are an important class of toxicants in smoke4,38, as has been recognized 
by WHO TobReg in their advice for mandating lower levels2. While aldehyde levels 
in MSS have been studied before in several brands11,16,39,40, this is the first study 
that systematically studies the influence of the smoking protocol on these levels. By 
using four different smoking protocols, ISO (standard without taping filter ventilation 
holes), ISO-taped, HCI-untaped, and HCI (standard with taping filter ventilation 
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holes), and 11 brands, the effect of puff topography and filter ventilation can be 
compared. Furthermore, it was tested whether aldehyde levels correlate well with 
each other in order to test the hypothesis of Burns et al. that one or two components 
in a class can serve as indicator components. Finally, based on the findings, it was 
estimated whether brand differences impact a smoker’s exposure to aldehydes. 
Aldehyde levels in cigarette mainstream smoke 
The method developed by the WHO TobLabNet, which is based on the work of 
Uchiyama et al41, was used to measure aldehydes in 11 Dutch brands and two 
reference cigarettes in mainstream smoke generated using four different smoking 
protocols. Using the TobLabNet method, it was possible to measure aldehyde yields 
(CV< 35.7%) comparable with previous studies of Counts et al., Uchiyama et al., 
Bodnar et al., Cheah et al., Reilly et al. and the CORESTA report 70+7411,16,39-41. 
Despite the difference in smoking regime and cigarette brands, nearly all aldehyde 
yields showed comparable patterns regarding their relative ratios. Individual 
aldehyde levels were highly correlated with each other except for formaldehyde40. 
More specifically, the cigarette smoke yields of acrolein and acetaldehyde strongly 
correlated with a larger set of different aldehyde yields42. This supports the proposal 
of Burns et al. to use a few aldehydes to represent the full class of aldehydes under 
different smoking conditions2.
A notable exception to this pattern is formaldehyde. Because formaldehyde is 
classified as class 1 carcinogen by the IARC43, there is no doubt about the wish to 
regulate this compound. However, the method used is not the most suitable one to 
measure formaldehyde. There are several differences between formaldehyde and 
the other aldehydes. Uchiyama et al. indicated that formaldehyde shows a wide 
analytical variation and problems with trapping41. Our results also showed wide 
standard deviations, especially when the ISO regime was used. A more sophisticated 
method is therefore needed to measure formaldehyde. In particular, formaldehyde 
shows a different emission pattern under different smoking conditions and for 
different brands than the other 12 aldehydes. In addition, formaldehyde showed the 
poorest association with the other aldehydes40 and therefore seems less suitable as 
representative of the aldehyde class. 
Influence of smoking protocol
To test the effect of the smoking regime on the aldehyde yields, in combination with 
the cigarette design feature filter ventilation, both ISO and HCI regimes are used 
with and without taped filter ventilation holes. 
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The puff parameters of ISO and HCI differ in puff volume and interpuff interval, 
leading to additional smoke produced for HCI. In the present study, these two 
conditions were tested with and without accounting for the influence of filter 
ventilation. Thus, ISOcan be compared with HCI-untaped, and ISO-taped can be 
compared with HCI, allowing the effect of filter ventilation to be studied separately 
from the smoking topography. For both situations, the higher puff volume in 
combination with a shorter puff interval in HCI leads to a higher total puff volume 
and more puffs taken, when compared with ISO. Aldehyde yields in all cigarette 
brands increased when smoked according to HCI. Reilly et al. investigated the effect 
of puff parameters on the aldehyde yields in cigarette smoke and concluded that 
increased puff volume is the primary factor leading to higher aldehyde yields for the 
total volume per cigarette40. As they found a similar influence of interpuff interval, 
puff flow, puff shape and puff duration, they suggest that temperature changes play 
a minor role. 
Influence of filter ventilation
In all cigarette brands, the highest yields of aldehydes in the cigarette smoke are 
measured when the filter ventilation holes of the cigarettes are taped during machine 
smoking. In addition to preventing dilution by sidestream air via filter vents, closing 
filter vents causes an increased burn rate of the cigarette, leading to more of the 
tobacco rod being consumed with every puff, thereby reducing the total burn time 
of the cigarette, as well as the number of puffs needed to completely smoke the 
cigarette15. Aldehyde yields are increased during harsh burning conditions, gained 
by increasing puff volume or blocking ventilation. This explains why the effect of 
blocking ventilation holes is more pronounced for the ISO regime than the HCI 
regime. For the HCI regime, the harsh burning conditions due to intense smoking 
already lead to an increase in aldehyde yields. The addition of blocking ventilation 
for the HCI regime leads to a less distinct increase in aldehyde yields, compared 
with the ISO regime. This also explains why the impact of ventilation blocking on 
aldehyde yields was largest for those cigarettes with highest initial ventilation (1R5F, 
Phillip Morris One), as was also found by Counts et al16. 
Aldehyde-to-nicotine ratio per brand
Brands show different aldehyde yields for the different smoking regimes when 
calculated as ratio to nicotine. In regular cigarettes, taping filter vents in ISO 
conditions (ISO-taped) lead to the highest aldehyde-to-nicotine ratio. The increase 
in aldehyde-to-nicotine ratio is less distinct for the HCI regime when taping regular 
cigarettes. Thus intensifying the smoking protocol by taking a puff more often and 
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with a larger volume influences the aldehyde-to-nicotine ratio more than taping the 
filter vents. For the low-TNCO brands, the differences are even more prominent; 
these brands have a six times higher aldehyde production per mg nicotine for the 
intense smoking regimes, when compared to ISO. That the aldehyde-to-nicotine 
ratio increased when low-TNCO cigarettes are smoked more intensely, similar to real 
smokers, implies that a smoker of low-TNCO cigarettes has an increased potential 
for higher aldehyde exposures as compared to a smoker of regular cigarettes.
Brand differences; filter ventilation
Intensifying the smoking regime in combination with blocked filter ventilation 
substantially influences the aldehyde and TNCO yields in smoke. The filter tip 
ventilation is a design feature differing between brands. The filter tip ventilation for 
the 11 Dutch brands varied between 18 and 77%. There is a trend that increasing 
filter ventilation leads to lower aldehyde yields, which is also found in literature44. 
Especially filter tip ventilation higher than 60% significantly lowers the yields of 
nicotine, tar and the aldehydes, seen for the low-TNCO cigarettes12. 
Aldehyde exposure estimation and risk assessment
Based on the aldehyde-to-nicotine ratios, and a smoker’s nicotine need, an 
estimation of aldehyde exposure when smoking according to different regimes 
can be made. Afternoon blood or plasma nicotine levels in smokers range from 10 
to 50ng/mL45.  To maintain this level, a smoker needs 1 mg of nicotine every two 
hours (taking a half-life of 1.5hours into account), and thus a total amount of 12mg 
per day46. For example, based on the ISO regime, a Marlboro Red (0.8mg nic/cig) 
smoker would need 15 cigarettes per day, compared to six cigarettes when smoking 
according to HCI (2mg nic/cig). This means a daily exposure to acetaldehyde of 
respectively 5.4mg/day (ISO 359.1 µg/cig) or 5.6mg/day (HCI933.4µg/cig). For the 
Philip Morris One, this means the smoker might need to smoke 60 cigarettes based 
on ISO (0.2mg nic/cig) and ten cigarettes for HCI(1.2mg nic/cig). The daily exposure 
to acetaldehyde is then 2.2mg/day (ISO 36.7 µg/cig) and 10.6mg/day (HCI1055.6 
µg/cig), a much larger difference between the two regimes than calculated for the 
Marlboro Red.
Recent risk assessment studies show large adverse effects of aldehydes on human 
health. These methods combine machine-generated yields with known chemical 
and toxicological properties. Risk assessment studies using inhalatory exposure 
risk factors were performed for the individual aldehydes4,6,9. These computer 
models show a different order of chemical hazard ranking: acrolein > formaldehyde 
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> acetaldehyde9 compared to acrolein > acetaldehyde > formaldehyde6. The ideal 
risk assessment methods in the case of cigarette smoke exposure use a mixture 
of aldehydes or assess a cumulative risk. The non-existence of well-functioning 
mixture toxicity models is partly due to lack of inhalatory exposure assessments. 
The accurate smoke analysis data of the present study can advance inhalatory 
exposure assessments and the precision of mixture toxicity models. Especially 
the changing levels in aldehydes due to choosing a different smoking regime may 
improve the accuracy of the models as designed e.g. by Corley et al. and other future 
comprehensive and specific risk assessments9. 
Regulatory implications
The ISO smoking regime is prescribed in the European Union Directive 2014/40/
EU and used by manufacturers to declare TNCO yields47. However, the standard 
ISO regime produced substantially lower aldehyde yields than the HCI regime, thus 
resulting in an underestimation of smokers exposure. Specifically, when regular and 
low-ISO-TNCO-level cigarettes were smoked with the HCI regime or when filter 
ventilation holes were blocked (ISO-taped), overall aldehyde levels increased, as 
compared to the ISO regime. Since real smokers smoke more intensely than the 
ISO regime, the increased aldehyde levels when smoking more intensely or blocking 
filter vents can lead to higher aldehyde exposure. Thus, the present study results 
underline the need for a smoking regime that is more representative of actual human 
smoking behavior, like HCI, as also proposed in literature. 
It has been proposed in the literature that toxicant levels should be regulated relative 
to mg of nicotine in mainstream smoke2. The rationale for using exposures per mg of 
nicotine is that smokers need a certain amount of nicotine to sustain their addiction, 
and therefore adapt their smoking behavior in response to the cigarette design. 
The validity of this approach is demonstrated again by the present study results: 
for instance, the aldehyde levels that increased at least 50% more than the nicotine 
levels when a low-ISO-TNCO cigarette is smoked with the HCI regime, compared to a 
regular cigarette. Presuming that smokers smoke more intensely than the ISO regime, 
highly filter-ventilated cigarettes, often marketed as less harmful with a potentially 
reduced exposure claim, actually lead to a higher exposure to toxic aldehydes. An 
alternative to regulation with respect to mg of nicotine is to regulate cigarette 
design characteristics. For instance, regulating cigarette design characteristics is a 
straightforward measure to prevent the high aldehyde-to-nicotine ratios that occur 
in cigarette smoke of low-ISO-TNCO cigarettes. A more specific regulatory approach 
involves setting maximum allowed aldehyde levels in cigarette smoke or a maximum 
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exposure concentration range based on scientific arguments which are in line with 
previous proposals2,48As stated previously, the ISO regime underestimates the 
smokers’ exposure to cigarette smoke toxicants, including  aldehydes. The HCI regime 
is a better representative of human smoking and the associated aldehyde yields in 
the cigarette smoke of an actual smoker. To adapt smoking machine protocols so 
that they better represent typical exposure levels, human studies measuring natural 
smoking behavior are needed. Smokers have varying puff volumes and durations, 
and because each puff has its own characteristic chemical composition this can 
lead to a complex smoke composition17. The measured human smoking profile can 
be mimicked on the smoking machine to determine the exact associated aldehyde 
exposure49. Specifically, a relevant set of aldehyde biomarkers can be measured in 
human fluids to link inhalatory exposure to internal dose. In the future, such data will 
show whether the reductions in machine-measured yields of specific constituents 
result in a reduction of exposure in smokers.
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Supplemental information
Table S1: The table shows the mean TNCO values for the Dutch market cigarette brands and 
reference cigarettes (1R5F and 3R4F) when machine smoked following the ISO or HCI regime 
(both with and without taped filter ventilation holes). Tar and nicotine content were from 5 
replicates, while for CO 3 replicates of 3 cigarettes are shown (mg/cigarette (SD)).
Brands Dutch market Nicotine (mg/cigarette (SD)) Tar (mg/cigarette (SD))
ISO ISO-taped HCI-untaped HCI ISO ISO-taped HCI-untaped HCI
Marlboro red 0.8 (0.1) 0.9 (0.0) 1.9 (0.1) 2.0 (0.2) 10.4 (1.8) 15.4 (1.6) 25.0 (1.8) 34.0 (4.6)
L&M red 0.8 (0.0) 0.9 (0.1) 1.9 (0.2) 2.0 (0.1) 8.4 (1.2) 16.2 (4.3) 23.1 (2.3) 34.0 (3.3)
Lucky Strike red 0.9 (0.0) 1.1 (0.1) 2.0 (0.1) 2.1 (0.1) 11.2 (1.3) 18.9 (6.5) 24.6 (2.2) 36.5 (4.6)
Kent surround 0.5 (0.1) 0.7 (0.1) 1.3 (0.1) 1.5 (0.1) 5.8 (1.9) 10.3 (1.9) 12.4 (3.2) 22.8 (2.5)
Philip Morris One 0.2 (0.0) 0.5 (0.0) 0.6 (0.1) 1.2 (0.1) 0.9 (1.1) 9.4 (3.4) 3.4 (1.3) 17.2 (1.6)
Marlboro gold 0.7 (0.0) 0.8 (0.0) 1.6 (0.1) 1.7 (0.1) 8.6 (0.9) 12.7 (2.4) 19.4 (1.7) 20.3 (9.8)
Dunhill red 0.8 (0.1) 0.8 (0.1) 1.8 (0.2) 1.8 (0.2) 10.6 (0.7) 12.5 (2.9) 22.2 (0.5) 28.6 (3.4)
Camel filter 1.0 (0.1) 1.1 (0.1) 2.1 (0.1) 2.0 (0.1) 12.2 (1.6) 17.0 (3.1) 24.1 (2.3) 29.7 (3.9)
Gauloises blondes blue 0.9 (0.1) 0.9 (0.1) 2.0 (0.2) 1.9 (0.1) 12.0 (0.8) 14.7 (2) 25.3 (1.2) 28.9 (1.6)
Lucky Strike additive free 0.8 (0.1) 0.8 (0.1) 1.9 (0.1) 1.9 (0.1) 10.7 (1.7) 14.0 (3.5) 24.2 (1.4) 39.3 (17.8)
Marlboro menthol 0.8 (0.1) 0.8 (0.1) 1.7 (0.1) 1.7 (0.1) 10.9 (3.3) 17.4 (4.3) 24.5 (1.7) 33.8 (3.3)
1R5F 0.3 (0.2) 0.5 (0.0) 0.7 (0.1) 1.0 (0.1) 2.6 (1.1) 8.3 (4.7) 7.0 (1.3) 21.1 (2.8)
3R4F 0.7 (0.0) 0.9 (0.1) 1.8 (0.2) 1.9 (0.1) 7.8 (1.6) 13.4 (2.9) 21.5 (1.7) 30.8 (4.7)
Carbon monoxide (mg/cigarette (SD)) Puffs per cigarette (SD)
ISO ISO-taped HCI-untaped HCI ISO ISO-taped HCI-untaped HCI
Marlboro red 8.5 (0.2) 15.1 (0.2) 20.7 (0.4) 26.3 (2.5) 7.9 (0.2) 6.9 (0.4) 10.9 (0.6) 8.9 (0.5)
L&M red 9.2 (0.7) 13.8 (1.1) 21.9 (0.8) 28.1 (1.7) 8.3 (0.3) 7.3 (0.6) 11.1 (0.6) 9.1 (0.6)
Lucky Strike red 10.1 (0.4) 13.3 (1.1) 22.0 (0.5) 28.9 (0.1) 8.7 (0.6) 8.2 (1.1) 12.2 (0.4) 10.5 (0.6)
Kent surround 6.7 (1.2) 12.4 (1.5) 17.6 (0.5) 24.2 (2.2) 6.7 (0.4) 5.7 (0.4) 10.5 (1.0) 8.2 (0.5)
Philip Morris One 1.6 (0.1) 13.3 (0.3) 7.4 (0.3) 27.0 (1.3) 7.8 (0.8) 6.0 (0.1) 11.7 (0.5) 7.4 (0.5)
Marlboro gold 8.3 (0.4) 14.0 (1.7) 19.4 (0.1) 25.5 (1.9) 6.8 (0.3) 6.2 (0.4) 9.3 (0.4) 8.2 (0.5)
Dunhill red 10.0 (0.3) 13.8 (2.1) 21.0 (0.1) 24.8 (1.1) 6.2 (0.3) 5.8 (0.5) 8.1 (0.2) 7.5 (0.8)
Camel filter 10.0 (0.8) 13.3 (3.2) 23.8 (0.8) 27.5 (1.9) 7.8 (0.4) 6.9 (0.4) 10.1 (0.3) 8.8 (0.7)
Gauloises blondes blue 9.7 (1.1) 13.7 (1.6) 20.9 (0.7) 25.3 (0.9) 6.5 (0.4) 5.7 (0.7) 8.7 (0.7) 7.8 (0.4)
Lucky Strike additive free 9.6 (0.4) 15.3 (4.9) 20.7 (2.2) 23.7 (0.8) 6.7 (0.4) 6.1 (0.5) 9.2 (0.2) 8.7 (0.5)
Marlboro menthol 9.9 (0.2) 17.7 (2.3) 21.3 (1.7) 29.4 (1.4) 8.1 (0.3) 7.2 (0.8) 10.3 (0.3) 8.7 (0.6)
1R5F 3.6 (0.0) 17.3 (3.8) 17.5 (0.9) 37.0 (0.5) 7.0 (0.0) 4.9 (1.3) 10.1 (0.3) 6.7 (0.4)
3R4F 10.6 (0.1) 15.8 (1.2) 25.4 (2.3) 27.7 (0.7) 8.4 (0.3) 7.5 (0.4) 11.9 (0.2) 10.3 (1.0)
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Supplemental information
Table S1: The table shows the mean TNCO values for the Dutch market cigarette brands and 
reference cigarettes (1R5F and 3R4F) when machine smoked following the ISO or HCI regime 
(both with and without taped filter ventilation holes). Tar and nicotine content were from 5 
replicates, while for CO 3 replicates of 3 cigarettes are shown (mg/cigarette (SD)).
Brands Dutch market Nicotine (mg/cigarette (SD)) Tar (mg/cigarette (SD))
ISO ISO-taped HCI-untaped HCI ISO ISO-taped HCI-untaped HCI
Marlboro red 0.8 (0.1) 0.9 (0.0) 1.9 (0.1) 2.0 (0.2) 10.4 (1.8) 15.4 (1.6) 25.0 (1.8) 34.0 (4.6)
L&M red 0.8 (0.0) 0.9 (0.1) 1.9 (0.2) 2.0 (0.1) 8.4 (1.2) 16.2 (4.3) 23.1 (2.3) 34.0 (3.3)
Lucky Strike red 0.9 (0.0) 1.1 (0.1) 2.0 (0.1) 2.1 (0.1) 11.2 (1.3) 18.9 (6.5) 24.6 (2.2) 36.5 (4.6)
Kent surround 0.5 (0.1) 0.7 (0.1) 1.3 (0.1) 1.5 (0.1) 5.8 (1.9) 10.3 (1.9) 12.4 (3.2) 22.8 (2.5)
Philip Morris One 0.2 (0.0) 0.5 (0.0) 0.6 (0.1) 1.2 (0.1) 0.9 (1.1) 9.4 (3.4) 3.4 (1.3) 17.2 (1.6)
Marlboro gold 0.7 (0.0) 0.8 (0.0) 1.6 (0.1) 1.7 (0.1) 8.6 (0.9) 12.7 (2.4) 19.4 (1.7) 20.3 (9.8)
Dunhill red 0.8 (0.1) 0.8 (0.1) 1.8 (0.2) 1.8 (0.2) 10.6 (0.7) 12.5 (2.9) 22.2 (0.5) 28.6 (3.4)
Camel filter 1.0 (0.1) 1.1 (0.1) 2.1 (0.1) 2.0 (0.1) 12.2 (1.6) 17.0 (3.1) 24.1 (2.3) 29.7 (3.9)
Gauloises blondes blue 0.9 (0.1) 0.9 (0.1) 2.0 (0.2) 1.9 (0.1) 12.0 (0.8) 14.7 (2) 25.3 (1.2) 28.9 (1.6)
Lucky Strike additive free 0.8 (0.1) 0.8 (0.1) 1.9 (0.1) 1.9 (0.1) 10.7 (1.7) 14.0 (3.5) 24.2 (1.4) 39.3 (17.8)
Marlboro menthol 0.8 (0.1) 0.8 (0.1) 1.7 (0.1) 1.7 (0.1) 10.9 (3.3) 17.4 (4.3) 24.5 (1.7) 33.8 (3.3)
1R5F 0.3 (0.2) 0.5 (0.0) 0.7 (0.1) 1.0 (0.1) 2.6 (1.1) 8.3 (4.7) 7.0 (1.3) 21.1 (2.8)
3R4F 0.7 (0.0) 0.9 (0.1) 1.8 (0.2) 1.9 (0.1) 7.8 (1.6) 13.4 (2.9) 21.5 (1.7) 30.8 (4.7)
Carbon monoxide (mg/cigarette (SD)) Puffs per cigarette (SD)
ISO ISO-taped HCI-untaped HCI ISO ISO-taped HCI-untaped HCI
Marlboro red 8.5 (0.2) 15.1 (0.2) 20.7 (0.4) 26.3 (2.5) 7.9 (0.2) 6.9 (0.4) 10.9 (0.6) 8.9 (0.5)
L&M red 9.2 (0.7) 13.8 (1.1) 21.9 (0.8) 28.1 (1.7) 8.3 (0.3) 7.3 (0.6) 11.1 (0.6) 9.1 (0.6)
Lucky Strike red 10.1 (0.4) 13.3 (1.1) 22.0 (0.5) 28.9 (0.1) 8.7 (0.6) 8.2 (1.1) 12.2 (0.4) 10.5 (0.6)
Kent surround 6.7 (1.2) 12.4 (1.5) 17.6 (0.5) 24.2 (2.2) 6.7 (0.4) 5.7 (0.4) 10.5 (1.0) 8.2 (0.5)
Philip Morris One 1.6 (0.1) 13.3 (0.3) 7.4 (0.3) 27.0 (1.3) 7.8 (0.8) 6.0 (0.1) 11.7 (0.5) 7.4 (0.5)
Marlboro gold 8.3 (0.4) 14.0 (1.7) 19.4 (0.1) 25.5 (1.9) 6.8 (0.3) 6.2 (0.4) 9.3 (0.4) 8.2 (0.5)
Dunhill red 10.0 (0.3) 13.8 (2.1) 21.0 (0.1) 24.8 (1.1) 6.2 (0.3) 5.8 (0.5) 8.1 (0.2) 7.5 (0.8)
Camel filter 10.0 (0.8) 13.3 (3.2) 23.8 (0.8) 27.5 (1.9) 7.8 (0.4) 6.9 (0.4) 10.1 (0.3) 8.8 (0.7)
Gauloises blondes blue 9.7 (1.1) 13.7 (1.6) 20.9 (0.7) 25.3 (0.9) 6.5 (0.4) 5.7 (0.7) 8.7 (0.7) 7.8 (0.4)
Lucky Strike additive free 9.6 (0.4) 15.3 (4.9) 20.7 (2.2) 23.7 (0.8) 6.7 (0.4) 6.1 (0.5) 9.2 (0.2) 8.7 (0.5)
Marlboro menthol 9.9 (0.2) 17.7 (2.3) 21.3 (1.7) 29.4 (1.4) 8.1 (0.3) 7.2 (0.8) 10.3 (0.3) 8.7 (0.6)
1R5F 3.6 (0.0) 17.3 (3.8) 17.5 (0.9) 37.0 (0.5) 7.0 (0.0) 4.9 (1.3) 10.1 (0.3) 6.7 (0.4)
3R4F 10.6 (0.1) 15.8 (1.2) 25.4 (2.3) 27.7 (0.7) 8.4 (0.3) 7.5 (0.4) 11.9 (0.2) 10.3 (1.0)
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Table S2: The produced individual aldehyde yields of 5 replicates per individual cigarette 
brand per smoking condition are listed in a table (µg/cigarette (SD))
Acrolein Acetaldehyde
ISO ISO-taped HCI-untaped HCI ISO ISO-taped HCI-untaped HCI
Marlboro red 36.0 (20.3) 78.1 (4.4) 82.7 (12.9) 100.1 (8.8) 359.1 (190.4) 773.5 (84.2) 838.9 (81.2) 933.4 (86.5)
L&M red 50.5 (2.8) 69.8 (8.8) 75.7 (9.5) 94.9 (12.0) 480.7 (35.7) 681.1 (54.0) 958.8 (39.9) 924.8 (68.3)
Lucky Strike red 45.1 (8.2) 77.6 (7.3) 70.6 (18.7) 94.5 (9.1) 476.8 (103.7) 803.8 (72.0) 981.6 (171) 928.7 (84.8)
Kent surround 18.3 (12.3) 29.9 (13.9) 39.8 (12.3) 71.9 (23.2) 268.0 (113.4) 442.1 (158.8) 811.5 (227.7) 916.6 (120.5)
Philip Morris One 1.3 (0.8) 63.8 (12.5) 13.9 (3.6) 97.4 (7.5) 36.7 (18.4) 636.4 (83.4) 418.3 (76.1) 1055.6 (62.2)
Marlboro gold 40.3 (12.5) 69.0 (8.7) 66.0 (22.9) 77.9 (6.2) 402.4 (129.7) 657.5 (36.9) 972.6 (223.9) 898.6 (69.6)
Dunhill red 52.9 (11.4) 49.6 (11.4) 73.8 (4.1) 89.1 (11.6) 506.0 (67.5) 539.3 (173.1) 825.6 (62.5) 858.7 (59.2)
Camel filter 62.0 (3.3) 66.6 (30.8) 87.8 (8.1) 121.7 (10.9) 511.1 (36.4) 612.6 (244.3) 851.0 (99.7) 924.5 (50.6)
Gauloises blondes blue 50.8 (3.3) 69.6 (9.3) 80.9 (15.5) 100.1 (11.8) 488.1 (16.2) 697.9 (95.1) 817.5 (72.8) 884.9 (42.7)
Lucky Strike additive free 58.7 (6.2) 68.8 (10.6) 74.4 (15.5) 93.9 (9.1) 515.0 (36.8) 673.6 (95.1) 853.5 (40.6) 874.1 (38.5)
Marlboro menthol 46.4 (18.4) 79.2 (2.7) 85.7 (19.1) 114.1 (13.1) 475.6 (143.4) 827.5 (44.1) 980.8 (166.2) 1072.5 (111.0)
1R5F 4.6 (2.2) 59.4 (6.0) 34.4 (9.6) 93.6 (9.9) 115.7 (24.1) 732.0 (71.6) 669.9 (146.1) 907.8 (85.0)
3R4F 45.2 (11.4) 73.6 (14.2) 81.5 (22.3) 114.7 (18.6) 481.3 (74.1) 806.9 (109.9) 1199.5 (261.2) 1103.0 (66.0)
Formaldehyde Crotonaldehyde
ISO ISO-taped HCI-untaped HCI ISO ISO-taped HCI-untaped HCI
Marlboro red 13.9 (4.6) 42.5 (24.8) 39.6 (4.9) 46.3 (6.6) 14.3 (6.6) 29.5 (2.1) 38.3 (3.8) 56.0 (1.6)
L&M red 14.6 (2.1) 30.5 (23.3) 40.2 (2.6) 41.2 (5.0) 19.1 (2.4) 27.1 (3.1) 41.3 (1.8) 53.8 (1.1)
Lucky Strike red 13.6 (3.0) 30.7 (21.7) 34.5 (10.8) 32.5 (4.6) 16.5 (2.8) 30.6 (1.7) 38.8 (6.8) 53.8 (4.1)
Kent surround 5.5 (2.7) 15.9 (20.2) 23.5 (9.8) 26.6 (6.3) 5.4 (2.5) 8.1 (5.0) 19.2 (10.9) 33.8 (8.4)
Philip Morris One 0.7 (0.5) 23.7 (26.1) 8.4 (2.8) 36.0 (5.7) 6.9 (10.0) 19.3 (5.5) 6.6 (1.7) 47.9 (5.4)
Marlboro gold 13.9 (3.5) 43.4 (26.5) 45.7 (13.5) 39.7 (5.4) 12.5 (2.7) 23.1 (2.0) 32.6 (4.0) 36.8 (4.2)
Dunhill red 16.7 (2.2) 28.0 (37.0) 39.2 (4.5) 34.4 (7.2) 20.4 (2.4) 22.8 (5.0) 42.1 (2.9) 47.0 (4.1)
Camel filter 17.6 (1.6) 41.4 (41.0) 37.9 (5.3) 49.6 (5.7) 20.9 (0.9) 23.9 (12.0) 43.0 (3.9) 54.2 (3.4)
Gauloises blondes blue 19.4 (2.8) 49.3 (37.6) 44.4 (3.4) 43.6 (3.6) 25.0 (8.5) 28.4 (4.2) 43.9 (2.4) 51.5 (4.0)
Lucky Strike additive free 28.6 (5.4) 42.9 (43.3) 38.5 (4.5) 40.2 (6.7) 21.3 (4.2) 25.5 (3.5) 40.5 (2.7) 47.4 (4.9)
Marlboro menthol 28.0 (12.8) 54.9 (43.0) 45.4 (10.7) 54.8 (10.0) 18.2 (7.7) 30.7 (2.8) 42.4 (3.2) 57.6 (7.8)
1R5F 4.0 (2.1) 17.8 (21.4) 14.1 (4.6) 27.5 (4.6) 2.9 (1.1) 21.0 (1.5) 14.8 (2.7) 48.4 (7.3)
3R4F 13.7 (1.8) 40.8 (26.3) 46.3 (16.4) 48.5 (7.4) 17.4 (1.8) 25.5 (7.4) 43.3 (3.1) 54.9 (4.8)
Acetone Butyraldehyde
ISO ISO-taped HCI-untaped HCI ISO ISO-taped HCI-untaped HCI
Marlboro red 315.7 (184.5) 377.7 (32.7) 467.2 (38.3) 598.3 (31.6) 22.9 (11.2) 45.9 (3.0) 60.7 (4.9) 76.4 (4.3)
L&M red 439.5 (96.2) 351.2 (25.1) 506.6 (8.3) 591.0 (29.4) 31.2 (2.3) 42.8 (3.4) 67.5 (2.2) 74.7 (4.5)
Lucky Strike red 428.2 (133.8) 408.6 (25.8) 513.4 (66.4) 607.1 (32.8) 32.3 (6.9) 52.1 (1.8) 69.1 (8.6) 75.4 (4.9)
Kent surround 242.0 (131.8) 192.2 (77.9) 355.2 (95.6) 476.3 (85.8) 16.4 (5.4) 23.4 (8.6) 41.6 (10.2) 51.9 (9.2)
Philip Morris One 32.7 (22.9) 297.7 (46.4) 154.9 (30.6) 556.8 (28.6) 2.5 (1.8) 34.9 (4.6) 19.6 (3.5) 61.0 (3.0)
Marlboro gold 355.5 (156.4) 318.0 (16.4) 431.3 (26.7) 454.5 (23.8) 24.8 (7.4) 38.9 (2.4) 54.9 (4.0) 53.6 (3.1)
Dunhill red 455.7 (129.5) 312.5 (76.1) 475.3 (25.0) 535.9 (39.8) 34.5 (3.4) 38.4 (6.8) 64.2 (4.8) 68.7 (5.1)
Camel filter 457.9 (98.8) 310.2 (121.9) 491.7 (42.4) 596.1 (44.2) 35.6 (1.8) 38.5 (14.2) 64.8 (5.6) 75.0 (4.2)
Gauloises blondes blue 427.1 (102.1) 324.6 (41.4) 472.4 (34.1) 533.8 (28.5) 32.1 (0.8) 42.0 (5.5) 64.0 (3.8) 70.4 (3.7)
Lucky Strike additive free 414.6 (100.8) 329.3 (27.7) 483.4 (18.6) 534.8 (31.6) 34.8 (3.0) 42.5 (3.8) 65.6 (2.5) 70.4 (5.0)
Marlboro menthol 406.9 (208.1) 383.4 (16.0) 525.0 (47.3) 642.9 (72.2) 31.4 (9.7) 47.1 (1.5) 67.6 (6.9) 80.2 (9.2)
1R5F 102.7 (20.0) 373.3 (44.4) 339.4 (55.4) 660.2 (48.1) 8.0 (1.0) 38.1 (4.6) 35.8 (5.0) 62.0 (4.2)
3R4F 427.4 (107.1) 359.9 (102.9) 592.0 (48.5) 675.5 (51.7) 30.6 (2.7) 43.9 (10.6) 73.4 (5.7) 80.0 (5.9)
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Table S2: The produced individual aldehyde yields of 5 replicates per individual cigarette 
brand per smoking condition are listed in a table (µg/cigarette (SD))
Acrolein Acetaldehyde
ISO ISO-taped HCI-untaped HCI ISO ISO-taped HCI-untaped HCI
Marlboro red 36.0 (20.3) 78.1 (4.4) 82.7 (12.9) 100.1 (8.8) 359.1 (190.4) 773.5 (84.2) 838.9 (81.2) 933.4 (86.5)
L&M red 50.5 (2.8) 69.8 (8.8) 75.7 (9.5) 94.9 (12.0) 480.7 (35.7) 681.1 (54.0) 958.8 (39.9) 924.8 (68.3)
Lucky Strike red 45.1 (8.2) 77.6 (7.3) 70.6 (18.7) 94.5 (9.1) 476.8 (103.7) 803.8 (72.0) 981.6 (171) 928.7 (84.8)
Kent surround 18.3 (12.3) 29.9 (13.9) 39.8 (12.3) 71.9 (23.2) 268.0 (113.4) 442.1 (158.8) 811.5 (227.7) 916.6 (120.5)
Philip Morris One 1.3 (0.8) 63.8 (12.5) 13.9 (3.6) 97.4 (7.5) 36.7 (18.4) 636.4 (83.4) 418.3 (76.1) 1055.6 (62.2)
Marlboro gold 40.3 (12.5) 69.0 (8.7) 66.0 (22.9) 77.9 (6.2) 402.4 (129.7) 657.5 (36.9) 972.6 (223.9) 898.6 (69.6)
Dunhill red 52.9 (11.4) 49.6 (11.4) 73.8 (4.1) 89.1 (11.6) 506.0 (67.5) 539.3 (173.1) 825.6 (62.5) 858.7 (59.2)
Camel filter 62.0 (3.3) 66.6 (30.8) 87.8 (8.1) 121.7 (10.9) 511.1 (36.4) 612.6 (244.3) 851.0 (99.7) 924.5 (50.6)
Gauloises blondes blue 50.8 (3.3) 69.6 (9.3) 80.9 (15.5) 100.1 (11.8) 488.1 (16.2) 697.9 (95.1) 817.5 (72.8) 884.9 (42.7)
Lucky Strike additive free 58.7 (6.2) 68.8 (10.6) 74.4 (15.5) 93.9 (9.1) 515.0 (36.8) 673.6 (95.1) 853.5 (40.6) 874.1 (38.5)
Marlboro menthol 46.4 (18.4) 79.2 (2.7) 85.7 (19.1) 114.1 (13.1) 475.6 (143.4) 827.5 (44.1) 980.8 (166.2) 1072.5 (111.0)
1R5F 4.6 (2.2) 59.4 (6.0) 34.4 (9.6) 93.6 (9.9) 115.7 (24.1) 732.0 (71.6) 669.9 (146.1) 907.8 (85.0)
3R4F 45.2 (11.4) 73.6 (14.2) 81.5 (22.3) 114.7 (18.6) 481.3 (74.1) 806.9 (109.9) 1199.5 (261.2) 1103.0 (66.0)
Formaldehyde Crotonaldehyde
ISO ISO-taped HCI-untaped HCI ISO ISO-taped HCI-untaped HCI
Marlboro red 13.9 (4.6) 42.5 (24.8) 39.6 (4.9) 46.3 (6.6) 14.3 (6.6) 29.5 (2.1) 38.3 (3.8) 56.0 (1.6)
L&M red 14.6 (2.1) 30.5 (23.3) 40.2 (2.6) 41.2 (5.0) 19.1 (2.4) 27.1 (3.1) 41.3 (1.8) 53.8 (1.1)
Lucky Strike red 13.6 (3.0) 30.7 (21.7) 34.5 (10.8) 32.5 (4.6) 16.5 (2.8) 30.6 (1.7) 38.8 (6.8) 53.8 (4.1)
Kent surround 5.5 (2.7) 15.9 (20.2) 23.5 (9.8) 26.6 (6.3) 5.4 (2.5) 8.1 (5.0) 19.2 (10.9) 33.8 (8.4)
Philip Morris One 0.7 (0.5) 23.7 (26.1) 8.4 (2.8) 36.0 (5.7) 6.9 (10.0) 19.3 (5.5) 6.6 (1.7) 47.9 (5.4)
Marlboro gold 13.9 (3.5) 43.4 (26.5) 45.7 (13.5) 39.7 (5.4) 12.5 (2.7) 23.1 (2.0) 32.6 (4.0) 36.8 (4.2)
Dunhill red 16.7 (2.2) 28.0 (37.0) 39.2 (4.5) 34.4 (7.2) 20.4 (2.4) 22.8 (5.0) 42.1 (2.9) 47.0 (4.1)
Camel filter 17.6 (1.6) 41.4 (41.0) 37.9 (5.3) 49.6 (5.7) 20.9 (0.9) 23.9 (12.0) 43.0 (3.9) 54.2 (3.4)
Gauloises blondes blue 19.4 (2.8) 49.3 (37.6) 44.4 (3.4) 43.6 (3.6) 25.0 (8.5) 28.4 (4.2) 43.9 (2.4) 51.5 (4.0)
Lucky Strike additive free 28.6 (5.4) 42.9 (43.3) 38.5 (4.5) 40.2 (6.7) 21.3 (4.2) 25.5 (3.5) 40.5 (2.7) 47.4 (4.9)
Marlboro menthol 28.0 (12.8) 54.9 (43.0) 45.4 (10.7) 54.8 (10.0) 18.2 (7.7) 30.7 (2.8) 42.4 (3.2) 57.6 (7.8)
1R5F 4.0 (2.1) 17.8 (21.4) 14.1 (4.6) 27.5 (4.6) 2.9 (1.1) 21.0 (1.5) 14.8 (2.7) 48.4 (7.3)
3R4F 13.7 (1.8) 40.8 (26.3) 46.3 (16.4) 48.5 (7.4) 17.4 (1.8) 25.5 (7.4) 43.3 (3.1) 54.9 (4.8)
Acetone Butyraldehyde
ISO ISO-taped HCI-untaped HCI ISO ISO-taped HCI-untaped HCI
Marlboro red 315.7 (184.5) 377.7 (32.7) 467.2 (38.3) 598.3 (31.6) 22.9 (11.2) 45.9 (3.0) 60.7 (4.9) 76.4 (4.3)
L&M red 439.5 (96.2) 351.2 (25.1) 506.6 (8.3) 591.0 (29.4) 31.2 (2.3) 42.8 (3.4) 67.5 (2.2) 74.7 (4.5)
Lucky Strike red 428.2 (133.8) 408.6 (25.8) 513.4 (66.4) 607.1 (32.8) 32.3 (6.9) 52.1 (1.8) 69.1 (8.6) 75.4 (4.9)
Kent surround 242.0 (131.8) 192.2 (77.9) 355.2 (95.6) 476.3 (85.8) 16.4 (5.4) 23.4 (8.6) 41.6 (10.2) 51.9 (9.2)
Philip Morris One 32.7 (22.9) 297.7 (46.4) 154.9 (30.6) 556.8 (28.6) 2.5 (1.8) 34.9 (4.6) 19.6 (3.5) 61.0 (3.0)
Marlboro gold 355.5 (156.4) 318.0 (16.4) 431.3 (26.7) 454.5 (23.8) 24.8 (7.4) 38.9 (2.4) 54.9 (4.0) 53.6 (3.1)
Dunhill red 455.7 (129.5) 312.5 (76.1) 475.3 (25.0) 535.9 (39.8) 34.5 (3.4) 38.4 (6.8) 64.2 (4.8) 68.7 (5.1)
Camel filter 457.9 (98.8) 310.2 (121.9) 491.7 (42.4) 596.1 (44.2) 35.6 (1.8) 38.5 (14.2) 64.8 (5.6) 75.0 (4.2)
Gauloises blondes blue 427.1 (102.1) 324.6 (41.4) 472.4 (34.1) 533.8 (28.5) 32.1 (0.8) 42.0 (5.5) 64.0 (3.8) 70.4 (3.7)
Lucky Strike additive free 414.6 (100.8) 329.3 (27.7) 483.4 (18.6) 534.8 (31.6) 34.8 (3.0) 42.5 (3.8) 65.6 (2.5) 70.4 (5.0)
Marlboro menthol 406.9 (208.1) 383.4 (16.0) 525.0 (47.3) 642.9 (72.2) 31.4 (9.7) 47.1 (1.5) 67.6 (6.9) 80.2 (9.2)
1R5F 102.7 (20.0) 373.3 (44.4) 339.4 (55.4) 660.2 (48.1) 8.0 (1.0) 38.1 (4.6) 35.8 (5.0) 62.0 (4.2)
3R4F 427.4 (107.1) 359.9 (102.9) 592.0 (48.5) 675.5 (51.7) 30.6 (2.7) 43.9 (10.6) 73.4 (5.7) 80.0 (5.9)
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Propionaldehyde Benzaldehyde
ISO ISO-taped HCI-untaped HCI ISO ISO-taped HCI-untaped HCI
Marlboro red 38.2 (16.5) 70.8 (5.2) 90.9 (9.5) 122.0 (6.4) 1.6 (1.6) 4.4 (0.8) 8.4 (1.2) 13.4 (2.8)
L&M red 52.5 (2.5) 68.1 (7.5) 96.2 (3.8) 117.4 (11.3) 2.7 (1.4) 4.0 (1.2) 10.3 (1.2) 12.1 (2.1)
Lucky Strike red 50.8 (8.5) 75.7 (5.4) 93.4 (12) 114.9 (5.7) 2.3 (1.1) 4.6 (0.5) 10.1 (3.5) 12.7 (1.2)
Kent surround 25.4 (10.5) 31.1 (13.3) 53.9 (11.2) 77.3 (15.6) 0.9 (0.7) 1.1 (1.3) 4.7 (2.1) 5.6 (1.3)
Philip Morris One 5.5 (2.8) 53.1 (7.6) 23.6 (5.2) 95.0 (9.0) 0.1 (0.1) 1.9 (1.4) 1.1 (0.5) 7.5 (0.9)
Marlboro gold 41.0 (10.0) 59.4 (5.1) 77.6 (6.9) 86.1 (5.5) 2.2 (1.5) 3.2 (1.2) 8.2 (3.4) 7.0 (0.4)
Dunhill red 53.3 (7.5) 55.9 (11.9) 84.5 (5.3) 98.4 (7.9) 2.4 (1.1) 3.8 (1.8) 10.3 (1.9) 10.9 (1.1)
Camel filter 55.5 (4.5) 56.3 (22.9) 93.2 (7.1) 122.1 (10.4) 2.4 (1.4) 2.7 (1.8) 8.8 (1.5) 11.7 (1.5)
Gauloises blondes blue 53.9 (4.0) 66.9 (8.9) 94.7 (7.8) 114.1 (12.7) 2.9 (1.3) 4.5 (1.2) 10.9 (1.9) 12.5 (0.4)
Lucky Strike additive free 54.1 (6.3) 59.5 (4.9) 87.8 (8.4) 102.7 (11.6) 3.4 (1.7) 4.1 (0.2) 10.1 (2.0) 11.8 (2.9)
Marlboro menthol 48.7 (15.2) 72.8 (3.7) 99.7 (9.8) 132.0 (16.5) 2.4 (1.7) 4.5 (0.6) 10.2 (2.3) 14.2 (3.0)
1R5F 13.8 (1.8) 59.0 (8.5) 51.1 (9.5) 94.8 (8.1) 0.3 (0.3) 3.2 (1.1) 3.2 (1.0) 8.7 (1.0)
3R4F 50.9 (8.7) 64.5 (20) 105.5 (8.3) 122.5 (12.3) 2.6 (1.3) 4.3 (2.2) 11.7 (3.9) 12.2 (1.8)
Isovaleraldehyde Hexaldehyde
ISO ISO-taped HCI-untaped HCI ISO ISO-taped HCI-untaped HCI
Marlboro red 45.1 (21.9) 92.5 (8.6) 133.7 (19.0) 180.4 (9.9) 2.9 (1.8) 8.0 (1.7) 14.9 (1.6) 9.5 (2.5)
L&M red 60.6 (9.8) 86.3 (10.8) 146.0 (16.2) 174.4 (9.1) 2.4 (2.2) 6.9 (1.4) 17.4 (2.9) 9.9 (3.2)
Lucky Strike red 58.7 (13.7) 103.8 (13.5) 142.7 (16.8) 184.3 (7.8) 3.6 (0.5) 6.6 (0.9) 12.5 (2.1) 6.9 (2.6)
Kent surround 25.7 (11.4) 34.4 (17.8) 80.2 (31.9) 111.0 (27.0) 1.4 (0.4) 2.1 (0.4) 4.7 (2.0) 3.1 (1.0)
Philip Morris One 6.7 (3.8) 60.8 (15.1) 30.8 (7.7) 140.1 (12.7) 0.3 (0.3) 3.3 (0.9) 2.3 (0.7) 4.7 (1.6)
Marlboro gold 48.2 (14.8) 75.6 (14.8) 124.6 (21.3) 123.2 (13.7) 3.2 (1.0) 6.2 (1.0) 13.0 (2.8) 6.9 (1.4)
Dunhill red 63.6 (7.9) 72.2 (22.0) 132.7 (11.1) 146.6 (13.9) 3.5 (1.4) 6.0 (2.7) 15.0 (2.8) 8.6 (3.6)
Camel filter 71.3 (6.7) 73.5 (32.4) 140.9 (14.2) 168.4 (18.4) 3.6 (0.9) 6.3 (2.6) 15.3 (2.6) 10.7 (2.8)
Gauloises blondes blue 64.2 (4.7) 80.9 (13.9) 138.8 (13.5) 148.7 (9.5) 4.4 (1.6) 8.4 (2.1) 18.1 (1.5) 10.6 (1.7)
Lucky Strike additive free 66.6 (5.9) 75.2 (3.8) 134.5 (16.1) 144.7 (15.8) 3.4 (1.4) 6.4 (2.0) 16.0 (1.8) 10.2 (3.2)
Marlboro menthol 59.2 (23.2) 92.3 (10.9) 143.0 (10.4) 177.8 (23.2) 3.2 (0.8) 8.7 (1.1) 19.3 (4.1) 12.2 (4.7)
1R5F 12.9 (4.7) 69.4 (7.0) 64.4 (12.0) 147.0 (13.7) 0.4 (0.3) 3.4 (0.6) 3.4 (0.9) 4.9 (1.8)
3R4F 64.0 (7.5) 87.4 (35.8) 159.6 (16.7) 183.7 (17.6) 3.0 (0.8) 6.4 (2.2) 17.4 (3.5) 10.6 (3.7)
o-, m-, p-tolualdehyde 2,5-dimethylbenzaldehyde
ISO ISO-taped HCI-untaped HCI ISO ISO-taped HCI-untaped HCI
Marlboro red 35.7 (7.5) 62.1 (4.4) 83.1 (5.5) 78.6 (7.4) 49.2 (35.1) 115.1 (64.0) 215.1 (50.4) 281.7 (48.3)
L&M red 36.8 (6.6) 51.3 (5.4) 84.8 (2.6) 73.4 (5.3) 58.5 (24.3) 79.9 (37.5) 262.3 (12.2) 272.9 (27.9)
Lucky Strike red 31.3 (3.3) 50.1 (4.8) 71.6 (7.7) 60.5 (4.1) 58.5 (29.3) 119.6 (39.0) 262.0 (69.4) 279.0 (33.6)
Kent surround 10.7 (4.4) 17.7 (7.5) 35.5 (10.6) 37.0 (5.6) 23.7 (14.6) 45.3 (21.0) 136.2 (79.0) 207.4 (56.7)
Philip Morris One 2.0 (0.7) 27.3 (7.4) 16.0 (4.2) 41.2 (4.3) 6.9 (6.7) 76.5 (43.5) 73.2 (18.3) 270.5 (8.7)
Marlboro gold 34.1 (6.4) 51.4 (8.3) 80.2 (6.9) 64.6 (7.0) 64.1 (41.6) 97.7 (9.7) 229.5 (30.0) 230.9 (23.4)
Dunhill red 31.4 (7.5) 37.3 (11.3) 63.0 (6.2) 51.0 (2.9) 83.4 (39.9) 95.2 (53.6) 262.2 (20.5) 271.9 (31.2)
Camel filter 37.3 (2.8) 43.6 (16.9) 74.3 (7.0) 73.7 (5.9) 85.8 (42.6) 110.1 (62.6) 257.6 (30.0) 295.7 (26.3)
Gauloises blondes blue 35.8 (6.6) 50.2 (4.2) 81.8 (4.4) 65.1 (4.2) 89.1 (38.4) 120.9 (44.0) 263.2 (23.2) 269.1 (20.4)
Lucky Strike additive free 31.7 (9.2) 38.5 (6.0) 69.0 (5.1) 57.0 (8.1) 63.8 (39.2) 88.7 (48.6) 252.6 (27.1) 273.8 (30.4)
Marlboro menthol 31.3 (11.5) 54.6 (3.2) 81.7 (10.3) 76.1 (7.3) 71.6 (48.5) 134.9 (31.0) 235.9 (56.5) 331.0 (53.0)
1R5F 3.5 (0.9) 23.7 (2.9) 24.2 (3.4) 31.0 (2.4) 17.0 (11.8) 37.5 (15.4) 75.7 (16.1) 233.3 (38.2)
3R4F 28.4 (4.5) 42.5 (16.4) 76.2 (7.5) 64.2 (6.1) 75.0 (35.9) 107.4 (48.3) 280.3 (54.5) 341.8 (23.5)
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Propionaldehyde Benzaldehyde
ISO ISO-taped HCI-untaped HCI ISO ISO-taped HCI-untaped HCI
Marlboro red 38.2 (16.5) 70.8 (5.2) 90.9 (9.5) 122.0 (6.4) 1.6 (1.6) 4.4 (0.8) 8.4 (1.2) 13.4 (2.8)
L&M red 52.5 (2.5) 68.1 (7.5) 96.2 (3.8) 117.4 (11.3) 2.7 (1.4) 4.0 (1.2) 10.3 (1.2) 12.1 (2.1)
Lucky Strike red 50.8 (8.5) 75.7 (5.4) 93.4 (12) 114.9 (5.7) 2.3 (1.1) 4.6 (0.5) 10.1 (3.5) 12.7 (1.2)
Kent surround 25.4 (10.5) 31.1 (13.3) 53.9 (11.2) 77.3 (15.6) 0.9 (0.7) 1.1 (1.3) 4.7 (2.1) 5.6 (1.3)
Philip Morris One 5.5 (2.8) 53.1 (7.6) 23.6 (5.2) 95.0 (9.0) 0.1 (0.1) 1.9 (1.4) 1.1 (0.5) 7.5 (0.9)
Marlboro gold 41.0 (10.0) 59.4 (5.1) 77.6 (6.9) 86.1 (5.5) 2.2 (1.5) 3.2 (1.2) 8.2 (3.4) 7.0 (0.4)
Dunhill red 53.3 (7.5) 55.9 (11.9) 84.5 (5.3) 98.4 (7.9) 2.4 (1.1) 3.8 (1.8) 10.3 (1.9) 10.9 (1.1)
Camel filter 55.5 (4.5) 56.3 (22.9) 93.2 (7.1) 122.1 (10.4) 2.4 (1.4) 2.7 (1.8) 8.8 (1.5) 11.7 (1.5)
Gauloises blondes blue 53.9 (4.0) 66.9 (8.9) 94.7 (7.8) 114.1 (12.7) 2.9 (1.3) 4.5 (1.2) 10.9 (1.9) 12.5 (0.4)
Lucky Strike additive free 54.1 (6.3) 59.5 (4.9) 87.8 (8.4) 102.7 (11.6) 3.4 (1.7) 4.1 (0.2) 10.1 (2.0) 11.8 (2.9)
Marlboro menthol 48.7 (15.2) 72.8 (3.7) 99.7 (9.8) 132.0 (16.5) 2.4 (1.7) 4.5 (0.6) 10.2 (2.3) 14.2 (3.0)
1R5F 13.8 (1.8) 59.0 (8.5) 51.1 (9.5) 94.8 (8.1) 0.3 (0.3) 3.2 (1.1) 3.2 (1.0) 8.7 (1.0)
3R4F 50.9 (8.7) 64.5 (20) 105.5 (8.3) 122.5 (12.3) 2.6 (1.3) 4.3 (2.2) 11.7 (3.9) 12.2 (1.8)
Isovaleraldehyde Hexaldehyde
ISO ISO-taped HCI-untaped HCI ISO ISO-taped HCI-untaped HCI
Marlboro red 45.1 (21.9) 92.5 (8.6) 133.7 (19.0) 180.4 (9.9) 2.9 (1.8) 8.0 (1.7) 14.9 (1.6) 9.5 (2.5)
L&M red 60.6 (9.8) 86.3 (10.8) 146.0 (16.2) 174.4 (9.1) 2.4 (2.2) 6.9 (1.4) 17.4 (2.9) 9.9 (3.2)
Lucky Strike red 58.7 (13.7) 103.8 (13.5) 142.7 (16.8) 184.3 (7.8) 3.6 (0.5) 6.6 (0.9) 12.5 (2.1) 6.9 (2.6)
Kent surround 25.7 (11.4) 34.4 (17.8) 80.2 (31.9) 111.0 (27.0) 1.4 (0.4) 2.1 (0.4) 4.7 (2.0) 3.1 (1.0)
Philip Morris One 6.7 (3.8) 60.8 (15.1) 30.8 (7.7) 140.1 (12.7) 0.3 (0.3) 3.3 (0.9) 2.3 (0.7) 4.7 (1.6)
Marlboro gold 48.2 (14.8) 75.6 (14.8) 124.6 (21.3) 123.2 (13.7) 3.2 (1.0) 6.2 (1.0) 13.0 (2.8) 6.9 (1.4)
Dunhill red 63.6 (7.9) 72.2 (22.0) 132.7 (11.1) 146.6 (13.9) 3.5 (1.4) 6.0 (2.7) 15.0 (2.8) 8.6 (3.6)
Camel filter 71.3 (6.7) 73.5 (32.4) 140.9 (14.2) 168.4 (18.4) 3.6 (0.9) 6.3 (2.6) 15.3 (2.6) 10.7 (2.8)
Gauloises blondes blue 64.2 (4.7) 80.9 (13.9) 138.8 (13.5) 148.7 (9.5) 4.4 (1.6) 8.4 (2.1) 18.1 (1.5) 10.6 (1.7)
Lucky Strike additive free 66.6 (5.9) 75.2 (3.8) 134.5 (16.1) 144.7 (15.8) 3.4 (1.4) 6.4 (2.0) 16.0 (1.8) 10.2 (3.2)
Marlboro menthol 59.2 (23.2) 92.3 (10.9) 143.0 (10.4) 177.8 (23.2) 3.2 (0.8) 8.7 (1.1) 19.3 (4.1) 12.2 (4.7)
1R5F 12.9 (4.7) 69.4 (7.0) 64.4 (12.0) 147.0 (13.7) 0.4 (0.3) 3.4 (0.6) 3.4 (0.9) 4.9 (1.8)
3R4F 64.0 (7.5) 87.4 (35.8) 159.6 (16.7) 183.7 (17.6) 3.0 (0.8) 6.4 (2.2) 17.4 (3.5) 10.6 (3.7)
o-, m-, p-tolualdehyde 2,5-dimethylbenzaldehyde
ISO ISO-taped HCI-untaped HCI ISO ISO-taped HCI-untaped HCI
Marlboro red 35.7 (7.5) 62.1 (4.4) 83.1 (5.5) 78.6 (7.4) 49.2 (35.1) 115.1 (64.0) 215.1 (50.4) 281.7 (48.3)
L&M red 36.8 (6.6) 51.3 (5.4) 84.8 (2.6) 73.4 (5.3) 58.5 (24.3) 79.9 (37.5) 262.3 (12.2) 272.9 (27.9)
Lucky Strike red 31.3 (3.3) 50.1 (4.8) 71.6 (7.7) 60.5 (4.1) 58.5 (29.3) 119.6 (39.0) 262.0 (69.4) 279.0 (33.6)
Kent surround 10.7 (4.4) 17.7 (7.5) 35.5 (10.6) 37.0 (5.6) 23.7 (14.6) 45.3 (21.0) 136.2 (79.0) 207.4 (56.7)
Philip Morris One 2.0 (0.7) 27.3 (7.4) 16.0 (4.2) 41.2 (4.3) 6.9 (6.7) 76.5 (43.5) 73.2 (18.3) 270.5 (8.7)
Marlboro gold 34.1 (6.4) 51.4 (8.3) 80.2 (6.9) 64.6 (7.0) 64.1 (41.6) 97.7 (9.7) 229.5 (30.0) 230.9 (23.4)
Dunhill red 31.4 (7.5) 37.3 (11.3) 63.0 (6.2) 51.0 (2.9) 83.4 (39.9) 95.2 (53.6) 262.2 (20.5) 271.9 (31.2)
Camel filter 37.3 (2.8) 43.6 (16.9) 74.3 (7.0) 73.7 (5.9) 85.8 (42.6) 110.1 (62.6) 257.6 (30.0) 295.7 (26.3)
Gauloises blondes blue 35.8 (6.6) 50.2 (4.2) 81.8 (4.4) 65.1 (4.2) 89.1 (38.4) 120.9 (44.0) 263.2 (23.2) 269.1 (20.4)
Lucky Strike additive free 31.7 (9.2) 38.5 (6.0) 69.0 (5.1) 57.0 (8.1) 63.8 (39.2) 88.7 (48.6) 252.6 (27.1) 273.8 (30.4)
Marlboro menthol 31.3 (11.5) 54.6 (3.2) 81.7 (10.3) 76.1 (7.3) 71.6 (48.5) 134.9 (31.0) 235.9 (56.5) 331.0 (53.0)
1R5F 3.5 (0.9) 23.7 (2.9) 24.2 (3.4) 31.0 (2.4) 17.0 (11.8) 37.5 (15.4) 75.7 (16.1) 233.3 (38.2)
3R4F 28.4 (4.5) 42.5 (16.4) 76.2 (7.5) 64.2 (6.1) 75.0 (35.9) 107.4 (48.3) 280.3 (54.5) 341.8 (23.5)
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Table S3: Statistical comparison (p-values) per individual aldehyde for different smoking 

















Formaldehyde 4.34E-10 0.726718 3.53E-10 2.79E-09 1.30E-09 8.17E-15
Acetaldehyde 1.28E-12 9.31E-05 5.58E-08 8.22E-06 9.13E-15 3.52E-63
Acrolein 6.05E-14 9.38E-06 4.05E-11 1.31E-06 5.33E-26 2.71E-54
Acetone 1.69E-06 0.000312 1.89E-18 3.18E-10 5.62E-18 9.97E-38
Propanal 2.35E-14 2.37E-05 5.68E-22 7.43E-11 5.00E-39 4.69E-83
Crotonaldehyde 5.55E-09 6.32E-07 1.46E-21 1.27E-09 4.48E-34 4.68E-84
Butyraldehyde 6.16E-15 9.47E-06 1.09E-21 7.20E-13 2.58E-41 1.19E-91
Benzaldehyde 0.001612 0.001154 4.61E-10 1.09E-10 6.00E-26 2.62E-76
Isovaleraldehyde 3.52E-13 0.000111 1.92E-17 9.30E-11 1.92E-34 3.60E-87
o-m-p-tolualdehyde 1.74E-15 8.12E-10 1.38E-26 4.30E-21 4.25E-67 3.82E-73
Hexanal 4.74E-06 3.37E-07 1.91E-18 1.89E-05 2.29E-32 3.48E-58
2,5 dimethylbenz
aldehyde 0.002360 0.022678 1.86E-12 5.08E-06 4.02E-21 5.63E-86
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Table S4: Correlation factors of individual aldehyde emissions produced by 13 cigarette 
brands (5 replicates) for the different smoking conditions. The lower triangle represents the 
















































































Formaldehyde X 0.789 0.773 0.718 0.764 0.688 0.794 0.618 0.801 0.732 0.633 0.657
IS
O
Acetaldehyde 0.367 X 0.963 0.866 0.979 0.777 0.979 0.736 0.960 0.869 0.662 0.672
Acrolein 0.451 0.880 X 0.823 0.975 0.812 0.964 0.704 0.941 0.869 0.666 0.595
Acetone 0.218 0.850 0.811 X 0.843 0.670 0.867 0.422 0.837 0.714 0.412 0.739
Propanal 0.188 0.818 0.843 0.950 X 0.807 0.984 0.687 0.950 0.877 0.681 0.591
Crotonaldehyde 0.409 0.793 0.875 0.891 0.940 X 0.804 0.638 0.821 0.737 0.592 0.605
Butyraldehyde 0.287 0.836 0.854 0.955 0.971 0.952 X 0.674 0.969 0.850 0.645 0.663
Benzaldehyde 0.099 0.662 0.635 0.807 0.864 0.822 0.850 X 0.737 0.703 0.667 0.510
Isovaleraldehyde 0.102 0.753 0.766 0.920 0.962 0.899 0.948 0.895 X 0.860 0.668 0.756
o-m-p-tolualde-
hyde 0.331 0.649 0.746 0.721 0.835 0.866 0.822 0.761 0.847 X 0.779 0.583




0.643 0.591 0.585 0.537 0.527 0.682 0.621 0.451 0.522 0.674 0.839 X
ISO-taped
HCI







Acetaldehyde 0.538 X 0.467 0.841 0.732 0.666 0.791 0.799 0.773 0.690 0.666 0.772
Acrolein 0.543 0.503 X 0.817 0.894 0.863 0.822 0.519 0.747 0.793 0.714 0.686
Acetone 0.280 0.512 0.731 X 0.959 0.921 0.975 0.818 0.931 0.837 0.816 0.867
Propanal 0.598 0.366 0.807 0.734 X 0.951 0.969 0.798 0.923 0.903 0.869 0.846
Crotonaldehyde 0.468 0.330 0.766 0.815 0.902 X 0.966 0.830 0.951 0.901 0.897 0.921
Butyraldehyde 0.619 0.433 0.758 0.754 0.904 0.881 X 0.875 0.962 0.890 0.885 0.920
Benzaldehyde 0.656 0.276 0.551 0.570 0.803 0.758 0.877 X 0.886 0.816 0.897 0.878
Isovaleraldehyde 0.448 0.353 0.644 0.812 0.884 0.911 0.877 0.776 X 0.902 0.888 0.921
o-m-p-tolualde-
hyde 0.762 0.164 0.479 0.234 0.737 0.561 0.663 0.695 0.616 X 0.909 0.852




0.766 0.682 0.660 0.597 0.631 0.627 0.767 0.732 0.635 0.539 0.722 X
HCI
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Abstract
Smokers are exposed to more than 6000 (toxic) smoke components including 
volatile organic compounds (VOCs). In this study VOCs levels in headspace of 
blood and exhaled breath, in the mainstream smoke of three types of cigarettes 
of one brand varying in declared tar, nicotine and carbon monoxide (TNCO) yields 
are investigated. The objective was to identify whether VOC levels correlate with 
TNCO yields of cigarettes smoked according to ISO 3308. Our data show that 
smoking regular and low-TNCO cigarettes result in comparable levels of VOCs in 
blood and exhaled breath. Hence, declared TNCO-yields as determined with the ISO 
3308 machine smoking protocol are irrelevant for predicting VOC exposure upon 
human smoking. Venous blood and exhaled breath were sampled from twelve male 
volunteers directly before and 10 minutes after smoking cigarettes on 3 days (day 
1 Marlboro Red (regular), day 2 Marlboro Prime (highly ventilated, low-TNCO), day 
3 Marlboro Prime with blocked filter ventilation (taped)). Upon smoking, the levels 
of toluene, ethylbenzene, m/p-xylene, o-xylene, and 2,5-dimethylfuran in both 
headspace of venous blood and exhaled breath increase within the same range for 
all three cigarette types smoked. However, no strong correlation was found between 
VOC levels in exhaled breath and VOC levels in headspace of blood because of 
variations between the individual smoking volunteers. More research is required 
in order to use exhaled breath sampling as a non-invasive quantitative marker for 
volatile toxicants from cigarette smoke exposure of different brands.
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Introduction
Worldwide one in every four men and one in every twenty women are daily smokers 
1. These smokers are all at risk of developing smoking-related diseases, most 
prominently cardiovascular diseases, cancers and chronic respiratory diseases 1. 
Smokers are exposed to more than 6000 different chemicals with varying toxicological 
and chemical characteristics 2. The majority of the chemicals is associated with 
particles and aerosols in the smoke and are usually quantified as a mixture named 
‘tar’. Carbon monoxide (CO) and other volatile organic compounds (VOCs) are 
gases produced during smoldering and puffing, that are sampled and quantified 
separately due to their volatile characteristics. The development of smoking-related 
diseases is partially the consequence of exposure to toxicants associated to tar 
such as carcinogenic nitrosamines and polycyclic aromatic hydrocarbons. Moreover, 
also volatile toxic chemicals of the gas phase of cigarette smoke like acetonitrile, 
1,3-butadiene, and aldehydes are associated with cancer and non-cancerous disease 
risks, as initially shown by risk assessments of Fowles and Dybing 3 and later by 
WHO-IARC 4. Risk assessment studies indicate that gas-phase chemicals of tobacco 
mainstream smoke pose very high risk towards consumers. Fowles and Dybing, for 
instance, noted a 6% contribution of benzene to the total cancer risk index. However, 
most cigarette emission studies mainly focus on the particulate phase, particularly 
on aromatic hydrocarbons and tobacco-specific nitrosamines 5,6. 
For risk and exposure assessments of smoke chemicals, usually emissions from 
machine smoking of cigarettes are used 3,4. Initially, exposure of smokers was assessed 
by using smoking machine data generated with ISO 3308 settings for the smoking 
regime 7. In Europe, cigarettes with approximately 10 mg tar/cig, 1 mg nicotine/cig 
and 10 mg CO/cig (TNCO) as determined with ISO 3308 settings, are often referred 
to as ‘regular’. The use of the ISO-regime to determine TNCO yields in cigarettes is 
mandatory in many jurisdictions despite the critique that it largely underestimates 
human smoking topography 8. It may particularly underestimate the exposure to 
toxic smoke gases during the consumption of highly ventilated cigarettes with such 
as Marlboro Prime, which show low-nicotine yields when machine smoked using ISO 
3308 9. However, several studies showed that smokers consuming cigarettes with 
reduced declared TNCO-levels (referred to as low-TNCO cigarettes) only slightly 
lower their exposure to tar and nicotine, according to biomarker measurements, 
compared to consuming regular cigarettes 10-16. For example, an only 6% reduction of 
tar and nicotine uptake was observed when smoking reduced tar-nicotine cigarettes 
(<7 mg tar/cig) 14. This contrasts with the observed 50% lower tar and nicotine yields 
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in low-TNCO versus regular cigarettes as determined with a smoking machine using 
ISO 3308 14. Whereas some information is available regarding the exposure and 
uptake of tar-phase chemicals by smokers consuming low-TNCO cigarettes, data 
about the influence of cigarette ventilation on gas-phase toxicants is scarce 10,16. In 
several studies, no reduction in human exposure of CO is observed when consumers 
switched from regular to low-TNCO products 10,12,17,18. Furthermore, for acrolein, 
1,3-butadiene and benzene, exposure biomarker studies in adult smokers showed 
marginal to no differences in uptake levels after consumption of cigarettes with 
varying smoking machine determined TNCO levels 10,11. These observations indicate 
that tar and nicotine levels determined with ISO 3308 smoking machine settings do 
not mimic the actual smokers’ exposure to gas-phase toxicants, and are improper to 
use as input for risk assessment. 
In order not to rely on machine smoking data, and to further improve the assessment 
of consumers risks associated with the exposure to volatile toxicants, it is important 
to quantify the actual exposure of smokers during smoking various types of cigarettes 
19. However, direct measurements of exposure during human puffing of a cigarette is 
experimentally not feasible as it impacts the smoking topography 20. Sampling after 
puffing is probably the best option to assess actual exposure.
During smoking a cigarette, a part of the inhaled chemicals is exhaled immediately 
after puffing. Another part of the inhaled chemicals is retained in the oral/nasal 
cavity and the lung for some period and exhaled with regular breathing, while a 
fraction of the inhaled compound may be metabolized in the lung 20. Besides, a part 
of smoke toxicants, such as nicotine, diffuses through the alveoli into the circulation. 
VOCs circulating in the blood may diffuse from the blood back into the lungs for 
exhalation in either unchanged or metabolized forms. Levels of VOCs in breath 
and blood increase due to active cigarette smoking 21-24. Former studies showed 
that after exposure, VOCs show peak concentrations and go rapidly back towards 
‘baseline’ levels in blood and breath 22,23. Respiration models show that remainder of 
tobacco smoke in the lung after puffing is rapidly exhaled during regular breathing 
20. However, by measuring the presence of certain VOCs in breath and headspace 
of blood, previous human smoking studies could report a clear distinction between 
smokers and non-smokers 25-27. Moreover, benzene levels in blood were shown to be 
10 times higher in persons who had recently smoked, compared to nonsmokers 24. It 
may thus be assumed that exhaled breath provides information about physiological 
as well as pathological processes occurring within the body, although there are 
limitations and difficulties interpreting actual measurements 28-31. Difference in 
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metabolism and pharmacokinetics (human absorption, distribution, metabolism, 
and excretion) may cause that the profiles of concentrations of VOCs in the inhaled 
smoke are not fully mimicked in the blood, nor that they are preserved in exhaled 
breath for extended periods. Marco et al. quantified both exposure and breath 
concentrations 30 minutes after smoking, thereby not reflecting acute exposure 
but previous uptake of the chemicals into the body 32. Measuring VOCs in exhaled 
breath may be a noninvasive opportunity to assess previous exposure to tobacco 
smoke which can be used for frequent sampling, in contrast to sampling blood 33.
In addition to the pharmacokinetics of VOCs, the actual concentrations of VOCs 
in blood may be influenced by the puffing topography of the smoker. Puffing 
topography of a smoker entails puff volume, puff duration, puff interval and number 
of puffs taken 34. Previously, we have shown that individuals have characteristic 
puffing profiles which can generate more TNCO than ISO 3308 and Health Canada 
Intense (HCI) regimes on smoking machines when the same brand is smoked 35. 
Puffing behavior of individuals influence the smoldering and burning periods of the 
cigarette, as well as the burning conditions at the rod of the cigarette, all influencing 
actual exposure of the smoker to mainstream toxicants. Furthermore, the yields of 
VOCs in tobacco smoke depend on the blend and cigarette design of the cigarette 
brands 36,37. Consequently, the amount and (VOC) composition of the smoke and 
smoke toxicants inhaled during puffing may be characteristic for individuals as well 
as for the consumed tobacco product 34.
The first objective of the present study is to determine the level of VOCs in blood 
upon smoking three types of cigarettes of one brand with varying declared TNCO 
yields according to ISO 3308. Furthermore, we study the relation with VOC yields in 
headspace of blood to explore the potential use of exhaled breath as non-invasive 
biomarker of exposure to tobacco smoke of different cigarette brands.  In the 
present study, we report about a human exposure study with active smokers of 
whom blood and exhaled air were sampled regularly for VOCs measurements upon 
smoking Marlboro Red (regular), Marlboro Prime (highly ventilated, low-TNCO), and 
Marlboro Prime with blocked filter ventilation (taped). Benzene 38, ethylbenzene 39, 
o-, m- and p-xylene 40 and toluene 40 are studied because they are known toxicants 
present in cigarette smoke, exogenously sourced 41 and measurable in blood samples 
42. Cigarette smoke accounts for 90% of the exposure to benzene 43 and benzene is 
often proposed as smoking biomarker 44. Benzene is carcinogenic to humans (Group 
1) 38 and on the WHO priority list for regulation 45, and styrene 46, ethylbenzene 39 
and isopropylbenzene 47 are possibly carcinogenic to human (group 2B). The different 
78 | Chapter 3
isoforms of xylene, o-, m- and p-xylene and toluene 40 are central nervous system 
toxicants, and at present not classifiable to their carcinogenicity to humans (Group 
3) 44. The volatile 2,5-dimethylfuran has been added to the measurements because it 
is considered a validated qualitative biomarker of smoking status 48. Previously it was 
shown in a study with a series of brands of cigarettes in The Netherlands, that the 
yields of the various VOCs generated during machine smoking correlate with each 




The cigarette brands used in the study were Marlboro Red king-size and Marlboro 
Prime king-size because Marlboro is the most popular brand in the United States in 
2017 50 and has the largest market share in the Netherlands (35% in 2017) 51. The 
‘regular’ cigarette Marlboro Red has ISO 3308 declared TNCO yields of 10, 0.8 and 
10 mg/cigarette respectively. To cover the range of TNCO-yields available on the 
consumer market, we included Marlboro Prime, which is the lowest declared TNCO-
cigarette commercially available in The Netherlands with TNCO levels of respectively 
1, 0.1 and 1 mg/cigarette. The declared yields are based on the ISO smoking machine 
method 3308:2012 52. As a third cigarette type variation, the Marlboro Prime was 
also used in the human study with closed ventilation holes, called Marlboro Prime 
taped throughout this manuscript. A 100% vent blocking was achieved by taping the 
vents with 19 mm width Scotch Magic TM tape (Cat no: 810, 3M, USA). According 
to ISO 3308 machine smoking measurement of the Marlboro Prime taped, TNCO 
levels where 9.4, 0.5, and 13.3 mg/cig, respectively. Cigarette packages were bought 
in 2017 at a tobacconist in the Netherlands to guarantee matching batch numbers. 
Participant characteristics
A recruitment company (Link2Trials) recruited smoking volunteers using 
advertisements via national social media. The participants had to meet the following 
inclusion criteria; male, Caucasian/Europe-originated, age range of 25-34 years old, 
and smoking 13-25 Marlboro Red cigarettes per day (CPD) (~package/day) for at least 
three years. Exclusion criteria were suffering from respiratory diseases or chronic 
illness, daily medication use, and experiencing adverse effects due to smoking. 
This human study was conducted upon approval of the accredited medical ethical 
committee (NL63420.068.17 / METC173038) in Maastricht (The Netherlands) and 
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registered online at www.Clinicaltrials.gov (NCT03498053). Informed consent was 
signed before the experiment started and participation was rewarded with € 100,- 
per experimental day.
Study protocol
Twelve male participants were enrolled in the study and were studied during three 
identical experimental days of 10 hours that only differed by the type of cigarette 
smoked. During the first day, the smoking volunteers smoked their usual brand 
Marlboro Red. One week later, during the second experimental day the volunteers 
smoked Marlboro Prime, followed by the third study day of smoking Marlboro Prime 
taped. During the experimental day, participants could smoke cigarettes ad libitum. 
Because we included participants used to smoke 13-25 CPD, we expected >13 CPD 
during the study, which would comply with the study design. 
The study location was an apartment with a homelike atmosphere. During the 
experimental days, all participants consumed the same food products for breakfast, 
lunch, dinner, snacks and drinks that were ad libitum at their disposal. The interval 
days between the first and second study day were an adjustment period of a week 
at home to get used to the supplied Marlboro Prime. 
Participants arrived at 8 am and were instructed not to smoke before the start of 
the experiment. At the beginning of the first experimental day, participants signed 
the informed consent. Upon arrival, an intravenous peripheral canula was placed 
for blood sampling throughout the day (Figure 1). The baseline sampling included 
a venous blood sample followed by a breath sample (t=BL). Directly after baseline 
sampling, participants were allowed to light the first cigarette of the day which was 
noted as the start of the experimental day. After smoking this first cigarette, blood 
and breath, respectively, were sampled (T=0). To prevent imposing the participants 
to smoke at a certain time point in order to maintain their natural smoking behavior, 
the experimental day was divided in four timeslots of 2.5 hrs (Figure 1). Blood and 
breath sampling took place before and directly after (within 10 minutes) smoking the 
first cigarette in every timeslot (T=BL – 2.5; T=2.5 – 5; T=5 – 7.5; T=7.5 – 10). More 
specifically, first blood (duration ~2 min) and then breath (duration ~5 min) where 
sampled. To avoid excessive sampling, no blood and breath were sampled before and 
after smoking the possible additional cigarettes in a timeslot. After sampling T=10, 
the peripheral venous canula was removed and participants could go home.
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Figure 1: Schematic overview of the study design per study day. Only the hypothetical 
time point of smoking the first cigarette in a timeslot is depicted. 
VOCs analysis in blood headspace
Blood sampling
Via the peripheral venous canula, four mL of venous blood was sampled into EDTA 
containing Vacutainers® (Beckton Dickenson; K2E (EDTA) 7.2 mg; REF 368861) 
after which the tubes were stored in the fridge (> 5°C) until analysis. In total, eight 
blood tubes were sampled for determination of VOCs in headspace. 
Standards
A VOC mixture consisted of benzene, ethylbenzene, isopropylbenzene, m/p-
xylene, o-xylene, styrene, toluene (M-502A-R2; 0.2 mg/mL), 2,5-dimethylfuran 
(177717-25ML) and benzene–D6 (561509-10X.75ML) was acquired from Sigma-
Aldrich (Zwijndrecht, The Netherlands). Ethylbenzene–D10 (AccuStandard, 
M-624-SS-08) was acquired from DaVinci Laboratory Solutions (Rotterdam, The 
Netherlands). The internal standard (IS) comprised of benzene-D6 (200 ng/mL) and 
ethylbenzene-D10 (200 ng/mL) was mixed in purge and trap grade methanol (J.T. 
Baker; 61009077.1000, acquired from Boom B.V. (Meppel, The Netherlands). Blood 
of a 41-year-old Caucasian male non-smoker was spiked with VOC mixture and IS to 
create a calibration curve ranging from 0 to 2000 pg/mL. 
GC-MS-detection and quantitation of blood headspace VOCs
Blood sample preparation was performed on ice (0 °C). Two mL of venous blood 
was transferred from the EDTA Vacutainers® into 20 mL glass headspace vials 
(VWR; 548-0248) and closed with a magnetic screw cap with septum (VWR; 548-
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0245), in duplicate. Solid-phase micro extraction (SPME) was used to sample VOCs 
in the headspace of venous blood (intermediate phase) with instrumental setup 
based on a published method 42. Results of control experiments can be found in the 
Supplementary Materials. Headspace vials were transferred into a rotating agitator 
oven (40°C at 500 rpm) where after 10 sec, a 75-µm SPME fiber (Carboxen®/
polydimethylsiloxane (PDMS) was injected for VOC adsorption (6 min). After 
adsorption, the fiber was injected into the hot inlet (300°C) of an Agilent Technologies 
7890 GC system for 35.5 minutes. The split-splitless injector was set to use pulsed 
splitless mode. After the first 1.5 min pressure pulse, a laboratory-grade helium flow 
was kept at 1 mL/min. The DB-624 UI column (Agilent Technologies) was kept in an 
oven at 50°C for 5 min followed by a ramp of 5°C/min to 200°C (hold time 0 min) 
and a ramp of 30°C/min to 260°C (hold time 1 min). After a total run time of 38 min, 
a transfer line to the Agilent Technologies 5977 Mass Selective Detector (MSD) was 
kept at 280°C. 
The MSD was set to scan/SIM (single ion monitoring) in high-resolution mode 
for masses between 35 and 200 m/z. The most abundant m/z was used for 
quantification. The run was divided into timeframes of 1 min. For the target 
components benzene, ethylbenzene, isopropylbenzene, m/p-xylene, o-xylene, 
styrene, toluene, 2,5-dimethylfuran, quantifier and qualifier masses were identified 
using the National Institute of Standard and Technology (NIST) library. The highest 
mass of each compound was used for quantification. Integration of peaks of the 
quantifier mass was checked manually for each compound, whereby qualifier peaks 
were used as a control. First, peak area of the IS was used to correct for sampling 
variation. Hereby was benzene-D6 used for benzene, 2,5-dimethylfuran and toluene, 
and ethylbenzene-D10 for all other compounds. Secondly, VOC concentrations 
were calculated according to their specific calibration line.
VOC analysis in breath
Breath sampling
The ReCIVA Breath Sampler (Owlstone Medical, Cambridge, UK) was used for breath 
sampling in combination with the ‘Clean Air Supply Pump for ReCIVA’ (CASPER) 
(Owlstone Medical, Cambridge, UK). The CASPER allowed a continuous supply of 
room air at a flow rate of 40 L/min, passed through a scrubber containing Airpel® 
(Desotec Ltd, Roeselare, Belgium) activated carbon and HEPA filter to diminish the 
concentration of ambient VOCs in breath samples. Before sampling, the participants 
breathe through the CASPER for one minute to minimize exhaling VOCs coming 
from inhaled ambient air. Using the ReCIVA Breath Sampler VOCs were trapped 
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on two ¼’’ x 3.5’’ stainless steel tubes with tenax TA 35/60 carbograph 5TD 40/60 
sorbent (Camsco, Houston TX USA) with a sample flow of 200 mL/min. Because of 
continuous monitoring of pressure and CO2 levels within the mask during breathing, 
the device was able to sample 500 mL of the alveolar fraction of the exhaled air onto 
one tube. Each participant was asked to breath normally via nose-mouth mask. The 
inhalation took place by nose and exhalation by mouth. Each participated delivered 
two tubes, each filled with 500 mL of alveolar air. After trapping, the airtight-capped 
tubes were stored refrigerated (4 °C) until analysis.
GC-TOF-MS instrumentation of breath VOCs
VOCs were measured with thermal desorption (TD100, Markes International)-gas 
chromatography mass spectrometry combined with time-of-flight mass spectrometry 
(GC-TOF-MS), as previously described 27 with minor modifications. VOCs were 
released from the desorption tubes at 250 °C under a flow of helium with the use 
of automated thermal desorption and divided into two parts. Half of the vaporous 
sample was recollected on an identical tube whereas the other half was transmitted 
to an electrically-cooled sorbent trap programmed at 5 °C from which it was 
injected into a GC (Thermo Fischer Scientific, Austin, USA, column: Restek RTX-5ms, 
30 m × 0.25 mm ID, coated with 1.0 μm HP-5 phase). The gas chromatography started 
at 40 °C for 5 min and rose by 10 °C every minute until 300 °C was reached and kept 
for 5 min. After separation by GC the compounds were identified by TOF-MS (Bench 
TOF-dx, Alsmco International, Llantrisant, Wales, UK). Within TOF-MS part electron 
ionization at 70 eV was utilized with 5 Hz scanning rate over a range of m/z 35–350. 
Breath VOCs identification
Benzene, ethylbenzene, isopropylbenzene, m/p-xylene, o-xylene, styrene, toluene 
and 2,5-dimethylfuran were first manually identified in chromatograms using 
retention time and a NIST database (2018). An Xcalibur 2.2 processing method 
was set up to extract the base peak chromatogram (BPC) for each compound. The 
appropriate peaks were detected and integrated using the Genesis peak detection 
algorithm. The base peaks of mass spectrum were used for relative quantification 
of the target compounds. Bromobenzene-D5 (Art. 42269, Alfa Faser, Karslruhe 
Germany) was used as internal standard for all compounds and for normalization of 
retention times.
Statistical analysis
VOCs in headspace from blood were corrected for internal standard and a mean 
per duplicate was calculated and depicted in pg per mL blood. In case of <LOD, the 
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lowest measured value divided by two was used. The net increase in blood VOCs 
was calculated by subtracting the ‘before smoking’-concentration from the ‘after 
smoking’-concentration. The mean of four cigarettes, originating from the four 
different timeslots, demonstrated the average net increase per participant. Spearman 
correlation coefficients were calculated to show the relation between the increase 
of the individual VOCs in blood upon smoking (significant if p<0.01). Peak areas of 
VOCs in alveolar exhaled breath were corrected for the internal standard. From the 
raw area data, outliers were removed (values beyond 1st and 3rd quartile +/- 1.5* 
interquartile range). Statistical significance of differences were determined using a 
two-way ANOVA with participants and brands as factors, with p-value adjustment 
for multiple testing using the false discovery rate (FDR). Next, we calculated the 
Spearman correlation coefficients for the relation between the increase of individual 
VOCs in alveolar exhaled breath upon smoking, and deemed significant if <0.01. The 
Spearman correlation coefficients were calculated to relate increases in VOCs in 
blood with those in exhaled air, which were deemed significant if p<0.01.
Results
Participants characteristics
Twelve male participants in the age of 26 to 34 years old (mean age 29.8 years) were 
included. As self-reported, on average they smoked 19 cigarettes per day (15–20 cig/
day) since the age of 20 (16–28 years) old. During the study, participants smoked on 
average 11.7 Marlboro cigarettes (SD 2.7), 12.1 Marlboro Prime cigarettes (SD 2.4) 
and 12.2 Marlboro Prime taped cigarettes (SD 2.5). To adjust to the Marlboro Prime, 
during the period at home, participants smoked on overage 15.9 cigarettes (SD 5.4) on 
a daily basis. The number of cigarettes smoked per day differed between participants 
and the type of cigarette smoked (Figure S1). All participants smoked less cigarettes 
during the experiment than self-reported daily average. However, with a fluctuation of 
four cigarettes, most participants (except participant 11) held on their daily number of 
cigarettes smoked when they switched from Marlboro Red, to Prime, or Prime taped.
VOCs in headspace of venous blood
Benzene (155 pg/mL (SD 21.0)), toluene (473 pg/mL (SD 326)), styrene (128 pg/mL 
(SD 143)) and 2,5-dimethylfuran (62.7 pg/mL (SD 19.5)) were identified in headspace 
of all venous blood samples of the smokers in the morning before starting smoking. 
The other VOCs were inconsistently present (i.e. Day 1 BL present, Day 2 BL <LOD) 
in the early morning samples of participants after a night without smoking. After 
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smoking the first cigarette of Marlboro Red, Marlboro Prime or Marlboro Prime 
taped, all VOCs were detected in the consecutive samples during the day. The VOC 
levels in blood, except for isopropylbenzene, increased substantially (1.2-fold to 
5.5-fold) after smoking each cigarette (Figure 2, Figure S2, Table S2). Before the 
smoking in the n+1 timeslot, the concentrations of most VOCs decreased to levels 
close, but not similar, to that of the start of timeslot n. For example, concentrations 
of benzene in blood were less than 200 pg/mL blood in the early morning samples 
of all participants (table S1). After smoking the first cigarette of Marlboro Red, the 
concentration increased in most cases beyond 200 pg/mL, with almost 800 pg/mL 
as the highest for participant 5. At the start of the second timeslot concentrations of 
benzene in all participants had decreased to below 300 pg/mL, but for the majority 
of the participants not below 200 pg/mL. With increasing timeslot-numbers 
the ‘before-smoking’ samples had higher VOC concentrations than those of the 
previous timeslot. This gradual increase of ‘baseline’ was observed for all participants 
although differences were found. The ‘baseline’ increase was the least for benzene 
and 2,5-dimethylfuran. The gradual increase of ‘baseline’ throughout the day was 
observed for all three types of cigarettes smoked by the participants. Only the levels 
of isopropylbenzene before and after smoking do not show a ‘baseline’ pattern.
When the ‘before-smoking’ VOC levels in blood of all participants and all timeslots 
were averaged, and compared to the averaged ‘after-smoking’ levels, the increases of 
VOCs substantially varied between participants. VOC levels after smoking Marlboro 
Prime and Marlboro Prime taped are significantly higher than that of Marlboro Red 
for most VOCs (except styrene and isopropylbenzene) (Table S2).
The net increase of the levels of VOCs in blood (except isopropylbenzene and styrene) 
upon smoking one cigarette differs significantly (all p<4.5E-06, FDR<1.2E-05) 
between the individual participating smokers (Table 1). However, smokers with 
relatively low net increases of VOC levels in blood upon smoking Marlboro Red also 
show relatively low net increases upon smoking Marlboro Prime and Marlboro Prime 
taped. Smoking Marlboro Prime taped typically gave the largest net increases for all 
VOCs (except isopropylbenzene).
The net increase of levels in blood upon smoking the three cigarette types for all 
participants correlated well for most of the VOCs, i.e., correlation coefficient varied 
from 0.9 to 0.97 (all p<1.08E4) (Figure S3). Correlation coefficients of styrene were 
>0.61 but not significant whereas isopropylbenzene showed no correlation at all 
with the other VOCs (Figure S3).
































Benzene upon smoking Marlboro Red



























Benzene upon smoking Marlboro Prime


































































Ethylbenzene upon smoking Marlboro Red



























Ethylbenzene upon smoking Marlboro Prime
































































Toluene upon smoking Marlboro Red



























Toluene upon smoking Marlboro Prime






























































m/p-xylene upon smoking Marlboro Red



























m/p-xylene upon smoking Marlboro Prime


































Sample moment relative to smoking
Figure 2: Benzene levels in headspace of blood (pg/mL) before and after smoking Marlboro 
(left), Marlboro Prime (middle) or Marlboro Prime taped (right) for the first cigarette in the four 
subsequent timeslots during the experimental day (left to right on X-axis). Different colors 
depict the individual participants. 
VOCs in breath
VOC levels could only be expressed relative to each other as no absolute 
concentrations can be calculated due to methodological limitations. VOCs in breath 
data is missing for participant 1-Marlboro and participant 10 due to analytical 
problems. For the other participants, benzene, ethylbenzene, m/p-xylene, o-xylene, 
styrene, isopropylbenzene and toluene were detected in ‘baseline’ breath samples 
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of all participants after early morning sampling. After smoking, on average VOCs 
showed an increase in breath concentrations after smoking all cigarette types (Figure 
3). Participants’ VOC levels in exhaled breath typically increased 1.3-fold (benzene) 
to 4.6-fold (2,5-dimethylfuran) upon smoking Marlboro Red (Table 2). Almost similar 
fold-increases in exhaled breath levels were found in all smokers upon smoking 
Marlboro Prime. Smoking Marlboro Prime taped resulted in even larger increases of 
breath levels of VOCs. The highest increase in levels in exhaled breath were found 
for 2,5-dimethylfuran when Marlboro Prime taped was smoked (7.1-fold increase).
The individual VOC increases in breath due to smoking showed significant correlation 
coefficients varying from R=0.77 to 0.90 (p<2.4E-3) (Figure S4). Isopropylbenzene, 
styrene and 2,5-dimethylfuran have a weak, not significant, relationship with the 
other VOCs. 
Table 1: Net and fold increases per VOC in headspace of blood (pg/mL) upon smoking 
Marlboro red, Marlboro Prime or Marlboro Prime taped
VOC


















Benzene 295.3 256.0 2.5 326.4 265.5 2.5 505.1 388.4 3.4 7.1E-01 4.8E-03
Ethylben-
zene 183.7 123.4 3.1 210.2 134.6 3.1 290.9 192.1 3.8 2.9E-01 7.4E-03
Toluene 1274.7 969.9 2.8 1513.8 1059.2 2.9 2191.7 1600.9 3.4 2.8E-01 8.2E-03
m/p-
Xylene 182.3 113.3 3.0 226.1 143.6 2.9 284.1 207.9 3.6 5.2E-02 7.6E-02
o-Xylene 70.5 44.7 2.3 94.4 65.5 2.4 115.9 86.0 2.8 2.5E-02 1.3E-01
Styrene 224.8 179.5 2.1 271.3 204.7 2.4 384.3 278.8 2.7 3.8E-01 2.9E-02
Isopropyl-




356.6 255.7 4.2 371.6 254.1 4.0 513.8 380.9 5.5 9.3E-01 2.1E-02
pg/mL pg/mL pg/mL pg/mL pg/mL pg/mL
Net increase: mean ‘after smoking’ minus mean ‘before smoking’. Fold increase: mean ‘after 
smoking’ divided by mean ‘before smoking’. n=4 cigarettes per participant and thus n=48 in 
total per VOC. In case of a higher ‘before smoking’ than ‘after smoking’, zero was used. MR; 
Marlboro Red, MP; Marlboro Prime, MPT; Marlboro Prime taped. Bold; false discovery rate 
significant if <0.05
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Relation between VOCs in blood and breath
The relations between the individual VOC-increases in blood and exhaled air upon 
smoking of the three types of cigarettes is shown in Figure 4. Ethylbenzene, toluene 
and m/p-xylene levels show the strongest relation between blood and breath 
samples (respectively R=0.51, R=0.50, R=0.46, all significant). The relation between 
blood and breath levels varies between R=0.32 and R=0.43 for o-xylene, benzene, 








































































































































































































































Figure 3: mean percentage increase of VOCs. Benzene, ethylbenzene, m/p-xylene, o-xylene, 
styrene, isopropylbenzene and toluene in alveolar exhaled breath is depicted in the left 
graph and 2,5-dimethylfuran in the right graph. The mean percentage increase is based on 
measurements in alveolar exhaled breath before and after the first cigarette in the three 
timeslots during the experimental day. The different symbols indicate the different participants. 
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Table 2: Average fold increase of VOCs in breath upon smoking Marlboro Red, Marlboro 
Prime and Marlboro Prime taped.
VOC
Average fold increase per cigarette type
Marlboro Red Marlboro Prime Marlboro Prime taped
Benzene 1.3 1.4 1.6
Ethylbenzene 1.8 1.9 2.1
Isopropylbenzene 0.9 1.2 1.3
m/p-Xylene 1.6 1.7 1.9
o-Xylene 1.9 2.0 1.9
Styrene 2.3 2.4 1.8
Toluene 1.6 1.7 2.1
2,5-dimethylfuran 4.6 3.4 7.1
Discussion
The objective of the present study is to determine the level of VOCs uptake in blood 
upon smoking and the relation between VOCs in blood and breath upon smoking 
three types of Marlboro cigarettes. By including only male volunteers which are 
familiar Marlboro smokers we limited variations of smoking topography based on 
gender or brand. The study design enabled us to focus on the influence of ventilation 
on toxicant exposure. 
Consumption of each cigarette resulted in exposure of the smoker’s lung and 
increased concentrations of many of the VOCs in blood and breath. Elevated VOC 
levels in breath are considered to provide information about the presence of smoke 
constituents taken up into the blood and other body tissues. As exhaled breath was 
sampled after a few minutes of regular breathing, elevated VOC concentrations in 
breath are not caused by remains of mainstream smoke in the lungs 20. Since VOCs 
are omnipresent in ambient air already, baseline levels can also be present in the 
blood of non-smokers. However, the average morning before smoking (=baseline) 
benzene levels in blood of the 12 participants in the study at hand were 155 pg/
mL blood, was substantially higher than levels in non-smokers, which were <28 
pg/mL 53. These levels are comparable to blood levels of daily smokers measured 
in the National Health and Nutrition Examination Survey (NHANES) (139 pg/mL 
blood) 53. As expected, smokers in the present study have 2,5-dimethylfuran blood 
levels (321.5 pg/mL blood) far above non-smoker levels (<14 pg/mL blood) 54. Upon 
inhalation, only a fraction of the VOCs is absorbed into the circulation as not all 
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chemicals reach the alveoli due to depth of inhalation 20. Another fraction is exhaled 
immediately; the mean residence time of benzene in the lungs is short (0.9 min) with 
decay rate in exhaled breath of approximately 15 min 22. Moreover, it was estimated 
that approximately 50% of the benzene exposure dose is absorbed in the body (range 
between 20–60%) 55. We sampled respectively blood and exhaled within 10 minutes 
after smoking and found substantial increases of VOC levels in exhaled breath and 
blood upon smoking cigarettes (except for isopropylbenzene). Others were able to 
use exhaled breath levels of VOCs as acute internal dose markers to quantify the 
systemic uptake of chemicals into the blood or the body56,57. However, in the study 
at hand, we observed only weak correlations with VOC levels in breath and levels 
determined in blood. Whereas we assumed that breath measurements can be seen 
as a headspace measurement of blood (depending on Henry’s constant), the addition 
of direct exhaled residual lung VOCs are putatively hampering to show this relation 
56,58. An explanation for this may be that we first sampled blood (duration of ~2 min) 
followed by breath (duration of ~5 min) in the 10 min after smoking, instead of at the 
same time which was not possible due to practical limitations.
The distribution of VOCs in tissues, their metabolism and their excretion via breath 
and urine may have been changed during these 10 minutes. Furthermore, the 
exhaled end-tidal breath concentrations may not equal the alveolar concentrations 
for VOCs, but reflect the bronchial concentrations, and hence the influence of 
the upper airways should be taken into account. In spite of these limitations the 
semi-quantitative breath VOCs markers are sensitive enough to reflect exposure 
to different types of cigarettes. Further research is required before exhaled breath 
can fully be used as an external exposure marker assessing the dose delivered to 
the lungs and the associated toxic burdening of pulmonary epithelium.  Particularly 
research is needed about the impact of the timing of the sampling after smoking.
The rapid rise in VOC concentrations in blood illustrates that all VOCs (except 
isopropylbenzene) are rapidly taken up into the blood during smoking. The increases 
of various VOCs in blood are also related to each other, suggesting that despite their 
different chemical and physico-chemical characteristics all these VOCs reach the 
alveoli and are taken up into the circulation. Only the isopropylbenzene, and to some 
degree styrene, uptake differs which can be due to their lower boiling point and gas 
pressure. It is likely that these two compounds are not only present in the gas phase 
of tobacco smoke, but may also be part of the particulate phase and are therefore not 
measured with the used method 59. Furthermore, the concentrations of these chemicals 
are low, which makes the chemical analysis sensitive for background exposure.





Figure 4: Scatter plots for the net increase of VOCs in blood versus exhaled breath upon smoking. Every 
symbol circle in the scatter plots represents per participant the mean net increase in the specific VOC upon 
smoking. Correlation coefficients and corresponding p-values are depicted. significant when p<0.01. Red is 
Marlboro Red, Green is Marlboro Prime and Blue is Marlboro Prime taped. 
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Individual smoking puffing patterns 35 influence the emission and actual uptake of 
chemicals after smoking a cigarette. This phenomenon, probably in combination 
with differences in metabolic capacity of individuals [23] is exemplified in our study, 
as for instance the level of benzene in blood of participant 1 smoking the first 
Marlboro Red cigarette of the day increased less than a factor two relative to the 
measurement before smoking. For participant 5 the increase was approximately a 
factor 4 when smoking the same type of cigarette under similar conditions. After 
uptake, blood concentrations drop because of xenobiotic metabolism, excretion 
and internal distribution of the chemicals. The analysis of blood samples in the 
various time slots shows that the time intervals are not sufficient to fully return to 
baseline levels for the VOCs 60. Gradually, VOC concentrations increase during the 
day, with strong pulses of increase upon smoking consecutive cigarettes. This was 
observed for all smokers and all three types of cigarettes. Interestingly, the number 
of cigarettes smoked by the participants was not substantially influenced by the type 
of cigarettes. Only one participant (P 11) smoked substantially less Marlboro Prime 
taped and Marlboro Prime, than Marlboro Red. Consequently, the gradual increase 
of ‘baseline’ concentration during the day was almost absent in this subject when 
smoking Marlboro Prime and Marlboro Prime taped.
Blood levels of VOCs showed the highest increase for toluene and a minimal 
increase for isopropylbenzene for Marlboro Red as well as Marlboro Prime (toluene 
> benzene > styrene > ethylbenzene > m/p-xylene > o-xylene > isopropylbenzene). 
The NHANES study reported a comparable order (toluene > m/p-xylene > benzene 
> styrene > ethylbenzene > o-xylene) of VOCs measured in blood of daily smokers 
61. Moreover, smoking increased blood concentrations of VOCs on average 2.7-fold 
for Marlboro Red and Marlboro Prime, and even more for Marlboro Prime taped 
(on average 3.3-fold). For example, the average increase for all participants for 
benzene in blood for Marlboro Red was 295 pg/mL, for Marlboro Prime 326 pg/
mL and for Marlboro Prime taped 505 pg/mL. Of the VOCs, toluene concentrations 
were the highest; an increase of 1275 pg/mL, 1514 pg/mL and 2192 pg/mL for 
the three cigarette types, respectively. When it is assumed that an adult man has 
approximately 5.6 L of blood, we can estimate that on average between 6.7 and 
11.7 µg of toluene is found in the blood circulation 10 minutes after smoking one 
cigarette for the three types of Marlboro cigarettes. There is no clear difference 
of VOC uptake into the circulation between Marlboro Red and Marlboro Prime, 
although these cigarettes have substantially different declared TNCO yields with ISO 
3308. In a laboratory study with smoking machines, we measured VOC yields with 
different smoking regimes (unpublished data) in a similar study design as described in 
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Pauwels et al. 62. With the HCI regime (55 mL per puff of 2 seconds, and 30 seconds 
inter-puff interval), yields were measured for toluene; 190.6 µg/cig for Marlboro Red 
(taped) and 163.2 µg/cig for Prime (taped), i.e. -14% difference. For Marlboro Red 
(taped) and Prime (taped) under modified ISO 3308 conditions (35 mL per puff of 2 
seconds, and 1 minute inter-puff interval) also -14% difference was found. However, 
when the ISO 3308 regime was used without taping the cigarettes, almost a 9-fold 
difference in yields was determined, i.e. 50.9 µg/cig for Marlboro Red versus 6.1 µg/
cig for Marlboro Prime (unpublished data). The results shown here for toluene were 
also found for benzene and the other VOCs studied, except for isopropylbenzene. 
The ISO 3308 regime with untaped cigarettes is in many jurisdictions mandatory for 
measuring TNCO emissions. We previously measured 0.9 mg tar, 0.2 mg nicotine 
and 1.6 mg CO per cigarette under ISO conditions for Marlboro Prime, and 10.4 mg 
tar, 0.8 mg nicotine and 8.5 mg CO per cigarette for Marlboro Red 62. The differences 
between emission yields of Prime and Red disappeared when cigarettes were taped, 
and/or smoked with a smoking machine according to the HCI regime. It supports the 
criticism on the use of the ISO 3308 regime as a foundation for risk assessment and 
tobacco product regulation. The large difference in yields generated with ISO 3308 
were not in line with the results in the human volunteer study at hand. Actually, 
in some cases the opposite is observed as indicated above. Whereas Marlboro 
Prime generates low yields for VOCs under ISO 3308 conditions compared to 
HCI or modified ISO 3308, like it does for TNCO, some smokers are exposed to 
higher concentrations of VOCs. Siu et al. compared the ‘less harmful’ ‘super slim’ 
cigarette with a reference cigarette and concluded increased levels of ammonia and 
formaldehyde in ‘super slim’ cigarettes, but not for CO, carbonyls, aromatic amines 
and volatile organics 63. Another study found only 14% lower levels of uptake of a 
biomarker of exposure of acrolein when smokers consumed low-TNCO cigarettes, 
but no statistically significant differences were measured of a biomarker for 1,3 
butadiene exposure 11. A recent study described no increase in VOC biomarkers who 
switched to low-TNCO cigarettes 64.
Most concentrations of VOCs in blood and breath were higher when smoking 
Marlboro Prime than smoking Marlboro Red within all participants, although often 
the difference was less than 20% between the two products. The difference between 
individuals for each of the VOCs was often larger. For example, VOC levels in blood 
differ up to 4-fold for participants 4 and 10. Similar differences could be observed 
in exhaled breath samples of VOCs in Figure 4. It shows that the actual exposure 
to smoke toxicants is to a large extent determined by the puffing topography of the 
individual. It also shows that different declared TNCO levels, as determined with ISO 
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3308, do not indicate differences in exposure of the smoker. Cigarettes with lower 
declared TNCO levels may expose smokers to similar or even higher levels of smoke 
toxicants. The actual uptake of smoke toxicants by the smoker may not be reduced 
when switching to brands with lower declared TNCO levels, since the characteristic 
individual puffing topography dominates the inhalation and exposure. Particularly 
for highly ventilated cigarettes, the determination of mainstream smoke yields with 
ISO 3308 generates data which are irrelevant for human smoking. 
Conclusions and Implications
The present study adds that ISO 3308 mainstream smoke yields of VOCs do not 
correspond to uptake of smoke toxicants during human smoking. Comparable 
biomarker concentrations of VOCs in blood and VOCs in breath resulted after 
smoking the three cigarette types: Marlboro Red, Marlboro Prime and Marlboro 
Prime taped. The study at hand reports internal doses of several VOCs upon 
smoking which can improve health risk assessments. Exhaled breath samples further 
support data of blood samples. Both blood and exhaled breath samples show that 
substantial differences exist between smokers. A characteristic puffing topography 
is more important for actual exposure to smoke toxicants than the brand smoked 35. 
Exhaled breath can serve as a semi-quantitative non-invasive marker for external 
dose exposure of volatile toxicants resulting from cigarette smoke exposure. The 
resulting data can be used in exposure assessments to relate to health outcomes. 
However, further research is required to improve quantifying the exhaled breath 
measurements, and to link exhaled breath chemicals to the toxicokinetics and 
metabolism of the individual smoke chemicals. In addition, research that resolves 
how internal and external dose data can be used in risk assessment is eligible.
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Supplemental information
Figure S1: Time of 
smoking Marlboro 
Red, Marlboro Prime 
or Marlboro Prime 
taped per individual 
participant in the four 
timeslots (10 hours). 
Blood and breath was 
sampled upon the first 
smoked cigarette in a 
timeslot (solid circle). 
Lighting the first 
cigarette of the day 
was defined as t=0. 
Participant 10 was a no 
show for experimental 
day 2 and 3.































Benzene upon smoking Marlboro Red
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Ethylbenzene upon smoking Marlboro Red



























Ethylbenzene upon smoking Marlboro Prime
































































Toluene upon smoking Marlboro Red



























Toluene upon smoking Marlboro Prime






























































m/p-xylene upon smoking Marlboro Red
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Figure S2: VOC levels in headspace of blood (pg/mL) before and after smoking Marlboro (left), 
Marlboro Prime (middle) or Marlboro Prime taped (right) for the first cigarette in the four 
subsequent timeslots during the experimental day (left to right on X-axis). Different colors 



























o-xylene upon smoking Marlboro Red



























o-xylene upon smoking Marlboro Prime
































































Styrene upon smoking Marlboro Red



























Styrene upon smoking Marlboro Prime
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Table S1: Baseline levels of VOCs in blood
Brand Baseline Benzene Ethyl-
benzene







red Mean 155.0 56.0 473.2 61.2 41.2 127.6 63.6 62.7
SD 21.0 49.3 325.9 48.8 36.8 142.4 107.6 19.5
Marlboro 
Prime Mean 169.5 68.6 532.0 81.1 50.0 115.4 88.4 77.5




Mean 148.9 63.1 546.4 77.2 46.7 127.8 142.4 56.3
SD 12.8 36.6 359.5 33.5 17.9 110.2 155.4 14.6
Average Mean 157.8 62.6 517.2 73.2 46.0 123.6 98.1 65.5
SD 8.6 5.2 31.7 8.6 3.6 5.8 32.9 8.9
Table S2: Net increase per VOC in blood (pg/mL) upon smoking Marlboro red, Marlboro Prime 
or Marlboro Prime taped for the different participants including an average net increase per 
participant (mean (SD))
Brand Benzene SD Ethylben-
zene
SD Toluene SD m/p-Xy-
lene






P1 MR 167.5 118.4 122.9 60.1 1088.1 440.3 123.1 50.6 48.3 21.6 217.6 126.0 79.8 79.8 297.8 171.3
MP 160.9 55.0 136.4 18.1 927.0 263.0 155.3 1.5 77.4 9.5 167.4 100.0 14.6 8.5 218.4 57.9
MPT 222.8 176.3 195.5 92.7 1406.8 790.5 170.1 99.8 88.2 40.3 879.0 335.9 42.8 38.0 238.5 129.2
Mean 180.2 123.9 147.6 68.3 1116.5 549.9 147.7 63.5 69.8 30.5 379.7 366.2 46.0 59.3 252.8 132.9
P2 MR 436.3 263.6 252.9 153.7 1469.7 865.4 250.3 149.4 96.1 60.3 311.2 262.5 0.0 0.0 431.0 261.7
MP 433.8 315.0 304.8 144.7 2309.4 1419.2 333.9 166.9 131.8 59.4 484.4 171.3 69.9 47.0 563.4 384.8
MPT 653.5 479.0 352.8 232.8 2540.6 1873.5 354.9 248.3 125.8 95.4 354.7 196.9 35.9 36.0 639.7 454.8
Mean 507.9 378.6 303.5 186.0 2106.6 1517.5 313.0 198.3 117.9 75.3 383.4 226.0 35.3 44.5 544.7 385.5
P3 MR 439.0 301.0 266.6 142.2 1654.3 1152.4 254.9 122.3 93.2 37.8 237.7 235.5 84.0 145.5 505.9 301.9
MP 761.7 267.7 401.6 112.4 2802.0 701.2 398.3 129.1 142.8 37.1 495.4 194.3 128.6 116.0 634.2 208.6
MPT 818.4 522.3 416.3 240.3 2851.9 1835.8 383.0 251.3 157.1 97.7 475.8 143.5 2.3 4.0 599.1 399.3
Mean 673.0 415.9 361.5 186.4 2436.1 1426.9 345.4 189.0 131.0 69.7 403.0 227.3 71.6 119.5 579.7 317.8
P4 MR 103.3 42.7 98.1 45.8 886.4 318.1 99.3 66.4 38.6 24.2 339.9 181.6 63.5 64.4 159.3 66.6
MP 125.7 37.5 97.2 26.4 583.6 139.2 94.0 42.4 45.8 38.6 306.0 70.1 52.9 54.0 116.1 31.0
MPT 224.5 99.6 149.3 87.8 804.5 307.3 109.5 86.9 53.6 54.4 155.1 122.4 143.0 31.9 147.3 68.5
Mean 151.2 84.6 114.9 64.0 758.2 296.7 101.0 68.0 46.0 41.4 267.0 155.2 86.4 65.7 140.9 60.8
P5 MR 328.8 153.1 223.4 89.5 1135.4 329.2 233.6 55.4 90.0 19.8 246.9 159.1 83.1 109.3 304.7 132.3
MP 267.0 43.8 229.9 48.9 1567.2 200.1 242.7 51.1 100.3 30.7 140.9 130.4 121.9 86.0 291.4 49.1
MPT 729.9 302.1 488.6 134.3 3880.8 1333.9 536.7 207.9 218.1 99.1 511.1 120.9 51.8 89.7 970.7 441.4
Mean 441.9 284.6 314.0 157.3 2194.5 1447.6 337.6 190.1 136.1 84.3 299.7 207.9 85.6 99.7 522.3 414.9
P6 MR 264.3 208.3 196.1 141.7 761.8 874.8 214.4 120.8 78.8 59.4 232.9 239.5 110.5 191.3 264.4 170.0
MP 275.6 116.4 160.2 48.6 885.3 792.6 175.8 45.0 52.2 32.3 137.3 136.2 37.8 65.5 293.8 119.7
MPT 396.7 135.7 261.2 86.4 1885.3 1095.5 270.4 103.4 136.8 72.3 450.5 302.5 151.4 91.9 448.1 182.4
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Marlboro 
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SD 8.6 5.2 31.7 8.6 3.6 5.8 32.9 8.9
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or Marlboro Prime taped for the different participants including an average net increase per 
participant (mean (SD))
Brand Benzene SD Ethylben-
zene
SD Toluene SD m/p-Xy-
lene
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MP 433.8 315.0 304.8 144.7 2309.4 1419.2 333.9 166.9 131.8 59.4 484.4 171.3 69.9 47.0 563.4 384.8
MPT 653.5 479.0 352.8 232.8 2540.6 1873.5 354.9 248.3 125.8 95.4 354.7 196.9 35.9 36.0 639.7 454.8
Mean 507.9 378.6 303.5 186.0 2106.6 1517.5 313.0 198.3 117.9 75.3 383.4 226.0 35.3 44.5 544.7 385.5
P3 MR 439.0 301.0 266.6 142.2 1654.3 1152.4 254.9 122.3 93.2 37.8 237.7 235.5 84.0 145.5 505.9 301.9
MP 761.7 267.7 401.6 112.4 2802.0 701.2 398.3 129.1 142.8 37.1 495.4 194.3 128.6 116.0 634.2 208.6
MPT 818.4 522.3 416.3 240.3 2851.9 1835.8 383.0 251.3 157.1 97.7 475.8 143.5 2.3 4.0 599.1 399.3
Mean 673.0 415.9 361.5 186.4 2436.1 1426.9 345.4 189.0 131.0 69.7 403.0 227.3 71.6 119.5 579.7 317.8
P4 MR 103.3 42.7 98.1 45.8 886.4 318.1 99.3 66.4 38.6 24.2 339.9 181.6 63.5 64.4 159.3 66.6
MP 125.7 37.5 97.2 26.4 583.6 139.2 94.0 42.4 45.8 38.6 306.0 70.1 52.9 54.0 116.1 31.0
MPT 224.5 99.6 149.3 87.8 804.5 307.3 109.5 86.9 53.6 54.4 155.1 122.4 143.0 31.9 147.3 68.5
Mean 151.2 84.6 114.9 64.0 758.2 296.7 101.0 68.0 46.0 41.4 267.0 155.2 86.4 65.7 140.9 60.8
P5 MR 328.8 153.1 223.4 89.5 1135.4 329.2 233.6 55.4 90.0 19.8 246.9 159.1 83.1 109.3 304.7 132.3
MP 267.0 43.8 229.9 48.9 1567.2 200.1 242.7 51.1 100.3 30.7 140.9 130.4 121.9 86.0 291.4 49.1
MPT 729.9 302.1 488.6 134.3 3880.8 1333.9 536.7 207.9 218.1 99.1 511.1 120.9 51.8 89.7 970.7 441.4
Mean 441.9 284.6 314.0 157.3 2194.5 1447.6 337.6 190.1 136.1 84.3 299.7 207.9 85.6 99.7 522.3 414.9
P6 MR 264.3 208.3 196.1 141.7 761.8 874.8 214.4 120.8 78.8 59.4 232.9 239.5 110.5 191.3 264.4 170.0
MP 275.6 116.4 160.2 48.6 885.3 792.6 175.8 45.0 52.2 32.3 137.3 136.2 37.8 65.5 293.8 119.7
MPT 396.7 135.7 261.2 86.4 1885.3 1095.5 270.4 103.4 136.8 72.3 450.5 302.5 151.4 91.9 448.1 182.4
table
continues
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Mean 312.2 169.4 205.8 108.2 1177.4 1057.2 220.2 103.0 89.2 67.2 273.6 270.2 99.9 136.6 335.4 178.8
P7 MR 491.3 132.6 269.3 57.0 1614.7 304.3 229.4 50.5 84.3 22.2 226.5 71.6 1.4 2.4 464.8 97.7
MP 521.7 121.3 325.6 81.6 2396.1 500.9 354.0 80.0 180.5 69.1 364.0 105.4 32.0 26.9 600.7 110.6
MPT 410.4 272.2 227.9 141.5 1804.9 1095.3 221.9 138.4 91.9 47.1 237.9 166.4 19.6 27.0 485.8 289.0
Mean 474.5 194.1 274.3 107.6 1938.6 790.6 268.4 114.2 118.9 66.3 276.2 136.1 17.6 25.3 517.1 196.6
P8 MR 127.2 53.5 90.6 47.1 562.1 247.2 66.3 41.7 22.3 18.4 131.0 80.0 59.9 99.9 172.2 58.2
MP 101.2 101.0 69.3 74.2 509.2 463.4 85.7 78.3 46.2 47.8 213.8 304.2 68.8 119.1 135.7 103.3
MPT 350.0 99.3 210.0 45.7 1497.6 290.3 204.9 28.3 73.8 19.4 446.6 260.5 30.0 30.5 383.0 55.1
Mean 192.8 141.8 123.3 84.3 856.3 571.1 119.0 81.5 47.4 38.0 263.8 271.0 52.9 92.9 230.3 132.6
P9 MR 262.4 60.8 168.1 38.7 1497.2 312.3 189.0 36.9 86.2 13.7 241.1 153.1 101.3 98.3 397.2 100.3
MP 332.2 139.9 254.1 92.9 1842.6 647.2 292.0 94.9 134.6 43.3 303.5 148.6 4.0 6.9 578.0 193.5
MPT 810.0 344.9 422.9 160.4 3221.6 1353.1 419.2 170.8 152.2 65.7 282.7 179.3 49.2 83.2 812.4 301.5
Mean 468.2 326.5 281.7 152.2 2187.1 1156.4 300.1 148.5 124.4 53.9 275.8 163.0 51.5 84.4 595.9 273.9
P10 MR 137.7 44.6 93.8 31.1 774.4 234.4 98.9 24.2 45.6 10.9 104.1 71.2 16.8 29.0 233.2 49.8
P11 MR 649.9 415.8 303.9 167.3 2968.7 1739.9 299.5 146.9 120.5 54.3 280.8 167.2 8.8 15.3 783.0 416.5
MP 501.4 313.4 266.3 116.5 2192.9 1076.7 290.2 132.0 110.9 61.0 310.0 126.7 15.3 15.7 477.0 173.4
MPT 763.4 315.1 392.6 135.6 3517.8 1340.0 368.4 126.5 148.9 63.3 470.5 210.1 0.0 0.0 723.6 214.0
Mean 638.2 367.4 320.9 150.9 2893.1 1513.1 319.3 139.8 126.8 61.8 353.8 190.6 8.1 14.1 661.2 317.3
P12 MR 136.4 71.2 119.1 41.5 884.1 338.8 128.7 35.1 42.2 9.3 128.3 72.3 0.0 0.0 265.5 109.4
MP 109.2 23.2 66.5 9.5 636.6 92.9 65.1 3.2 15.7 4.6 61.5 22.3 0.0 0.0 178.6 33.3
MPT 106.3 40.3 58.4 5.6 500.4 121.1 57.5 5.3 21.8 4.2 87.1 40.3 0.0 0.0 134.9 51.3
Mean 117.3 50.9 81.3 36.6 673.7 266.9 83.8 38.0 26.6 13.0 92.3 56.6 0.0 0.0 193.0 90.5
ANOVA 
participants 1.91E-07 * 3.83E-07 * 3.83E-07 * 3.83E-07 * 1.21E-05 * 7.43E-02 9.2E-01 3.83E-07 *
ANOVA brands 1.80E-03 * 1.13E-03 * 1.13E-03 * 3.52E-03 * 3.52E-03 * 8.94E-03 * 9.20E-01 1.92E-02 *
Net increase: mean ‘after smoking’ minus mean ‘before smoking’. n=4 per participant per VOC 
and brand. In case of a higher ‘before smoking’ than ‘after smoking’, the average increase was 
set to zero. MR; Marlboro Red, MP; Marlboro Prime, MPT; Marlboro Prime taped. *;false 
discovery rate significant if <0.05
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Figure S3: Spearman correlation and scatter plots for mean net increase of benzene, toluene, ethylbenzene, 
m/p-xylene, o-xylene and 2,5-dimethylfuran in blood upon smoking. Every open circle in the scatter plots 
represents per participant the mean net increase in the specific VOC upon smoking. Red is Marlboro, Green 
is Marlboro Prime and Blue is Marlboro Prime taped. 
 
Figure S3: Spearman correlation and scatter plots for mean net increase of benzene, toluene, 
ethylbenzene, m/p-xylene, o-xylene and 2,5-dimethylfuran i  bl od upon smoking. Every 
open circle in the scatter plots represents per participant the mean net increase in the specific 
VOC upon smoking. Red is Marlboro, Green is Marlboro Prime and Blue is Marlboro Prime 
taped.






Figure S4: Spearman correlation and scatter plots for the percentage increase of VOCs in exhaled breath upon 
smoking. Every open circle in the scatter plots represents per participant the mean net increase in the specific 
VOC upon smoking. Correlation coefficients and complementary p-values are depicted. Significant when 
p<0.01. Red is Marlboro Red, Green is Marlboro Prime and Blue is Marlboro Prime taped. 
 
  
Figure S4: Spearman correlation and scatter plots for the percentage increase of VOCs in 
exhaled breath upon smoking. Every open circle in the scatter plots represents per participant 
the mean net increase in the specific VOC upon smoking. Correlation coefficients and 
complementary p-values are depicted. Significant when p<0.01. Red is Marlboro Red, Green 
is Marlboro Prime and Blue is Marlboro Prime taped.
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Supplementary information - Control and validation experiments
Table S3: calibration line data and calculated LOD and LOQ
Toluene 2,5-dimeth-
ylfuran






(pg/mL) area area area area area area area area
0 2234 44 573 173 84 231 574 25
0 2273 47 559 177 114 242 548 23
31 2247 125 790 203 195 354 697 96
31 2382 70 821 222 200 347 789 82
31 2211 95 767 184 193 326 710 62
31 2543 130 823 210 204 363 813 176
62 2540 135 979 320 255 379 921 165
62 2465 162 968 229 240 378 859 187
62 2831 162 1054 280 270 444 1041 306
62 2892 182 1126 263 273 398 957 210
125 2959 303 1354 295 418 546 1295 689
125 3142 353 1487 361 416 597 1409 574
125 3124 343 1382 352 425 590 1407 532
125 3318 359 1497 379 478 586 1445 659
250 3668 668 2107 540 696 851 2120 1632
250 3963 658 2224 535 726 911 2279 1761
250 3666 541 2029 471 667 792 2022 1299
250 4012 616 2222 488 716 797 2122 1705
500 5174 1208 3614 800 1326 1345 3456 3948
500 4745 1104 3480 884 1237 1336 3454 3455
500 4985 1150 3571 884 1241 1357 3428 3883
500 5071 1137 3623 894 1279 1417 3574 3677
1000 7683 2155 6414 1518 2299 2455 6450 8827
1000 8153 2350 6602 1674 2470 2614 6583 8920
1000 7423 2229 6264 1502 2414 2383 6141 8487
2000 13734 4615 13357 3073 4790 4891 12615 20851
2000 14368 5049 13594 3120 4990 4798 12717 22780
Intercept Stan-
dard Error 60.68 22.46 49.23 10.81 13.27 12.92 29.36 187.62
Slope 5.78 2.36 6.29 1.45 2.36 2.27 5.98 10.65
LOD 34.7 31.5 25.8 24.6 18.6 18.8 16.2 58.1
LOQ 105.0 95.3 78.3 74.6 56.2 56.9 49.1 176.2
LOD: 3.3*Intercept SE/slope. LOQ: 10*Intercept SE/slope
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Previous studies report about VOC background levels in Vacutainers 1 and in the 
Vacutainer stoppers 2. To check for background levels of VOCs, we filled Vacutainers 
with water. The measurements showed no contamination and only some background 
noise was seen. The Vacutainers with water and spiked VOCs found the right 
amounts.
We checked the loss of VOCs during storage and transfer. 
1. We tested that if the vacutainer were stored at <5°C (fridge) and pipetting was 
performed on ice, it resulted in a negligible loss of VOCs. 
2. A series of vacutainers filled with blood and spiked with VOCs were kept for 
2 weeks. Every day, an analysis was done. If analysis was performed within 10 
days, no loss of VOCs was found.
3. We tested the loss of VOCs because of open vacutainers and found that the 
loss of VOCs was negligible. We measured VOCs in spiked vacutainers after 
they were open for 15 sec, 30 sec, 45sec, 1min, 2 min and 5 min. The time blood 
is exposed to room air (open vacutainer, pipet blood to headspace vial, close 
vial) took ~5 sec. An open vacutainer for 15 sec resulted in a relative response 
of 92.7%.
Table S4: Results open vacutainers
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Table S5: VOCs, retention time, quantifier and qualifiers
Compound Retention time (min) Quantifier Qualifier 1 Qualifier 2
2-butene 1.39 41 56 39
1,3-butadiene 1.422 39 54 53
2,3-dimethyl-1,3-butadiene 5.72 67 82 41
Benzene-D6 9.02 84 52 56
Benzene 9.15 78 77 51
2-pentanone 11.64 43 86 41
2,5-dimethylfuran 11.378 96 95 43
Toluene 15.03 91 92 65
Ethylbenzeen-D10 19.29 98 116 114
Ethylbenzene 19.55 91 106 51
m/p-xylene 19.89 91 106 105
o-xylene 21.05 91 106 105
Styrene 21.08 104 103 78
Isopropylbenzene / cumene 22.17 105 120 77
1,2,4-trimethylbenzene 25.04 105 120 77
Naphthalene-D8 32.65 136 108 137
Naphthalene 32.75 128 127 102
Breath: in case of undetectable peaks (noise), the lowest AUC of the specific VOC was used 
and divided by 2. This was only applicable to 2,5-dimethylfuran (AUC 12 / 2 = 6), m,p-xylene 
(AUC 941.9 / 2 = 470.9) and isopropylbenzene (AUC 1.77 / 2 = 0.9).
References
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use in the analysis of volatile organic compounds in human blood at the low parts-per-
trillion level. J Chromatogr Sci. 1995;33(10):557-560.
2. Chambers DM, McElprang DO, Waterhouse MG, Blount BC. An improved approach for 
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Abstract
Human smoking behavior influences exposure to smoke toxicants and is important 
for risk assessment. In a prospective observational study, the smoking behavior of 
Marlboro smokers was measured for 36 h. Puff volume, duration, frequency, flow 
and inter-puff interval were recorded with the portable CReSSmicro™ device, as has 
often been done by other scientists. However, the use of the CReSSmicro™ device 
may lead to some registration pitfalls since the method of insertion of the cigarette 
may influence the data collection. Participants demonstrated consistent individual 
characteristic puffing behavior over the course of the day, enabling the creation 
of a personalized puffing profile. These puffing profiles were subsequently used as 
settings for smoking machine experiments and tar, nicotine and carbon monoxide 
(TNCO) emissions were generated. The application of human puffing profiles led to 
TNCO exposures more in the range of Health Canada Intense (HCI)-TNCO emissions 
than for those of the International Standardization Organization (ISO). Compared to 
the ISO regime, which applies a low puff volume relative to human smokers, the 
generation of TNCO may be at least two times higher than when human puffing 
profiles were applied on the smoking machine. Human smokers showed a higher 
puffing intensity than HCI and ISO because of higher puffing frequency, which 
resulted in more puffs per cigarette, than both HCI and ISO.
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Introduction
Around 6.5 million deaths are annually attributable to tobacco smoking worldwide 
and occur after suffering from tobacco related-diseases 1. The relationship between 
tobacco smoking and tobacco related-diseases depends on the quantity and 
composition of the inhaled cigarette smoke. The adverse health impact of exposure 
to smoke toxicants is determined by the number of smoked cigarettes, smoking 
years, cigarette brands, cigarette emissions and smoking topography 2-5. How these 
determinants influence the relationship between smoking and health effects and if 
they can be used to assess individual health risks require further elucidation 6. For 
example, carcinogen intake from mainstream smoke was shown to vary by four-
fold between smokers due to inter-individual differences in smoking behavior 7. In 
general, however, literature about personal smoking behavior and actual exposure 
of the lungs to smoke toxicants is scarce 6. The importance of these individual 
differences is underlined by the finding of Song et al. who demonstrated a relationship 
between lung adenocarcinoma and higher smoke volumes in combination with 
deeper inhalation of low-tar, nicotine and carbon monoxide (TNCO) cigarette smoke 
8. Two consecutive processes determine the individual exposure of a smoker: the 
generation and emission of tobacco smoke during puffing, followed by inhalation 
of this emission by the smoker 3. These two processes interplay and determine the 
intake of emitted smoke into the mouth cavity and lungs of the smoker. Interestingly, 
experienced smokers adjust their puffing topography, consciously or not, to modulate 
their nicotine, flavor and carbon monoxide (CO) exposure 9.
The puffing behavior relates to how a smoker smokes a cigarette and is characterized 
by parameters such as puff volume, puff duration, inter-puff interval and the 
number of puffs. Together, these puff parameters influence the airflow through 
the burning rod, which on its turn determines the combustion and pyrolysis rate of 
the tobacco and the physico-chemical processes inside the cigarette. For example, 
a high airflow induces higher temperatures and increases mass burn rate of the 
tobacco (mg/puff) 10,11. Additionally, an increased puffing intensity (i.e., the product 
of puff volume and puff frequency) leads to more rapid burning of tobacco and less 
increased tar, nicotine and CO yields 12-14. However, TNCO yields were shown to 
correlate linearly with total puff volume (i.e., the product of puff volume and puff 
number) 14. Moreover, several studies using machine smoking have shown that 
varying puffing profiles lead to differences in volatile organic compounds (VOCs) 
15, polycyclic aromatic compounds (PAHs) 16 and aldehydes 17 in cigarette emissions. 
For machine-smoked cigarettes, emissions of TNCO and other toxicants are at least 
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two times higher when a Health Canada Intense (HCI) regime 18 was applied than 
when International Standardization Organization (ISO) 3308 regime 19 settings were 
used 20. Among the different puff parameters, puff volume showed the greatest 
effect on carbonyl delivery 4. Smoking behavior has been widely studied and was 
summarized for the last time in a report in 2000 21. Since 2000, Chen et al. published 
a study wherein a total puffing volume of 360 mL/cigarette was determined 22, i.e., 
the lowest value we could identify. This is almost four times lower than the 1289 
mL/cigarette calculated with the data from Ross et al. and Farris et al. 23,24, i.e., the 
highest total puffing volume reported. The variation in puffing topography data 
published thus far may be explained by differences between cigarette brands as well 
as by inter-individual and intra-individual differences. Inter-individual differences 
in puffing topography are influenced by gender, ethnic background and type of 
cigarette. Indeed, it is known that women take smaller puffs of shorter duration but 
more puffs per cigarette than men 7, Korean-Americans, for instance, smoke with 
higher average puff flows and shorter inter-puff intervals than White-Americans 25, 
and that menthol and low-TNCO cigarettes are smoked with a higher puff volume 
and longer puff duration than regular cigarettes 26,27. Furthermore, intra-individual 
differences are observed and smokers vary their smoking depending on the setting 
28, cues 29, nicotine dependence, mood and emotional status 30. In addition, there 
is variation throughout the course of the day as, for instance, the first cigarette in 
the morning is puffed less intensely 31, whereas smokers leaving work-stations to 
smoke outside buildings smoke their cigarettes nearly 19% more intensely than 
cigarettes smoked in social settings 32. The research setting also affects smoking 
behavior, as smokers have more intense smoking behavior during lab visits than in 
a private setting 28. To minimize the influence of brand or experimental setting, we 
have performed a human volunteer study in a real world setting with 25- to 34-year-
old males to determine their puffing topography, when smoking only one brand of 
cigarettes ad libitum. Based on the observed puffing profiles of individuals, these 
personal smoking profiles were mimicked on a smoking machine and mainstream 
smoke TNCO levels were analyzed. With the results of the study, we aim to better 
understand the relevance of the machine smoking emission data (generated with 
ISO and Health Canada regimes) in relation to exposure of human smokers.
During analysis of the individual smoking topography data, we noticed unexpected 
outcomes in our study. Compared to the literature, a large number of puffs in combination 
with a high puffing volume were registered. Puffing topography was, like in many other 
studies, recorded with the CReSSmicro™ device. This device is described as a reliable and 
accurate instrument to record human smoking behavior 33-35. However, we know from 
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the literature that there is inconsistency in data treatment 36. Moreover; malfunctions 
or anomalous data have been described; for example, high volumes (up to 5 L) 37 and a 
wide range of puffs (7–43 puffs) 38. Furthermore, signal dropouts from unknown origin 
were found in the raw data of a study wherein the device was considered for measuring 
vaping behavior 39. To investigate the origin of the unexpected data, we evaluated 
the CReSSmicro™ device in its performance to record human smoking behavior. 
Materials and methods 
Literature search
The last review listing smoking behavior originates from 1999 9. Therefore, an 
extensive literature search was performed for articles reporting puffing topography 
data that where published since 2000. The sources were the electronic databases 
PubMed, SCOPUS, EMBASE and WHO report series. Search terms included smoking 
topography, puffing topography, smoking behavior, puffing parameters, and smoker(s) 
or smoking in combination with human study. Reference lists were reviewed for 
additional references. Studies were included if puffing parameters were recorded 
by a desk or portable smoking topography device. Only puffing topography data of 
(mentally) healthy participants were included, and also when this was a control group. 
Recruitment of participants
Five male participants were recruited by national social media. Only Caucasian/
Europe-originated male smokers accustomed to using Marlboro red/regular 
cigarettes were included. Participants had to be used to smoking 13–25 cigarettes 
a day for at least 3 years. Participants were excluded if suffering from respiratory 
diseases or chronic illnesses, daily medication use, and experience of adverse effects 
due to smoking. The study was approved, according to the Declaration of Helsinki, 
by the accredited medical ethical committee (METC 153057) in Maastricht (The 
Netherlands) and registered online at ToetsingOnline (NL55676.068) (i.e., Dutch 
internet portal for the submission, review, registration and publication of medical 
research involving human subjects). Informed consent was signed before the 
experiment started and participation was rewarded with €100,-.
Study protocol
The participants stayed in an apartment for 36 h to create a homelike atmosphere, 
where they had breakfast, lunch, dinner, snacks and drinks ad libitum at their disposal. 
Participants arrived at 8 p.m. to sign informed consent and receive CReSSmicro™ 
118 | Chapter 4
usage instructions. Hereafter, participants could settle in the apartment and were 
allowed to smoke freely. The next morning, lighting the first cigarette of the day 
was noted as the start of the experimental day (t = 0). During the day, participants 
could smoke Marlboro cigarettes ad libitum using the CReSSmicro™. The experiment 
ended after smoking the last cigarette of the evening before going to sleep. The next 
morning, participants could leave. 
Cigarette brand
The cigarette type used in the study was Marlboro red/regular king-size, since 
Marlboro is the most popular cigarette brand in the United States 40 and has the 
largest market share in the Netherlands, varying between 32% and 39% during the 
2012–2017 period 41. The researchers bought all cigarettes at a tobacconist in The 
Netherlands to pursue matching batch numbers. Cigarettes in the manufacturer’s 
unopened packaging were stored until their distribution to participants. Tar, nicotine 
and CO levels were 10, 0.8 and 10 mg/cigarette, respectively, as measured by the 
ISO method according to the package. 
CReSSmicro™ analysis
Time of smoking was noted to give an overview of the natural smoking moments 
during the day. Puff parameters of all cigarettes smoked during the experimental 
day were monitored and recorded with the handheld, portable version of the clinical 
research support system (CReSSmicro™ v2.0.0; Plowshare Technologies, Baltimore, 
MD, USA) 34,35,42. The device has a sterilized flow meter mouthpiece connected to a 
pressure transducer, which converts pressure into a digital signal that is sampled at 
50 Hz. CReSSmicro™ computer software transforms the signal to a flow rate (mL/s) 
to compute puffing topography data. The three CReSSmicro™ devices used were 
calibrated according to procedures described in the manufacturer’s user manual. The 
calibration was verified at the end of every experimental day. The software of the 
CReSSmicro™, designed by Borgwaldt, uses the 50 Hz raw data to show a summary of 
puff profiles in the viewer of the program. A puff cleanup procedure (using the CReSS 
CleanUp program) was followed to make correct machine-generated artefacts in the 
data. In the case of inter-puff interval (IPI) <300 msec, the volume and duration were 
combined with the previous puff and remaining puffs with duration <100 msec or 
volume <5 mL were deleted as they are most likely noise from the machine. The 
puff parameters according to the software were presented as descriptive statistics 
(frequencies, means and standard deviations) for puff duration (sec), puff volume 
(mL), inter-puff interval (sec), flow per puff (mL/sec) and the number of puffs taken 
per cigarette per participant. The summarized data were used to calculate a personal 
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puffing profile by linear regression of puff parameters versus the puff number, using 
a model with an intercept and slope for the overall data, as well as a first puff-specific 
parameter that allows for longer first puffs when lighting the cigarette. The raw data 
of the CReSSmicro™ device recordings were manually checked for anomalies such as 
flow rate dropouts or drops to zero (i.e., the record signal dropped to 0 mL/sec in the 
middle of a puff, and then went back up to the pre-dropout flow rate). 
Machine smoking and chemical analysis
The calculated personal puffing profiles were mimicked on the smoking machine. 
Mainstream smoke of Marlboro cigarettes was generated with a 10-port linear 
smoking machine (SM410RH, Cerulean, United Kingdom) with Human Puff Profile 
Software and a rounded sinusoidal waveform in 100 Hz steps. Cigarettes were 
smoked according to the personal puff profiles to determine tar and nicotine (in 
fivefold) and CO (in twofold) as described in detail in ISO 4387:2000, ISO 8454:2007, 
and ISO 10315:2014 21,43,44. 
CReSSmicro™ device evaluation experiment
An observatory experiment was performed to assess the impact of inserting a 
cigarette in the CReSSmicro™ device on flowrate recording. Based on the user 
manual, the insertion was guided with a beep to inform the smoker that the device 
is standing by and the smoking process will be recorded. We tested three methods 
of insertion; slow and loose insertion, normal insertion, and tight insertion whereby 
the cigarette is inserted as forcefully as possible without damaging it. The cigarettes 
were machine smoked with the CReSSmicro™ device positioned in the smoking 
machine, and in the adjacent port a cigarette was directly inserted into the cigarette 
holder of the smoking machine. The HCI regime 18 was set, which is a regularly used 
machine smoking regime (puff volume 55 mL, puff duration 2 sec, inter puff interval 
30 sec). A second smoking protocol derived from averaging puffing parameters in the 
literature included a puff volume of 65 mL, puff duration 2 sec and inter-puff interval 
18 sec. As an accuracy check, the recorded puff parameters by the CReSSmicro™ 
device were compared with the set smoking machine protocol. 
Results
The literature search resulted in 73 articles and reports specifying at least one or 
more puffing parameters. Table S1 in Supplementary Materials lists per article or 
report, the participants’ gender, age, Fagerström index, cigarettes per day, cigarette 
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type and recording device, if reported. The listed puffing parameters were puff 
volume, duration, flow, interval, count and total volume per cigarette and per day. If 
possible, missing puffing parameters were calculated. 
For the human study, the selected five male participants were 26 to 29 years old 
(mean 27.6 years). Based on self-assessment, they started smoking on average at 
the age of 16 years (10–20 years old) and had smoked on average 18 cigarettes per 
day (15–22 cig/day) since the age of 19 years (12–23 years old) (self-reported).
Smoking timepoints
Smokers could smoke ad libitum during the experimental day, which resulted in 
an average of 17 cigarettes per day (10–21 cig/day) (Figure 1). Time between two 
cigarettes differed between 20 min and 3 h. For all participants, the second cigarette 
of the day was smoked within an hour after the first cigarette and the final cigarette 
of the day within an hour before going to bed.
Figure 1. Smoking time points and total of cigarettes smoked by participants during the 
experimental day, describing their daily smoking behavior. Lighting the first cigarette of the 
day was defined as t = 0.
Personal puffing profile
The smokers included in the study expressed no differences in enjoyment or 
satisfaction between smoking with or without the CReSSmicro™ device. The 
average puff parameters per participant, according to the puff profile software of the 
CReSSmicro™ device, are depicted in Table 1. The number of cigarettes smoked during 
the day and the puff parameters (puff count, puff flow, puff duration, and inter-puff 
interval) per cigarette varied considerably between smokers. The average puff count 
ranged between 11 and 26 puffs. This is at least two puffs more than we previously 
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reported for machine smoking a Marlboro cigarette with smoking regimes of ISO 
and HCI 17. Smoker 1 had the highest puff count (26 puffs) and a high puff volume 
(80 mL), which is much higher than machine smoking under ISO or HCI regimes. 
Smoker 3 also had a high number of puffs (17 puffs) and the highest puff volume (93 
mL). Smokers 1 and 3 had a short smoldering period between two puffs (11 and 10 
sec), attributing to more puffs in total and the highest total puffing volumes. These 
highest total puffing volumes (2127 and 1582 mL) are at least five times the machine 
smoking ISO (280 mL) and three times the HCI (495 mL) total cigarette volume.




































Mean (SD) Mean (SD) Mean (SD)
Smoker 1 18 26 (8.9) 80 
(11.4)
43 (7.7) 1.9 (0.2) 11 (2.4) 2127 
(904)
38.3
Smoker 2 21 13 (1.3) 60 (5.7) 48 (3.0) 1.4 (0.1) 21 (5.8) 778 (123) 16.3
Smoker 3 10 17 (2.3) 93 
(13.9)
57 (7.3) 1.6 (0.1) 10 (4.6) 1582 
(296)
15.8
Smoker 4 13 11 (2.3) 44 (3.8) 51 (4.0) 0.9 (0.1) 26 (8.1) 495 (125) 6.4
Smoker 5 20 11 (1.0) 67 (4.1) 27 (2.3) 2.6 (0.2) 16 (3.1) 740 (79) 14.8
ISO * 8 35 17.5 2 60 280 $
HCI * 9 55 27.5 2 30 495 $
* Data originate from Pauwels et al. 17. (Marlboro red according to ISO 19 and HCI 18) # Cigarettes 
smoked during experiment. $ Puff count multiplied with puff volume. & Total cigarette volume 
multiplied with cigarette count. The italics represent calculated numbers.
The average puff volume (44 mL) of smoker 4 was in the range of the machine 
smoking regimes (35 and 55 mL). He had a short puff duration of 0.9 sec, which was 
half of the puff duration in the smoking regimes (2 sec). The longest puff duration was 
measured in smoker 5 (2.6 sec). As the puff volume (67 mL) and puff duration (2.6 
sec) were higher than in HCI (55 mL and 2 sec), it still led to a comparable puff flow 
as HCI (27 mL/sec). The average puff flow of all smokers was at least twice the puff 
flow of the ISO regime, except for smoker 5. A substantial different puffing profile can 
still lead to a total puffing volume per day in the same range, as is seen for smokers 
2, 3 and 5, with, respectively, a total puffing volume per day of 16.3, 15.8 and 14.8 L 
for all the cigarettes. However, as was shown by smokers 1 and 4, respectively, more 
than two times higher and lower total puffing volumes per day can also be observed
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Puff profile over the course of the cigarette
The puff-by-puff pattern over the course of a cigarette smoked, averaged for all 
cigarettes used during the day, is shown in Figure 2. Participants smoked all 
cigarettes according to a characteristic puff profile that displays large differences 
between individuals. Smoker 1 typically inhaled almost the same volume each 
consecutive puff of a cigarette with limited variation between cigarettes (Figure 2, 
panel a). His puff flow increased slightly with consecutive puffs (Figure 2, panel b), 
whereas the puff duration shortened (Figure 2, panel c). Only the first puff of each 
cigarette of this smoker was longer than the other puffs with lower puff flow. Except 
for smoker 5, the other participants also increased the puff flow after the first puff. 
All participants, except for smoker 3, shortened the puff duration with consecutive 
puffs. Smoker 3 doubled his puff volume during the course of the cigarette smoking 
with a stable duration of subsequent puffs and increasing puff flow during smoking 
cigarettes. However, this smoker showed significant differences in the way he smoked 
the various cigarettes, which resulted in large standard deviation of puff volumes. 
During the smoking process, the inter-puff interval or smoldering period was almost 
stable for smokers 1, 2 and 5 and slightly increased for smokers 3 and 4. However, all 
smokers had a deviating longer first to second puff interval. In summary, individual 
participants smoked all cigarettes according to personal puffing topography, allowing 
the generation of a characteristic profile using linear regression of the puff parameters 
(Figure 2, dashed line). Four randomly chosen cigarettes per participant were 
sufficient to calculate this personal puffing profile per participant, as adding more or 
different cigarettes to this calculation did not significantly modify the created profiles.
 
Machine Smoking Puffing Profile
The puffing parameters of the personal puffing profiles were used as input smoking 
regime settings (human puffing regime) for the smoking machine. The smoking 
machine successfully finished the human puffing regime of smokers 2, 4 and 5. The 
total puffing volume with machine smoking was within 10% range of the measured 
total puffing volumes with the CReSSmicro™ device in the human study for smokers 
2, 4 and 5. The human puffing regimes of smokers 1 and 3 consisted of an excessive 
number of puffs that was not possible to complete with the smoking machine as 
the tobacco was already completely burned before the total smoking protocol could 
be finished. This also explains why the total cigarette volume in machine smoking 
is lower than the total puffing volume measured with the CReSSmicro™ device for 
these smokers. The different human puffing regimes led to a range of TNCO yields 
in the smoke produced by the smoking machine (Table 2). Only the human puffing 
regime of smoker 4 showed TNCO yields within the range of HCI and ISO. When 
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human puffing regimes of the other smokers were applied on the smoking machine 
TNCO yields were almost twice the ISO TNCO yields. For most smokers, TNCO 
yields were even higher than yields produced with the HCI regime. The tar and 
nicotine yields of the human puffing regimes of smokers 1 and 3 were approximately 
70% more than the yield measured with HCI. CO yields were in the range between 
ISO and HCI, with an exception for the human puffing regime of smoker 1, which 
produced much higher yields.
Figure 2. Individual puffing profile consisting of volume (mL), average flow (mL/sec), duration 
(sec) and IPI (sec) of subsequent puffs (puff number) per smoker. Shown is the mean of all 
cigarettes smoked during the study day (black line) with SD (grey area), whereby the dashed 
line is the model fit.
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Table 2. Puff count per human puffing regime during machine smoking with associated total 













Smoker 1 12 (1.4) 1005 (116) 58 (9.6) 3.4 (0.4) 49 (0.8)
Smoker 2 12 (0.9) 710 (45) 32 (1.1) 2.1 (0.1) 18 (0.2)
Smoker 3 14 (1.0) 1200 (108) 59 (8.1) 3.3 (0.3) 27 (3.3)
Smoker 4 12 (0) 530 (0) 21 (1.4) 1.5 (0.1) 16 (&)
Smoker 5 11 (0.7) 754 (38) 38 (1.5) 2.4 (0.1) 20 (0.1)
ISO * 8 280 $ 10.37 0.8 8.51
HCI * 9 495 $ 34.04 1.97 26.27
* Data originate from Pauwels et al. 17. (Marlboro red according to ISO and HCI). & failed 
duplicate. $ calculated by puff count multiplied with puff volume.
Evaluation of CReSSmicro™ device
Marlboro cigarettes were machine smoked with the CReSSmicro™ device according 
to two different regime settings. The HCI regime settings were used, and a more 
intense setting with a higher puff volume (65 mL) and a shorter inter-puff interval 
(18 sec). The latter settings were close to the mean values of the five participants as 
listed in Table 1. 
The two smoking machine regimes were combined with the three methods of 
insertion of the cigarette into the CReSSmicro™ device (Table 3). The CReSSmicro™ 
recorded the puff duration, which was similar to the smoking machine setting in all 
cases. However, the puff volume as well as the inter-puff interval was not similar to 
the machine settings in most cases. The puff volume registered by the CReSSmicro™ 
was higher in all cases, whereas the inter-puff interval was shorter. For example, a 
~10% higher volume (59 mL) was measured with 55 mL puff volume after normal 
insertion with an inter-puff interval registered of 27 sec instead of 30 sec. 
The smoking machine generated 10–12 puffs to finish the cigarette directly inserted 
into the machine under smoking regimes (Table 3). For the cigarettes ‘tightly’ inserted 
into the CReSSmicro™ device and smoked on the smoking machine, a comparable 
number of puffs was observed for the two smoking regimes. For ‘normal’ or ‘loosely’ 
inserted cigarettes in the CReSSmicro™ device, however, up to 16 extra puffs were 
required to finish the cigarette on the smoking machine. 
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Higher puff count, higher puff volumes and shortened inter-puff intervals resulted in 
a higher total smoke volume for all experimental conditions when the CReSSmicro™ 
device was combined with the smoking machine.
Table 3. Puff parameters (mean) recorded by the CReSSmicro™ device while smoking via two 
regimes on the smoking machine. Cigarette insertion into the device in a ‘normal’, ‘loose’ and 
‘tight’ way.
Puff Parameter Smoking Machine or
CReSSmicro™ Device














Puff count Smoking machine 11 11 10 10 11 12
CReSSmicro™ device 18 20 18 26 11 13
Puff volume (ml) Smoking machine 55 65 55 65 55 65
CReSSmicro™ device 59 73 60 74 65 76
Puff duration (sec) Smoking machine 2 2 2 2 2 2
CReSSmicro™ device 2 2 2 2 2 2
Inter-puff interval 
(sec)
Smoking machine 30 18 30 18 30 18
CReSSmicro™ device 27 16 29 16 27 16
Total puffing 
volume (ml)
Smoking machine 990 1300 1008 1690 587 845
CReSSmicro™ device 1053 1453 1106 1932 692 983
Flow-dropouts CReSSmicro™ device 5 6 8 6 0 1
Regime 1: HCI settings (puff volume 55 mL, twice per minute for 2 sec). Regime 2: puff volume 
65 mL, 18 sec inter-puff interval and 2 sec duration.
The flow-dropouts in the raw data were characterized by the recorded signal dropping to zero 
followed by the pre-dropout flow rate, which could occur at any time during a puff and was 
visualized in Figure 3. In the case of a normal insertion, an occasional flow-dropout (five per 
cigarette) was measured in a single puff whereas when the cigarette is loosely inserted, more 
flow-dropouts occurred (nine per cigarette). No flow-dropouts occurred after tight insertion 
into the device, which means there was no failure in the flowrate recording.
Figure 3. Example of flow-dropouts in raw data collected with the CReSSmicro™ device, when 
recording the smoking (HCI regime) of an entire cigarette after different ways of inserting the 
cigarette. Every line represents one puff.
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Discussion
Characterizing human smoking behavior over the course of the day
Consumer exposure to smoke toxicants varies considerably due to differences in the 
emissions produced by different kinds of cigarette as well as differences in human 
smoking behavior. We measured puffing topography with the CReSSmicro™ device in 
smoking volunteers in a real-world situation. The puffing parameters of the participants 
were used as input for smoking machine experiments to determine TNCO emissions. 
Although some participants had a marginal variation in a specific puff parameter 
(e.g., participant 1 puff volume), overall, the puffing profiles of each cigarette smoked 
by the participants were not substantially different over the course of a day. This 
indicates that self-reported preferred cigarettes were not subject to change in puff 
parameters. This is in line with Hammond et al., who found a high degree of stability 
in puffing profile within subjects over time in three 1-week trials 45. Interestingly, a 
study of Grainge et al. found a slightly lower intensity of smoking of the first cigarette 
of the day compared to other cigarettes during the day 31.
Few studies have focused on puff parameters during the course of smoking a 
cigarette, i.e., puff-by-puff 46-48. We found a similar pattern as two other studies 
in adolescents, namely a decreased puff volume and duration, coupled with an 
increased puff flow and inter-puff interval 49,50. An increased puff flow over the 
course of the cigarette can be explained by the draw resistance due to a reduction 
in the length of the cigarette after each puff. An explanation of why smokers change 
their puff parameters over the course of the cigarette might be that as the cigarette 
shortens, the delivery of nicotine and other smoke constituents, including tar and 
CO, increases per puff 47. A decrease in the volume and duration of puffing may in 
turn bring about a consistent delivery of nicotine and CO throughout consecutive 
puffs of the cigarette. For all smokers, the first puff differs from the other puffs taken 
with a consequent different exposure content 51. This deviating first puff is referred 
to as the lighting puff as smokers might adapt their puffing in such a way to only 
light the cigarette properly, and not necessarily to dose nicotine, and therefore take 
a puff much shorter than the consecutive puffs. We assume that a short lighting puff 
is followed by a larger second puff that is fully inhaled. Furthermore, some other 
smokers take a large first puff (up to 3.5 sec instead of less than 2 sec on average), 
whereby we assume that a large first puff is fully inhaled in addition to lighting the 
cigarette. In a puff-by-puff study, the initial lighting puff and puffs between the first 
three and last three puffs were deleted 49. We suggest including all puffs because the 
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exposure estimate depends on smoking the whole cigarette.
Puffing topography in literature and the use of CReSSmicro™ device
The individual puff parameter data of smokers 2, 4 and 5 of the present study are 
in line with the wide range of puff parameter outcomes reported by other studies 
(Table S1 in Supplementary Materials), but not for smokers 1 and 3. Other studies 
vary in study design, setting, cigarette brand, changing cigarette characteristics over 
the years and study groups. Data reduction techniques and the impact of adjusting 
for puff count should be considered by interpreting different studies according to 
De Jesus et al., who systematically reviewed data produced with CReSSmicro™ 36.
In almost all studies, the puff duration is typically between 1 and 2 sec, although one 
study reported a shorter puff duration of 0.9 33, similar to participant 4 of the study 
at hand (0.9 sec), and another study reported a longer puff duration of 3 sec 52. Also, 
the lowest (31 mL 33) and highest (85.1 mL 53) puff volumes reported in the literature 
(Table S1 in Supplementary Materials) comprise the puff volumes in our study. The 
puff flow reported ranges from 25.6 54 to 62 mL/sec 53, which also comprises the 
puff flow in the present study (26–58 mL/sec). The average puff count reported in 
the literature (Table S1 in Supplementary Materials) is between 7.6 puffs (a low-tar 
cigarette) 22 and 20.4 puffs 24. 
We had a participant (smoker 1) with the extreme average puff count of 26. It was 
also this participant that had an extreme total puffing volume of 2127 mL, which is 
almost twice the highest total puffing volume reported in the literature (1451 mL/cig) 
55. For another participant (smoker 3), a very high puffing volume was also registered 
(1582 mL/cig), although the puff count was not high. Both smokers had a short 
inter-puff interval and a high puff volume registered by CReSSmicro™ device. When 
cigarettes were smoked with a large number of registered puffs in combination with 
a high puffing volume, a substantial number of flow-dropouts with the CReSSmicro™ 
device were observed. We randomly used three CReSSmicro™ devices following 
the instruction of the producer, and did not observe malfunctioning of individual 
devices.
We experimentally checked the outcomes of the CReSSmicro™ device data 
under controlled experimental conditions with a smoking machine and observed 
substantial differences between the CReSSmicro™ device data and the smoking 
machine settings. As was shown in the smoking machine experiment with the 
CReSSmicro™ device only flow-dropouts were registered for loose and normal 
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insertions, and were very limited with tight insertion (Figure 3). Tight insertion 
was the insertion method that produced a similar number of puffs in the smoking 
machine for a cigarette with and without the CReSSmicro™ device. When ‘normal’ 
insertion was applied, the number of puffs per cigarette increased, and consequently 
the total puffing volume. When ‘loose’ insertion was applied, the puff number more 
than doubled and puffing volume became extremely high, particularly when a high 
puff volume and short inter-puff interval was applied. This suggests that in the case 
of a loose or even normal insertion of cigarettes in the CReSSmicro™ device, in the 
human smoking experiment the smokers may depend on the insertion method, 
leading to the recording of puffing data which are a pitfall of the methodology. In 
our study, participants inserted the cigarettes themselves and did not indicate loose, 
normal or tight. However, they only followed the user manual of the device, and the 
researchers observed no deviating behavior. The summarized data in the software 
of the device gave no alert of incorrect or incomplete puff parameters, other than 
the flow-dropouts. Flow dropouts may, however, indicate that the device is not 
functioning properly. The recording of dropouts is also reported in the literature, but 
to the best of our knowledge no information is available whether or not data about 
‘high’ puffing volumes, or ‘high’ puff numbers, have been deleted in previous studies. 
During the machine smoking experiments, smoke was observed at the cigarette 
insertion opening in the device (Figure S1 in Supplementary Materials). During the 
smoking machine experiment, smoke at the mouth end of the cigarette was also 
observed, especially during the puff, and shortly after the puff. Human smoking with 
a loose insertion may lead to sidestream air entering the cigarette at the mouth 
end of the cigarette or air may be drawn directly into the device. In addition, as the 
filter (paper) is permeable at the mouth end of the cigarette, it may be possible that 
air is entering the device without passing or going through the cigarette, thereby 
diluting the smoke. On the other hand, it is also possible that smoke is leaking before 
entering the device. This was not mentioned by the participants nor observed by 
the researchers during our study. In the case of false air entering the device, we 
hypothesize that less tobacco is combusted with every puff, which makes it possible 
to take many puffs in total to finish the cigarette. If this artefact exists for a particular 
participant smoking a cigarette, he will try to inhale a large puff volume to satisfy 
his nicotine intake, probably in combination with many puffs. Due to the dilution of 
the smoke entering the smoker’s mouth and the low amount of tobacco burnt, the 
nicotine intake per puff will be low. The desired effect of nicotine is not attained 
because of this dilution, motivating the smoker to take larger puff volumes and more 
puffs than he would take without the device. 
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TNCO yields produced by machine smoking with personal human puffing 
regimes, ISO regime and HCI regime
There are three studies that had elements as in the present study. First, Hammond 
et al. recorded the puffing profile of 51 participants while smoking their usual brand; 
subsequently, the average puff volume and average puff frequency were used as 
parameters for machine smoking instead of the puff-by-puff profile as used in the 
study at hand 20. Second, Djordjevic et al. recorded puffing profiles of 133 smokers 
and 72 randomly chosen puffing profiles were used for smoking machine setting for 
the medium-yield cigarettes 56. Only averaged TNCO yields are reported and these are 
not linked to puffing parameters. In general, the literature data are averaged among 
study participants and almost no data from individuals are available. This hinders 
the comparison of study outcomes and identifying ‘extreme’ intense smoking. The 
third study, Dickens et al., is the only study found that reported individual puffing 
parameters (n = 7), but they were not replicated with a smoking machine 57. These 
participants also had intense puffing profiles with puff volumes in the range of 55 to 
119 mL per cigarette, with puff durations of 1.5 to 3.3 sec 57.
In our study, smoking machine experiments were used in a laboratory setting to 
determine cigarette smoke toxicant yields that are produced by puffing according to 
specified settings that were derived from the human smoking experiment. The linear 
regression (described in 2.5) showed that data of four cigarettes for a particular 
participant are sufficient to calculate the smokers’ personal human puffing regime. 
When the human puffing profiles of smoker 1 and smoker 3 were used for machine 
smoking settings, the cigarette was finished before the puff profile ended. In spite of 
this, these two human puffing regimes generated the highest TNCO yields. Since the 
recording of profiles with CReSSmicro™ device may have overestimated the actual 
inhalation, the data of these two smokers are not further taken into account. 
The least intense puffing profile (based on data of smoker 4, i.e., lowest puff volume 
and total cigarette volume, shortest puff duration and longest inter-puff interval) 
generated the smallest TNCO content. Hammond et al. reported less intense puff 
parameters (puff volume 53.3 mL, inter-puff interval 33.2 sec, puff duration 1.4 sec) 
than in the present study, and this might explain why they found lower TNCO values 
(tar 26.7 mg, nicotine 2 mg, CO 24.6 mg) for comparable ‘regular yield’ cigarettes 
(9–15 mg ISO tar) 20. In comparison with our puffing profiles of smokers 2, 4 and 5, 
the participants in the study of Djordjevic et al. had lower (total) puff volumes (523–
615 mL versus 495–778 mL in our study) and a longer inter-puff interval (19–21 sec 
versus 16–21 sec in our study) (similar puff duration (1.5 sec) and puff count (12 or 
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13 puffs)) 56. Our data, as well as data collected from the literature, indicated that 
the inter-puff intervals applied for ISO and for HCI (respectively 60 and 30 sec) are 
too long to represent human smoking. This leads to long smoldering and lower puff 
numbers when ISO and HCI regimes are applied.
In our study, tar yield was on average 29 mg/cig (21–38 mg/cig), nicotine 2.39 mg/cig 
(1.5–2.4 mg/cig) and CO 22.5 mg/cig (16–20 mg/cig). When TNCO yields generated 
according to human puffing regimes are compared to smoking machine generated 
emissions according to ISO and HCI settings (Table 2), it is clear that both ISO and 
HCI produce fewer puffs per cigarette. The HCI generates yields for TNCO which are 
in the same range yields produced with the human smoking regimes of smokers 2, 
4 and 5. This is consistent with previous studies 20. On average, the puff parameters 
of Hammond et al. 20 are more comparable with the HCI regime than those of the 
present study. They found that their human mimic regime on the smoking machine 
produced slightly less nicotine (2 vs. 2.4 mg/cig), tar (24.7 vs. 30.6 mg/cig) and CO 
(24.6 vs. 28.1 mg/cig) than the HCI regime, while they observed a larger total cigarette 
volume (53.3 mL × 11.5 puffs = 612.95 mL) and higher puff flow (38.6 mL/sec) 20. It 
was also clear that ISO regime underestimates human smoking substantially 20. The 
TNCO yields determined when using the human puffing profile regime were at least 
twice as high as the yields we determined with ISO 17 regimes on the same smoking 
machine. The total puff volume of 280 mL is very low compared to data reported in 
the literature, as well as the data generated in the study at hand. The lowest total 
puffing volume reported in the literature is 380 mL, which is close to that of the ISO 
regime for smoking machines 22. A higher volume per puff in combination with a 
higher puffing frequency better mimics human smoking intensity. 
The proxy of number of smoked cigarettes per day is often used in risk assessment 
modelling when estimating the dose of exposure to toxicants in smokers 7,58. 
However, as is shown in this study, this proxy has limitations for actual risk 
assessment of cigarettes since it does not correspond with total puffing volume per 
day. Others state that smoke volume correlates well with biochemically assessed 
human smoke exposure 31,45 and that total puff volume and duration measured 
with the CReSSmicro™ device are likely to give the best approximation for toxicant 
exposure estimates 36. Moreover, the inhalation of the cigarette smoke ultimately 
leads to systemic exposure. The puff parameters give an indication of total smoke 
volume and depth of inhalation 26, which provide information on which part of the 
lungs is reached by the smoke toxicants. To estimate the final systemic exposure 
to cigarette smoke toxicants, we need to relate smoke content, puffing parameters 
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and respiratory parameters, especially inhalation volume and duration. Knowledge 
about cigarette smoke inhalation parameters is limited and the realistic human 
puffing profiles and TNCO emissions from the present study can improve the 
predictions for (site-specific tissue dose) computer models 59. Studies often focus on 
the influence of a single determinant, i.e., age 49,50, gender 7, racial background 25,60,61, 
or cigarette brand 27,62 on smoking behavior in healthy smokers 33,63. The present 
study took place in a controlled, but not entirely artificial, real-world environment 
that accommodates the smoking experience 48,61,64. In the small but homogenous 
group, of smokers’ inter-individual differences in the number of cigarettes smoked, 
the time points of smoking, and the mean and total puff parameters were registered. 
This suggests that estimating overall exposure based on smokers’ characteristics is 
not sufficient and that variations of smoking topography contribute to the smoker’s 
risk. The limitation of the study at hand is that the current sample of smokers and 
cigarette brand is not representative for all smokers or cigarette brand. Moreover, 
other determinants might cause even more variations in cigarette emissions and 
exposures of the smokers.
Conclusions
Smokers smoke their cigarettes with consistent, individually characteristic puffing 
topography. These characteristic human puffing profiles show differences between 
smokers. The variety in puffing profiles within the homogenous study group of the 
present study was also seen in the compiled literature data of puffing topography 
studies since 2000 (Table S1 in Supplementary Materials). When the different 
characteristic human puffing regimes are mimicked on the smoking machine, 
differences in TNCO yields are generated. Comparison with machine smoking data 
shows that smokers are likely to be exposed to at least twice the TNCO yields as 
measured with ISO regimes on a smoking machine. This observation indicates that 
the ISO 3308 regime largely underestimates human exposure due to low puffing 
intensity. Smokers’ exposure to TNCO can probably be better estimated with 
machine smoking set on the HCI regime. However, the present study shows that 
the smoking machine with the HCI regime may also underestimate actual smokers’ 
exposure, because inter-puff intervals are shorter for human smokers than in the 
HCI regime.
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Supplemental information
Figure S1: Smoke is escaping (arrow) during the smoking with a smoking machine. The 
cigarette was loosely inserted in the CReSSmicro™ device.
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Table S1: Literature reporting puffing parameters in chronological order since 2000
Author Year Sort

























index SD Device Comments
Buchhalter 
et al 1  
2000 own brand 
(9,5 mg tar, 
0.73 mg 
nicotine)
10 ♂/♀ 23.2 3.4 15.3 4.1 38.4 11.7 1.2 0.4 32.0 35.0 17.9 10.3 2.1 395.5 6.1 4.0 1.2 CRSSPT
Djordjevic 
et al 2
2000 own brand 
(8.5 mg 
tar, 0.7 mg 
nicotine)























tar, 1.11 mg 
nicotine)























2002 own brand 
(10,2 mg 
tar, 0.8 mg 
nicotine)


















2002 own brand 
(9,4 mg tar, 
0.73 mg 
nicotine)








Dixon et al 5 2003 test cigarette 
(9.5 mg tar, 
0.77 mg 








(8.8 mg tar, 
0.48 mg 








(8.7 mg tar, 
0.81 mg 


















(7.7 mg tar, 
0.22 mg 







Lee et al 6 2003 own brand 
(16.7 mg 
tar, 1.2 mg 
nicotine)
7 ♂/♀ 37.0 25-44 25.0 10-38 30.8 SE 3.5 0.9 SE 0.1 44.6 SE 3.4 19.9 SE 3.5 9.3 284.9 7.1 6.8 4-10 CRSSPT 8, 8, 11, 10 puffs
own brand 
(12.8 mg 
tar, 1.0 mg 
nicotine)
10 ♂/♀ 24.5 20-37 25.0 17-40 45.1 SE 4.9 1.2 SE 0.1 54.4 SE 4.8 23.2 SE 3.0 10.0 451.0 11.3 6.0 3-9 CRSSPT
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Author Year Sort

























index SD Device Comments
Buchhalter 
et al 1  
2000 own brand 
(9,5 mg tar, 
0.73 mg 
nicotine)
10 ♂/♀ 23.2 3.4 15.3 4.1 38.4 11.7 1.2 0.4 32.0 35.0 17.9 10.3 2.1 395.5 6.1 4.0 1.2 CRSSPT
Djordjevic 
et al 2
2000 own brand 
(8.5 mg 
tar, 0.7 mg 
nicotine)























tar, 1.11 mg 
nicotine)























2002 own brand 
(10,2 mg 
tar, 0.8 mg 
nicotine)


















2002 own brand 
(9,4 mg tar, 
0.73 mg 
nicotine)








Dixon et al 5 2003 test cigarette 
(9.5 mg tar, 
0.77 mg 








(8.8 mg tar, 
0.48 mg 








(8.7 mg tar, 
0.81 mg 


















(7.7 mg tar, 
0.22 mg 







Lee et al 6 2003 own brand 
(16.7 mg 
tar, 1.2 mg 
nicotine)
7 ♂/♀ 37.0 25-44 25.0 10-38 30.8 SE 3.5 0.9 SE 0.1 44.6 SE 3.4 19.9 SE 3.5 9.3 284.9 7.1 6.8 4-10 CRSSPT 8, 8, 11, 10 puffs
own brand 
(12.8 mg 
tar, 1.0 mg 
nicotine)
10 ♂/♀ 24.5 20-37 25.0 17-40 45.1 SE 4.9 1.2 SE 0.1 54.4 SE 4.8 23.2 SE 3.0 10.0 451.0 11.3 6.0 3-9 CRSSPT
table continues
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index SD Device Comments
Aung et al 7 2004 own brand






Dixon$ 2004 10 mg tar, 1 
mg nicotine 100 ♂/♀ 46.2 1.9 24.2 24.7 12.6 558.0
4,8 mg tar, 
0.5 mg 
nicotine
100 ♂/♀ 58.6 1.9 31.7 21.7 16.6 939.0
2,8 mg tar, 
0.3 mg 
nicotine
100 ♂/♀ 57.6 1.9 30.6 19.7 15.0 844.0
1,2 mg tar, 
0.1 mg 
nicotine
100 ♂/♀ 63.4 1.9 33.2 18.7 18.8 1135.0
Dixon$ 2004 5,6 mg tar, 
0.5 mg 
nicotine
50 ♂/♀ 52.8 1.7 30.3 12.5 644.0
1 mg tar, 0.1 
mg nicotine 50 ♂/♀ 63.2 1.7 36.3 15.1 901.0
Hughes et 
al 8




34 ♂/♀ 48.0 30.0 SEM 2 50.0 SEM 2 12.7 SEM 0.7 612.0 SEM 34 18.4 6.4 2.0 CRSSPT
Omni light 
(12 mg 






tar, 1.0 mg 
nicotine)
34 ♂/♀ 48.0 31.0 SEM 2 49.0 SEM 2 11.6 SEM 0.5 547.0 SEM 25 17.0 6.4 2.0 CRSSPT
Lee et al 9 2004 own brand 
(14.5 mg 
tar, 1.1 mg 
nicotine)
10 ♂/♀ 30.3 19-46 21.3 13-30 60.1 4.0 1.1 57.1 3.5 11.5 0.7 691.2 14.7 5.4 3-9 CRSSPT
Strasser et 
al 10




113 ♂/♀ 45.8 10.7 21.2 7.8 54.8 16.9 1.6 0.5 34.3 8.2 24.8 11.9 12.7 4.0 675.7 244.7 14.3 5.5 2.1 CRSSPT
Wood et 
al 11
2004 own brand 24 ♀ 16.3 1.5 15.0 1-25 38.5 12.2 1.1 0.3 35.0 24.1 9.9 12.7 6.2 504.4 312.1 7.6 4.2 1.6 CRSSPT










2005 own brand 
(10-14 mg 
tar)




58 ♂/♀ 37.1 11.1 19.3 8.0 52.3 12.4 1.4 0.3 37.9 6.1 35.6 18.4 11.1 3.3 580.5 206.9 11.2 CRSSPT trial 2
Matinee 
Extra Mild (4 
mg tar, 0.8 
mg nicotine)
24 ♂/♀ 37.1 11.1 19.3 8.0 58.3 16.1 13.4 779.2 331.0 15.0 CRSSPT trial 3
Hitsman et 
al 14
2005 own brand 
(mean 0.8 mg 
nicotine)
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index SD Device Comments
Aung et al 7 2004 own brand






Dixon$ 2004 10 mg tar, 1 
mg nicotine 100 ♂/♀ 46.2 1.9 24.2 24.7 12.6 558.0
4,8 mg tar, 
0.5 mg 
nicotine
100 ♂/♀ 58.6 1.9 31.7 21.7 16.6 939.0
2,8 mg tar, 
0.3 mg 
nicotine
100 ♂/♀ 57.6 1.9 30.6 19.7 15.0 844.0
1,2 mg tar, 
0.1 mg 
nicotine
100 ♂/♀ 63.4 1.9 33.2 18.7 18.8 1135.0
Dixon$ 2004 5,6 mg tar, 
0.5 mg 
nicotine
50 ♂/♀ 52.8 1.7 30.3 12.5 644.0
1 mg tar, 0.1 
mg nicotine 50 ♂/♀ 63.2 1.7 36.3 15.1 901.0
Hughes et 
al 8




34 ♂/♀ 48.0 30.0 SEM 2 50.0 SEM 2 12.7 SEM 0.7 612.0 SEM 34 18.4 6.4 2.0 CRSSPT
Omni light 
(12 mg 






tar, 1.0 mg 
nicotine)
34 ♂/♀ 48.0 31.0 SEM 2 49.0 SEM 2 11.6 SEM 0.5 547.0 SEM 25 17.0 6.4 2.0 CRSSPT
Lee et al 9 2004 own brand 
(14.5 mg 
tar, 1.1 mg 
nicotine)
10 ♂/♀ 30.3 19-46 21.3 13-30 60.1 4.0 1.1 57.1 3.5 11.5 0.7 691.2 14.7 5.4 3-9 CRSSPT
Strasser et 
al 10




113 ♂/♀ 45.8 10.7 21.2 7.8 54.8 16.9 1.6 0.5 34.3 8.2 24.8 11.9 12.7 4.0 675.7 244.7 14.3 5.5 2.1 CRSSPT
Wood et 
al 11
2004 own brand 24 ♀ 16.3 1.5 15.0 1-25 38.5 12.2 1.1 0.3 35.0 24.1 9.9 12.7 6.2 504.4 312.1 7.6 4.2 1.6 CRSSPT










2005 own brand 
(10-14 mg 
tar)




58 ♂/♀ 37.1 11.1 19.3 8.0 52.3 12.4 1.4 0.3 37.9 6.1 35.6 18.4 11.1 3.3 580.5 206.9 11.2 CRSSPT trial 2
Matinee 
Extra Mild (4 
mg tar, 0.8 
mg nicotine)
24 ♂/♀ 37.1 11.1 19.3 8.0 58.3 16.1 13.4 779.2 331.0 15.0 CRSSPT trial 3
Hitsman et 
al 14
2005 own brand 
(mean 0.8 mg 
nicotine)
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index SD Device Comments
Strasser et 
al 15   
2005 Marlboro 
Light 100 
HP (10 mg 
tar, 0.8 mg 
nicotine)







HP (1 mg 
tar, 0.1 mg 
nicotine)







HP (1 mg 
tar, 0.1 mg 











2005 own brand 
(mean 1.1 mg 
nicotine)
20 ♂/♀ 51.0 12.0 29.0 11 47.5 10.4 1.3 0.2 36.5 42.0 21.5 8.9 2.3 429.0 159.0 12.4 7.4 1.3 CReSS
Breland et 
al 17
2006 own brand 
(9.89 mg 





















2006 own brand 66 ♂/♀ 15.1 1.3 19.0 8.4 36.0 13.5 1.1 0.4 35.6 10.6 18.2 10.6 5 180.0 3420.0 7.2 1.3 CReSS Fixed puff count
Hammond 
et al 19
2006 own brand 






Extra Mild (4 
mg tar, 0.4 
mg nicotine)










tar, 1.14 mg 
nicotine)




tar, 0.06 mg 
nicotine)
19 ♂/♀ 17.5 1.1 3.8 2 40.1 18.7 1.0 0.4 53.4 19.0 23.0 13.2 23.2 8.9 988.8 547.2 3.8 2.1 1.4 CReSS
Melikian et 
al 21
2007 own brand 
(10.1 mg 
tar, 1.92 mg 
nicotine)
129 ♀ 33.1 CI 31.2-35 15.9
CI 14.7-








tar, 2.2 mg 
nicotine)
128 ♂ 35.0 CI 33.3-36.9 16.8
CI 15.5-








2007 own brand 
(mean 12,9 
mg tar, 0.94 
mg nicotine)










832.0 CI 737-926 17.7 5.5 1.9 CReSS
Quest (10 mg 
tar, 0.6 mg 
nicotine)










580 11.5 5.5 1.9 CReSS
Quest (10 mg 
tar, 0.3 mg 
nicotine)










558 11.0 5.5 1.9 CReSS
Quest (10 mg 
tar, 0.05 mg 
nicotine)










614 12.2 5.5 1.9 CReSS
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index SD Device Comments
Strasser et 
al 15   
2005 Marlboro 
Light 100 
HP (10 mg 
tar, 0.8 mg 
nicotine)







HP (1 mg 
tar, 0.1 mg 
nicotine)







HP (1 mg 
tar, 0.1 mg 











2005 own brand 
(mean 1.1 mg 
nicotine)
20 ♂/♀ 51.0 12.0 29.0 11 47.5 10.4 1.3 0.2 36.5 42.0 21.5 8.9 2.3 429.0 159.0 12.4 7.4 1.3 CReSS
Breland et 
al 17
2006 own brand 
(9.89 mg 





















2006 own brand 66 ♂/♀ 15.1 1.3 19.0 8.4 36.0 13.5 1.1 0.4 35.6 10.6 18.2 10.6 5 180.0 3420.0 7.2 1.3 CReSS Fixed puff count
Hammond 
et al 19
2006 own brand 






Extra Mild (4 
mg tar, 0.4 
mg nicotine)










tar, 1.14 mg 
nicotine)




tar, 0.06 mg 
nicotine)
19 ♂/♀ 17.5 1.1 3.8 2 40.1 18.7 1.0 0.4 53.4 19.0 23.0 13.2 23.2 8.9 988.8 547.2 3.8 2.1 1.4 CReSS
Melikian et 
al 21
2007 own brand 
(10.1 mg 
tar, 1.92 mg 
nicotine)
129 ♀ 33.1 CI 31.2-35 15.9
CI 14.7-








tar, 2.2 mg 
nicotine)
128 ♂ 35.0 CI 33.3-36.9 16.8
CI 15.5-








2007 own brand 
(mean 12,9 
mg tar, 0.94 
mg nicotine)










832.0 CI 737-926 17.7 5.5 1.9 CReSS
Quest (10 mg 
tar, 0.6 mg 
nicotine)










580 11.5 5.5 1.9 CReSS
Quest (10 mg 
tar, 0.3 mg 
nicotine)










558 11.0 5.5 1.9 CReSS
Quest (10 mg 
tar, 0.05 mg 
nicotine)










614 12.2 5.5 1.9 CReSS
table continues
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index SD Device Comments
Strasser et 
al 24
2007 own brand 119 ♂/♀ 45.8 10.8 21.2 8.1 55.1 16.9 12.7 4.0 669.6 243.1 14.2 5.5 2.1 CReSS
Attwood et 
al 25
2008 own brand 55 ♂/♀ 22.0 4.0 11.0 5 49.0 12.0 1.6 0.4 31.6 14.0 5.0 17.0 6.0 833.0 9.2 4.0 2.0 CReSS
Collins et 
al 26
2008 own brand 67 ♂/♀ 15.3 1.3 >10 38.7 1.1 48.1 6 232.1 2.3 >5 CReSS Fixed puff count
Rees et al 27 2008 Marlboro 
Light (11 mg 
tar, 0.8 mg 
nicotine)
17 ♂/♀ 27.7 CI 24.3-31.0 15.7
CI 12.0-









Light (11 mg 
tar, 0.8 mg 
nicotine)
17 ♂/♀ 27.7 CI 24.3-31.0 15.7
CI 12.0-









Light (11 mg 
tar, 0.8 mg 
nicotine)
15 ♂/♀ 27.8 CI 35.5-32.1 15.9
CI 9.5-






- Salt Lake 
City group
Marlboro 
Light (11 mg 
tar, 0.8 mg 
nicotine)
15 ♂/♀ 27.8 CI 35.5-32.1 15.9
CI 9.5-











mg tar, 0.5 
mg nicotine)
17 ♂/♀ 27.7 CI 24.3-31.0 15.7
CI 12.0-










mg tar, 0.5 
mg nicotine)
17 ♂/♀ 27.7 CI 24.3-31.0 15.7
CI 12.0-










mg tar, 0.5 
mg nicotine)
15 ♂/♀ 27.8 CI 35.5-32.1 15.9
CI 9.5-










mg tar, 0.5 
mg nicotine)
15 ♂/♀ 27.8 CI 35.5-32.1 15.9
CI 9.5-











(5 mg tar, 0.4 

















(5 mg tar, 0.4 

















(5 mg tar, 0.4 

















(5 mg tar, 0.4 

















2008 own brand 131 ♂/♀ 31.4 10.4 13.4 5.7 54.2 14.0 1.5 0.5 37.7 7.8 25.8 10.3 13.6 4.5 712.0 232.0 9.5 2.3 1.4 CReSS
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index SD Device Comments
Strasser et 
al 24
2007 own brand 119 ♂/♀ 45.8 10.8 21.2 8.1 55.1 16.9 12.7 4.0 669.6 243.1 14.2 5.5 2.1 CReSS
Attwood et 
al 25
2008 own brand 55 ♂/♀ 22.0 4.0 11.0 5 49.0 12.0 1.6 0.4 31.6 14.0 5.0 17.0 6.0 833.0 9.2 4.0 2.0 CReSS
Collins et 
al 26
2008 own brand 67 ♂/♀ 15.3 1.3 >10 38.7 1.1 48.1 6 232.1 2.3 >5 CReSS Fixed puff count
Rees et al 27 2008 Marlboro 
Light (11 mg 
tar, 0.8 mg 
nicotine)
17 ♂/♀ 27.7 CI 24.3-31.0 15.7
CI 12.0-









Light (11 mg 
tar, 0.8 mg 
nicotine)
17 ♂/♀ 27.7 CI 24.3-31.0 15.7
CI 12.0-









Light (11 mg 
tar, 0.8 mg 
nicotine)
15 ♂/♀ 27.8 CI 35.5-32.1 15.9
CI 9.5-






- Salt Lake 
City group
Marlboro 
Light (11 mg 
tar, 0.8 mg 
nicotine)
15 ♂/♀ 27.8 CI 35.5-32.1 15.9
CI 9.5-











mg tar, 0.5 
mg nicotine)
17 ♂/♀ 27.7 CI 24.3-31.0 15.7
CI 12.0-










mg tar, 0.5 
mg nicotine)
17 ♂/♀ 27.7 CI 24.3-31.0 15.7
CI 12.0-










mg tar, 0.5 
mg nicotine)
15 ♂/♀ 27.8 CI 35.5-32.1 15.9
CI 9.5-










mg tar, 0.5 
mg nicotine)
15 ♂/♀ 27.8 CI 35.5-32.1 15.9
CI 9.5-











(5 mg tar, 0.4 

















(5 mg tar, 0.4 

















(5 mg tar, 0.4 

















(5 mg tar, 0.4 

















2008 own brand 131 ♂/♀ 31.4 10.4 13.4 5.7 54.2 14.0 1.5 0.5 37.7 7.8 25.8 10.3 13.6 4.5 712.0 232.0 9.5 2.3 1.4 CReSS
table continues
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index SD Device Comments
Blank et 
al 29
2009 own brand 
(mean 14.9 
mg tar, 1.1 
mg nicotine)
30 ♂/♀ 32.3 11.0 19.6 4.7 44.4 13.6 1.7 0.6 26.1 18.2 7.6 9.4 3.0 411.4 170.7 8.1 6.0 2.0 Portable CReSS
own brand 
(mean 14.9 
mg tar, 1.1 
mg nicotine)
30 ♂/♀ 32.3 11.0 19.6 4.7 57.0 20.1 1.7 0.7 33.5 18.1 8.8 9.7 3.3 578.7 327.2 8.1 6.0 2.0 Desktop CReSS
Merit ultra-
light (5 mg 
tar, 0.5 mg 
nicotine)
30 ♂/♀ 32.3 11.0 19.6 4.7 52.8 12.6 1.9 0.6 27.8 16.7 7.7 10.1 3.4 528.5 207.2 10.4 6.0 2.0 Portable CReSS
Merit ultra-
light (5 mg 
tar, 0.5 mg 
nicotine)






































2009 regular 130 ♂/♀ 31.4 10.5 13.6 6.1 56.2 13.8 1.6 0.5 35.6 26.6 10.5 13.2 4.1 711.7 208.3 9.7 Portable CReSS
Moolchan 
et al 31
2009 own brand 85 ♂/♀ 15.3 1.2 18.6 8.5 38.5 15.6 5 599.5 201.6 11.1 7.0 1.2 CReSS Fixed puff count
Collins et 
al 32
2010 own brand 89 ♂/♀ 15.3 1.3 18.6 9.2 41.5 1.2 1.3 0.0 53.9 2.0 14.5 0.7 15.2 630.8 11.7 7.3 1.3 CReSS
O'Connor 
et al 33
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index SD Device Comments
Blank et 
al 29
2009 own brand 
(mean 14.9 
mg tar, 1.1 
mg nicotine)
30 ♂/♀ 32.3 11.0 19.6 4.7 44.4 13.6 1.7 0.6 26.1 18.2 7.6 9.4 3.0 411.4 170.7 8.1 6.0 2.0 Portable CReSS
own brand 
(mean 14.9 
mg tar, 1.1 
mg nicotine)
30 ♂/♀ 32.3 11.0 19.6 4.7 57.0 20.1 1.7 0.7 33.5 18.1 8.8 9.7 3.3 578.7 327.2 8.1 6.0 2.0 Desktop CReSS
Merit ultra-
light (5 mg 
tar, 0.5 mg 
nicotine)
30 ♂/♀ 32.3 11.0 19.6 4.7 52.8 12.6 1.9 0.6 27.8 16.7 7.7 10.1 3.4 528.5 207.2 10.4 6.0 2.0 Portable CReSS
Merit ultra-
light (5 mg 
tar, 0.5 mg 
nicotine)






































2009 regular 130 ♂/♀ 31.4 10.5 13.6 6.1 56.2 13.8 1.6 0.5 35.6 26.6 10.5 13.2 4.1 711.7 208.3 9.7 Portable CReSS
Moolchan 
et al 31
2009 own brand 85 ♂/♀ 15.3 1.2 18.6 8.5 38.5 15.6 5 599.5 201.6 11.1 7.0 1.2 CReSS Fixed puff count
Collins et 
al 32
2010 own brand 89 ♂/♀ 15.3 1.3 18.6 9.2 41.5 1.2 1.3 0.0 53.9 2.0 14.5 0.7 15.2 630.8 11.7 7.3 1.3 CReSS
O'Connor 
et al 33
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2011 own brand 37 ♂/♀ 37.7 10.6 18.4 7.96 32.9 9.7 6.1 2.3 Portable CReSS
Strasser et 
al 37
2011 own brand 109 ♂/♀ 45.5 10.8 20.5 8.4 785.1 284.9 16.1 4.9 2.1 Portable CReSS
Veilleux et 
al 38















2012 Kent 100 
(non-






0.6 30.6 SEM 0.6 10.8
SEM 



















0.5 25.6 SEM 0.5 11.6
SEM 








2012 own brand 94 ♂/♀ 26.8 SE 1 19.5 SE 0.6 12.6 568.7 11.1 4.7 SE 0.2 Portable CReSS
Matsumoto 
et al 44
2013 Top 10 





One (1 mg 
tar, 0.1 mg 
nicotine)







(3-6 mg tar, 
0.3-0.5 mg 
nicotine)






10 mg tar, 
0.6-0.8 mg 
nicotine)
27 ♂/♀ 41.9 11.2 18.2 6.6 46.9 12.3 13.4 3.4 609.4 158.7 11.4 Portable CReSS
Hope, Seven 
Stars (14 mg 
tar, 1.1-1.2 
mg nicotine)
22 ♂/♀ 38.0 8.4 19.3 8.8 53.9 15.8 12.6 3.1 638.7 136.9 13.0 Portable CReSS
McClure et 
al  45
2013 own brand 135 ♀ 31.9 7.6 16.2 7 49.9 15.8 1.6 0.5 32.7 9.1 11.7 3.9 583.8 9.5 4.9 2.2 Portable CReSS
Strasser et 
al 46
2013 own brand 78 ♂/♀ 38.4 11.7 18.0 8 54.7 1.7 0.1 32.2 30.1 2.1 11.2 0.6 612.6 74.6 11.0 5.8 1.8 Portable CReSS
Day 1 - ci-
garette 1
own brand 78 ♂/♀ 38.4 11.7 18.0 8 46.7 1.7 0.1 27.4 33.7 3.2 11.1 0.8 517.9 36.8 9.3 5.8 1.8 Portable CReSS
Day 1 - ci-
garette 2
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2011 own brand 37 ♂/♀ 37.7 10.6 18.4 7.96 32.9 9.7 6.1 2.3 Portable CReSS
Strasser et 
al 37
2011 own brand 109 ♂/♀ 45.5 10.8 20.5 8.4 785.1 284.9 16.1 4.9 2.1 Portable CReSS
Veilleux et 
al 38















2012 Kent 100 
(non-






0.6 30.6 SEM 0.6 10.8
SEM 



















0.5 25.6 SEM 0.5 11.6
SEM 








2012 own brand 94 ♂/♀ 26.8 SE 1 19.5 SE 0.6 12.6 568.7 11.1 4.7 SE 0.2 Portable CReSS
Matsumoto 
et al 44
2013 Top 10 





One (1 mg 
tar, 0.1 mg 
nicotine)







(3-6 mg tar, 
0.3-0.5 mg 
nicotine)






10 mg tar, 
0.6-0.8 mg 
nicotine)
27 ♂/♀ 41.9 11.2 18.2 6.6 46.9 12.3 13.4 3.4 609.4 158.7 11.4 Portable CReSS
Hope, Seven 
Stars (14 mg 
tar, 1.1-1.2 
mg nicotine)
22 ♂/♀ 38.0 8.4 19.3 8.8 53.9 15.8 12.6 3.1 638.7 136.9 13.0 Portable CReSS
McClure et 
al  45
2013 own brand 135 ♀ 31.9 7.6 16.2 7 49.9 15.8 1.6 0.5 32.7 9.1 11.7 3.9 583.8 9.5 4.9 2.2 Portable CReSS
Strasser et 
al 46
2013 own brand 78 ♂/♀ 38.4 11.7 18.0 8 54.7 1.7 0.1 32.2 30.1 2.1 11.2 0.6 612.6 74.6 11.0 5.8 1.8 Portable CReSS
Day 1 - ci-
garette 1
own brand 78 ♂/♀ 38.4 11.7 18.0 8 46.7 1.7 0.1 27.4 33.7 3.2 11.1 0.8 517.9 36.8 9.3 5.8 1.8 Portable CReSS
Day 1 - ci-
garette 2
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index SD Device Comments
own brand 78 ♂/♀ 38.4 11.7 18.0 8 44.5 1.6 0.1 27.8 31.4 3.0 12.6 0.7 560.7 42.7 10.1 5.8 1.8 Portable CReSS Day 5
Tidey et 
al 47
2013 own brand 26 ♂/♀ 44.5 10.9 23.5 6.5 1451.0 835.0 34.1 6.7 1.8 Desktop CReSS
Hammond 
et al 48
2014 own brand 72 ♂/♀ 37.2 11.9 16.1 6.3 63.5 22.4 16.1 6.3 977.9 420.8 15.7 4.9 2.3 Portable CReSS
Quest 1 (0.6 
mg nicotine) 71 ♂/♀ 37.2 11.9 14.5 4.6 64.3 22.3 14.5 4.6 910.1 520.3 13.2 4.8 2.2
Portable 
CReSS
Quest 2 (0.3 
mg nicotine) 71 ♂/♀ 37.2 11.9 13.8 4.3 64.2 17.2 13.8 4.3 834.2 190.4 11.5 4.8 2.1
Portable 
CReSS
Quest 3 (0.05 





2014 own brand 16 ♂/♀ 45.5 SE 3.5 16.1 SE 1.4 67.5 SE 6.3 3.0 SE 1 36.1 SE 1.8 21.3 SE 6.2 13.2 SE 1.1 829.0 SE 51.4 13.3 Portable CReSS
Schneider 
et al 50
2014 own brand 25 ♂/♀ 45.9 12.4 16.7 4.6 62.2 18.5 1.7 0.5 36.8 18.7 7.7 10.2 2.7 635.5 10.6 5.6 2.0 Portable CReSS
own brand 25 ♂/♀ 45.9 12.4 16.7 4.6 58.8 18.3 1.6 0.4 36.3 19.2 7.6 11.4 2.7 667.5 11.2 5.6 2.0 Portable CReSS
own brand 23 ♂/♀ 39.1 13.8 15.6 4.22 55.3 18.5 1.7 0.4 31.8 14.3 5.0 14.2 4.7 783.6 12.2 4.2 1.9 Portable CReSS
own brand






2015 own brand 
(>13 mg tar) 20 ♂ 35.3 6.1 10-30 69.7 18.6 2.3 0.6 30.3 38.6 10.8 9.8 2.3 683.1 6.8 Portable CReSS
Total vol-
ume if 10 
cig/day
Test cigarette 
High Tar (~15 
mg tar) 20 ♂ 35.4 6.4
22.4-








Low tar (~7 
mg tar) 19 ♂ 35.1 6.2
20.5-














































mg tar, 0.97 
mg nicotine)




























Light (5.8 mg 
tar, 0.51 mg 
nicotine)





























2015 own brand - 
white 26 ♂ 39.2 10.1 >12 57.2 SE 2.69 1.6 SE 0.06 37.1
SE 




korean 27 ♂ 37.3 9.7 12.0 1.82 59.6 SE 3 1.5 SE 0.07 42.1
SE 
1.94 13.5 SE 1.7 13.8 SE 0.69 820.6 9.8 4.6 2.1
Portable 
CReSS
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index SD Device Comments
own brand 78 ♂/♀ 38.4 11.7 18.0 8 44.5 1.6 0.1 27.8 31.4 3.0 12.6 0.7 560.7 42.7 10.1 5.8 1.8 Portable CReSS Day 5
Tidey et 
al 47
2013 own brand 26 ♂/♀ 44.5 10.9 23.5 6.5 1451.0 835.0 34.1 6.7 1.8 Desktop CReSS
Hammond 
et al 48
2014 own brand 72 ♂/♀ 37.2 11.9 16.1 6.3 63.5 22.4 16.1 6.3 977.9 420.8 15.7 4.9 2.3 Portable CReSS
Quest 1 (0.6 
mg nicotine) 71 ♂/♀ 37.2 11.9 14.5 4.6 64.3 22.3 14.5 4.6 910.1 520.3 13.2 4.8 2.2
Portable 
CReSS
Quest 2 (0.3 
mg nicotine) 71 ♂/♀ 37.2 11.9 13.8 4.3 64.2 17.2 13.8 4.3 834.2 190.4 11.5 4.8 2.1
Portable 
CReSS
Quest 3 (0.05 





2014 own brand 16 ♂/♀ 45.5 SE 3.5 16.1 SE 1.4 67.5 SE 6.3 3.0 SE 1 36.1 SE 1.8 21.3 SE 6.2 13.2 SE 1.1 829.0 SE 51.4 13.3 Portable CReSS
Schneider 
et al 50
2014 own brand 25 ♂/♀ 45.9 12.4 16.7 4.6 62.2 18.5 1.7 0.5 36.8 18.7 7.7 10.2 2.7 635.5 10.6 5.6 2.0 Portable CReSS
own brand 25 ♂/♀ 45.9 12.4 16.7 4.6 58.8 18.3 1.6 0.4 36.3 19.2 7.6 11.4 2.7 667.5 11.2 5.6 2.0 Portable CReSS
own brand 23 ♂/♀ 39.1 13.8 15.6 4.22 55.3 18.5 1.7 0.4 31.8 14.3 5.0 14.2 4.7 783.6 12.2 4.2 1.9 Portable CReSS
own brand






2015 own brand 
(>13 mg tar) 20 ♂ 35.3 6.1 10-30 69.7 18.6 2.3 0.6 30.3 38.6 10.8 9.8 2.3 683.1 6.8 Portable CReSS
Total vol-
ume if 10 
cig/day
Test cigarette 
High Tar (~15 
mg tar) 20 ♂ 35.4 6.4
22.4-








Low tar (~7 
mg tar) 19 ♂ 35.1 6.2
20.5-














































mg tar, 0.97 
mg nicotine)




























Light (5.8 mg 
tar, 0.51 mg 
nicotine)





























2015 own brand - 
white 26 ♂ 39.2 10.1 >12 57.2 SE 2.69 1.6 SE 0.06 37.1
SE 




korean 27 ♂ 37.3 9.7 12.0 1.82 59.6 SE 3 1.5 SE 0.07 42.1
SE 
1.94 13.5 SE 1.7 13.8 SE 0.69 820.6 9.8 4.6 2.1
Portable 
CReSS
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Quest 1 (0.6 
mg nicotine)


























Quest 2 (0.3 
mg nicotine)


























Quest 3 (0.05 
mg nicotine)




























2016 own brand 110 ♂/♀ 28.2 9.4 15.8 6.2 26.6 11.4 14.4 4.0 Portable CReSS
Ross et al 60 2016 own brand



























Ross et al 61 2016 own brand 
(non-
menthol)





























26 ♂/♀ 36.7 10.8 17.5 10.17 41.5 12.6 1.4 0.4 29.9 21.0 8.2 11.3 3.2 444.4 200.1 7.8 5.2 2.7 Desktop CReSS
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mg nicotine)
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mg nicotine)


























Quest 3 (0.05 
mg nicotine)




























2016 own brand 110 ♂/♀ 28.2 9.4 15.8 6.2 26.6 11.4 14.4 4.0 Portable CReSS
Ross et al 60 2016 own brand



























Ross et al 61 2016 own brand 
(non-
menthol)





























26 ♂/♀ 36.7 10.8 17.5 10.17 41.5 12.6 1.4 0.4 29.9 21.0 8.2 11.3 3.2 444.4 200.1 7.8 5.2 2.7 Desktop CReSS
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26 ♂/♀ 36.7 10.8 17.5 10.18 38.6 12.5 1.4 0.4 28.0 21.3 6.1 11.7 3.1 411.9 184.2 7.2 5.2 2.7 Desktop CReSS
Hsu et al 65 2017 own brand 
(non-
menthol)
34 ♂/♀ 41.4 10.9 >10 52.7 18.0 1.6 0.8 32.9 21.0 14.7 12.3 6.6 690.3 547.8 6.9 5.4 2.7 CReSS
own brand 
(menthol) 71 ♂/♀ 43.8 9.3 >10 55.7 18.5 1.8 0.6 30.9 20.0 12.7 12.6 7.5 691.7 455.9 6.9 4.8 2.1 CReSS
Watson et 
al 66
2017 Kent 100 
(non-
menthol)




















2018 own brand 89 ♀ 29.7 6.4 15.3 6.1 48.3 2.9 1.3 0.1 36.5 1.4 20.5 1.0 14.8 0.6 716.4 11.0 4.6 2.2 Desktop CReSS










as Krebs et 
al 55
Kim et al 68 2018 own brand






































































ave et al 58
2018 own brand 










744.0 CI 681-806 10.3 5.5 1.8 CReSS
SPECTRUM 
400 (9 mg 
tar, 0.26 mg 
nicotine)





















200 (9 mg 
tar, 0.07 mg 
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26 ♂/♀ 36.7 10.8 17.5 10.18 38.6 12.5 1.4 0.4 28.0 21.3 6.1 11.7 3.1 411.9 184.2 7.2 5.2 2.7 Desktop CReSS
Hsu et al 65 2017 own brand 
(non-
menthol)
34 ♂/♀ 41.4 10.9 >10 52.7 18.0 1.6 0.8 32.9 21.0 14.7 12.3 6.6 690.3 547.8 6.9 5.4 2.7 CReSS
own brand 
(menthol) 71 ♂/♀ 43.8 9.3 >10 55.7 18.5 1.8 0.6 30.9 20.0 12.7 12.6 7.5 691.7 455.9 6.9 4.8 2.1 CReSS
Watson et 
al 66
2017 Kent 100 
(non-
menthol)




















2018 own brand 89 ♀ 29.7 6.4 15.3 6.1 48.3 2.9 1.3 0.1 36.5 1.4 20.5 1.0 14.8 0.6 716.4 11.0 4.6 2.2 Desktop CReSS










as Krebs et 
al 55
Kim et al 68 2018 own brand






































































ave et al 58
2018 own brand 










744.0 CI 681-806 10.3 5.5 1.8 CReSS
SPECTRUM 
400 (9 mg 
tar, 0.26 mg 
nicotine)





















200 (9 mg 
tar, 0.07 mg 
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Yuki et al 71 2018 own brand 























12.1 595.1 9.6 CReSS day 1
own brand








798.6 12.9 CReSS day 2
Calculated values in italic. SD = standard deviation, CI = 95% Confidence interval, 
SEM = Standard error of the mean, SE = Standard error, ♀ female, ♂ male, CRSSPT = 
Clinical Research Support System, Plowshare Technologies, CReSS = CReSSmicro™ 
(Clinical Research Support System), Plowshare Technologies. Dark grey: highest 
value. Light grey: lowest value. $ Data originates from ISO/TR 17219:2013 (stated 
as personal communication) [73]
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own brand








798.6 12.9 CReSS day 2
158 | Chapter 4
References
1. Buchhalter AR, Eissenberg T. Preliminary evaluation of a novel smoking system: effects 
on subjective and physiological measures and on smoking behavior. Nicotine Tob Res. 
2000;2(1):39-43.
2. Djordjevic MV, Stellman SD, Zang E. Doses of nicotine and lung carcinogens delivered to 
cigarette smokers. J Natl Cancer Inst. 2000;92(2):106-111.
3. Breland AB, Buchhalter AR, Evans SE, Eissenberg T. Evaluating acute effects of potential 
reduced-exposure products for smokers: clinical laboratory methodology. Nicotine Tob 
Res. 2002;4 Suppl 2:S131-140.
4. Breland AB, Evans SE, Buchhalter AR, Eissenberg T. Acute effects of Advance: a potential 
reduced exposure product for smokers. Tob Control. 2002;11(4):376-378.
5. Dixon M, Kochhar N, Prasad K, Shepperd J, Warburton DM. The influence of changing 
nicotine to tar ratios on human puffing behaviour and perceived sensory response. 
Psychopharmacology (Berl). 2003;170(4):434-442.
6. Lee EM, Malson JL, Waters AJ, Moolchan ET, Pickworth WB. Smoking topography: 
reliability and validity in dependent smokers. Nicotine Tob Res. 2003;5(5):673-679.
7. Aung AT, Pickworth WB, Moolchan ET. History of marijuana use and tobacco smoking 
topography in tobacco-dependent adolescents. Addict Behav. 2004;29(4):699-706.
8. Hughes JR, Hecht SS, Carmella SG, Murphy SE, Callas P. Smoking behaviour and toxin 
exposure during six weeks use of a potential reduced exposure product: Omni. Tob 
Control. 2004;13(2):175-179.
9. Lee EM, Malson JL, Moolchan ET, Pickworth WB. Quantitative comparisons between a 
nicotine delivery device (Eclipse) and conventional cigarette smoking. Nicotine Tob Res. 
2004;6(1):95-102.
10. Strasser AA, Pickworth WB, Patterson F, Lerman C. Smoking topography predicts 
abstinence following treatment with nicotine replacement therapy. Cancer Epidemiol 
Biomarkers Prev. 2004;13(11 Pt 1):1800-1804.
11. Wood T, Wewers ME, Groner J, Ahijevych K. Smoke constituent exposure and smoking 
topography of adolescent daily cigarette smokers. Nicotine Tob Res. 2004;6(5):853-862.
12. Zimmerman DM, Sehnert SS, Epstein DH, et al. Smoking topography and trajectory of 
asthmatic adolescents requesting cessation treatment. Prev Med. 2004;39(5):940-942.
13. Hammond D, Fong GT, Cummings KM, Hyland A. Smoking topography, brand switching, 
and nicotine delivery: results from an in vivo study. Cancer Epidemiol Biomarkers Prev. 
2005;14(6):1370-1375.
14. Hitsman B, Spring B, Wolf W, et al. Effects of acute tryptophan depletion on negative 
symptoms and smoking topography in nicotine-dependent schizophrenics and 
nonpsychiatric controls. Neuropsychopharmacology. 2005;30(3):640-648.
Characteristic puffing profiles generate more TNCO than ISO and HCI | 159
4
15. Strasser AA, Ashare RL, Kozlowski LT, Pickworth WB. The effect of filter vent blocking 
and smoking topography on carbon monoxide levels in smokers. Pharmacol Biochem 
Behav. 2005;82(2):320-329.
16. Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM. Cigarette smoking topography in 
smokers with schizophrenia and matched non-psychiatric controls. Drug Alcohol Depend. 
2005;80(2):259-265.
17. Breland AB, Kleykamp BA, Eissenberg T. Clinical laboratory evaluation of potential 
reduced exposure products for smokers. Nicotine Tob Res. 2006;8(6):727-738.
18. Franken FH, Pickworth WB, Epstein DH, Moolchan ET. Smoking rates and topography 
predict adolescent smoking cessation following treatment with nicotine replacement 
therapy. Cancer Epidemiol Biomarkers Prev. 2006;15(1):154-157.
19. Hammond D, Fong GT, Cummings KM, et al. Cigarette yields and human exposure: 
a comparison of alternative testing regimens. Cancer Epidemiol Biomarkers Prev. 
2006;15(8):1495-1501.
20. Kassel JD, Greenstein JE, Evatt DP, et al. Smoking topography in response to denicotinized and 
high-yield nicotine cigarettes in adolescent smokers. J Adolesc Health. 2007;40(1):54-60.
21. Melikian AA, Djordjevic MV, Hosey J, et al. Gender differences relative to smoking 
behavior and emissions of toxins from mainstream cigarette smoke. Nicotine Tob Res. 
2007;9(3):377-387.
22. Djordjevic MV, Fan J, Ferguson S, Hoffmann D. Self-regulation of smoking intensity. Smoke 
yields of the low-nicotine, low-’tar’ cigarettes. Carcinogenesis. 1995;16(9):2015-2021.
23. Strasser AA, Lerman C, Sanborn PM, Pickworth WB, Feldman EA. New lower nicotine 
cigarettes can produce compensatory smoking and increased carbon monoxide exposure. 
Drug Alcohol Depend. 2007;86(2-3):294-300.
24. Strasser AA, Malaiyandi V, Hoffmann E, Tyndale RF, Lerman C. An association of CYP2A6 
genotype and smoking topography. Nicotine Tob Res. 2007;9(4):511-518.
25. Attwood AS, O’Sullivan H, Leonards U, Mackintosh B, Munafo MR. Attentional bias 
training and cue reactivity in cigarette smokers. Addiction. 2008;103(11):1875-1882.
26. Collins CC, Lippmann BM, Lo SJ, Moolchan ET. Time spent with smoking parents and 
smoking topography in adolescents. Addict Behav. 2008;33(12):1594-1597.
27. Rees VW, Wayne GF, Connolly GN. Puffing style and human exposure minimally 
altered by switching to a carbon-filtered cigarette. Cancer Epidemiol Biomarkers Prev. 
2008;17(11):2995-3003.
28. Grainge MJ, Shahab L, Hammond D, O’Connor RJ, McNeill A. First cigarette on waking 
and time of day as predictors of puffing behaviour in UK adult smokers. Drug Alcohol 
Depend. 2009;101(3):191-195.
29. Blank MD, Disharoon S, Eissenberg T. Comparison of methods for measurement of 
smoking behavior: mouthpiece-based computerized devices versus direct observation. 
160 | Chapter 4
Nicotine Tob Res. 2009;11(7):896-903.
30. Dickens C, McGrath C, Warren N, Biggs P, McAughey J. Puffing and inhalation behaviour 
in cigarette smoking: Implications for particle diameter and dose. Journal of Physics: 
Conference Series. 2009;151(1):012019.
31. Moolchan ET, Parzynski CS, Jaszyna-Gasior M, et al. A link between adolescent nicotine 
metabolism and smoking topography. Cancer Epidemiol Biomarkers Prev. 2009;18(5):1578-1583.
32. Collins CC, Epstein DH, Parzynski CS, et al. Puffing behavior during the smoking of a single 
cigarette in tobacco-dependent adolescents. Nicotine Tob Res. 2010;12(2):164-167.
33. O’Connor RJ, Rees VW, Norton KJ, et al. Does switching to reduced ignition propensity 
cigarettes alter smoking behavior or exposure to tobacco smoke constituents? Nicotine 
Tob Res. 2010;12(10):1011-1018.
34. June KM, Norton KJ, Rees VW, O’Connor RJ. Influence of measurement setting and 
home smoking policy on smoking topography. Addict Behav. 2012;37(1):42-46.
35. June KM, Hammond D, Sjodin A, et al. Cigarette ignition propensity, smoking behavior, 
and toxicant exposure: A natural experiment in Canada. Tob Induc Dis. 2011;9(1):13.
36. McKee SA, Sinha R, Weinberger AH, et al. Stress decreases the ability to resist smoking 
and potentiates smoking intensity and reward. J Psychopharmacol. 2011;25(4):490-502.
37. Strasser AA, Benowitz NL, Pinto AG, et al. Nicotine metabolite ratio predicts smoking 
topography and carcinogen biomarker level. Cancer Epidemiol Biomarkers Prev. 
2011;20(2):234-238.
38. Veilleux JC, Kassel JD, Heinz AJ, et al. Predictors and sequelae of smoking topography 
over the course of a single cigarette in adolescent light smokers. J Adolesc Health. 
2011;48(2):176-181.
39. Williams JM, Gandhi KK, Lu SE, et al. Shorter interpuff interval is associated with higher nicotine 
intake in smokers with schizophrenia. Drug Alcohol Depend. 2011;118(2-3):313-319.
40. Williams JM, Gandhi KK, Lu SE, Steinberg ML, Benowitz NL. Nicotine intake and smoking 
topography in smokers with bipolar disorder. Bipolar Disord. 2012;14(6):618-627.
41. Brinkman MC, Chuang JC, Gordon SM, et al. Exposure to and deposition of fine and 
ultrafine particles in smokers of menthol and nonmenthol cigarettes. Inhal Toxicol. 
2012;24(5):255-269.
42. Faulkner GE, Arbour-Nicitopoulos KP, Hsin A. Cutting Down One Puff at a Time: 
The Acute Effects of Exercise on Smoking Behaviour. Journal of Smoking Cessation. 
2012;5(2):130-135.
43. Perkins KA, Karelitz JL, Giedgowd GE, Conklin CA. The reliability of puff topography 
and subjective responses during ad lib smoking of a single cigarette. Nicotine Tob Res. 
2012;14(4):490-494.
44. Matsumoto M, Inaba Y, Yamaguchi I, et al. Smoking topography and biomarkers of 
exposure among Japanese smokers: associations with cigarette emissions obtained 
Characteristic puffing profiles generate more TNCO than ISO and HCI | 161
4
using machine smoking protocols. Environ Health Prev Med. 2013;18(2):95-103.
45. McClure EA, Saladin ME, Baker NL, Carpenter MJ, Gray KM. Smoking topography and 
abstinence in adult female smokers. Addict Behav. 2013;38(12):2833-2836.
46. Strasser AA, Ashare RL, Kaufman M, et al. The effect of menthol on cigarette smoking 
behaviors, biomarkers and subjective responses. Cancer Epidemiol Biomarkers Prev. 
2013;22(3):382-389.
47. Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM, Ahnallen CG. Separate and combined 
effects of very low nicotine cigarettes and nicotine replacement in smokers with 
schizophrenia and controls. Nicotine Tob Res. 2013;15(1):121-129.
48. Hammond D, O’Connor RJ. Reduced nicotine cigarettes: smoking behavior and biomarkers 
of exposure among smokers not intending to quit. Cancer Epidemiol Biomarkers Prev. 
2014;23(10):2032-2040.
49. Norton KJ, June KM, O’Connor RJ. Initial puffing behaviors and subjective responses 
differ between an electronic nicotine delivery system and traditional cigarettes. Tob 
Induc Dis. 2014;12(1):17.
50. Schneider T, De Jesus S, Prapavessis H. The Effect of Acute Exercise on Smoking 
Topography: No Evidence for Cutting Down One Puff at a Time. Journal of Smoking 
Cessation. 2014;10(2):146-153.
51. Appleton S, Liu J, Lipowicz PJ, Sarkar M. Effect of cigarette design on biomarkers of exposure, 
puffing topography and respiratory parameters. Inhal Toxicol. 2015;27(3):174-180.
52. Brinkman MC, Kim H, Chuang JC, et al. Comparison of True and Smoothed Puff Profile 
Replication on Smoking Behavior and Mainstream Smoke Emissions. Chem Res Toxicol. 
2015;28(2):182-190.
53. Chung S, Kim SS, Kini N, et al. Smoking topography in Korean American and white men: 
preliminary findings. J Immigr Minor Health. 2015;17(3):860-866.
54. Gass JC, Germeroth LJ, Wray JM, Tiffany ST. The Reliability and Stability of Puff 
Topography Variables in Non-Daily Smokers Assessed in the Laboratory. Nicotine Tob 
Res. 2016;18(4):484-490.
55. Krebs NM, Chen A, Zhu J, et al. Comparison of Puff Volume With Cigarettes per Day in 
Predicting Nicotine Uptake Among Daily Smokers. Am J Epidemiol. 2016;184(1):48-57.
56. Chen A, Krebs NM, Zhu J, Muscat JE. Nicotine metabolite ratio predicts smoking 
topography: The Pennsylvania Adult Smoking Study. Drug Alcohol Depend. 2018;190:89-93.
57. Mercincavage M, Souprountchouk V, Tang KZ, et al. A Randomized Controlled Trial of 
Progressively Reduced Nicotine Content Cigarettes on Smoking Behaviors, Biomarkers of 
Exposure, and Subjective Ratings. Cancer Epidemiol Biomarkers Prev. 2016;25(7):1125-1133.
58. Mercincavage M, Lochbuehler K, Wileyto EP, et al. Association of Reduced Nicotine 
Content Cigarettes With Smoking Behaviors and Biomarkers of Exposure Among Slow 
and Fast Nicotine Metabolizers: A Nonrandomized Clinical Trial. JAMA Netw Open. 
162 | Chapter 4
2018;1(4):e181346-e181346.
59. Pulcu E. Self-report distortions of puffing topography in daily smokers. J Health Psychol. 
2016;21(8):1644-1654.
60. Ross KC, Dempsey DA, St Helen G, Delucchi K, Benowitz NL. The Influence of Puff 
Characteristics, Nicotine Dependence, and Rate of Nicotine Metabolism on Daily Nicotine 
Exposure in African American Smokers. Cancer Epidemiol Biomarkers Prev. 2016;25(6):936-943.
61. Ross KC, Juliano LM. Smoking Through a Topography Device Diminishes Some of the 
Acute Rewarding Effects of Smoking. Nicotine Tob Res. 2016;18(5):564-571.
62. Tidey JW, Cassidy RN, Miller ME. Smoking Topography Characteristics of Very Low 
Nicotine Content Cigarettes, With and Without Nicotine Replacement, in Smokers With 
Schizophrenia and Controls. Nicotine Tob Res. 2016;18(9):1807-1812.
63. Farris SG, Aston ER, Abrantes AM, Zvolensky MJ. Tobacco demand, delay discounting, 
and smoking topography among smokers with and without psychopathology. Drug 
Alcohol Depend. 2017;179:247-253.
64. Higgins ST, Heil SH, Sigmon SC, et al. Response to varying the nicotine content of 
cigarettes in vulnerable populations: an initial experimental examination of acute effects. 
Psychopharmacology (Berl). 2017;234(1):89-98.
65. Hsu PC, Lan RS, Brasky TM, et al. Menthol Smokers: Metabolomic Profiling and Smoking 
Behavior. Cancer Epidemiol Biomarkers Prev. 2017;26(1):51-60.
66. Watson CV, Richter P, de Castro BR, et al. Smoking Behavior and Exposure: Results of a 
Menthol Cigarette Cross-over Study. Am J Health Behav. 2017;41(3):309-319.
67. Bergeria CL, Heil SH, Bunn JY, Sigmon SC, Higgins ST. Comparing Smoking Topography 
and Subjective Measures of Usual Brand Cigarettes Between Pregnant and Non-
Pregnant Smokers. Nicotine Tob Res. 2018;20(10):1243-1249.
68. Kim S, Yu S. Smoking Topography among Korean Smokers: Intensive Smoking Behavior with 
Larger Puff Volume and Shorter Interpuff Interval. Int J Environ Res Public Health. 2018;15(5).
69. Shiffman S, Scholl S. Increases in Cigarette Consumption and Decreases in Smoking 
Intensity When Nondaily Smokers Are Provided With Free Cigarettes. Nicotine Tob Res. 
2018;20(10):1237-1242.
70. Vansickel AR, Edmiston JS, Liang Q, et al. Characterization of puff topography of a 
prototype electronic cigarette in adult exclusive cigarette smokers and adult exclusive 
electronic cigarette users. Regul Toxicol Pharmacol. 2018;98:250-256.
71. Yuki D, Takeshige Y, Nakaya K, Futamura Y. Assessment of the exposure to harmful and 
potentially harmful constituents in healthy Japanese smokers using a novel tobacco 
vapor product compared with conventional cigarettes and smoking abstinence. Regul 
Toxicol Pharmacol. 2018;96:127-134.
72. Watson CV, Richter P, Li Y, et al. Mouth Level Nicotine in a Clinical Setting versus Non-




puffing topography versus 
compensatory smoking
Charlotte G.G.M Pauwels, Agnes W. Boots, Wouter F. Visser, Jeroen L.A. Pennings, 







Chapter 6. Summary 
and general discussion

Summary and general discussion | 195
6
Worldwide tobacco pandemic
Worldwide, many far-reaching economic and social measures are taken in the fight 
against the COVID-19 pandemic in 2020, during which, according to the Johns 
Hopkins University, more than 1.8 million people died in that year 1. However, 
based on annual mortality rates in 2020, at least three times more world citizens 
(>7 million) died due to tobacco consumption 2, and this will continue every year in 
the near future. In the fight against COVID-19, governments worldwide dramatically 
restricted freedom and liberty of all citizens and took dramatic measures to save 
lives and reduce virus-related morbidity in society. The measures did not only affect 
the subpopulation at high risk, but also low risk subpopulations such as children 
and adolescents, in an attempt to protect citizens against the virus, and to mitigate 
the COVID-19 pandemic by vaccination when exposure could not be prevented. 
To solve the worldwide tobacco pandemic, ideally producing and selling tobacco 
products should be banned and consumption stopped worldwide to prevent 
exposure of citizens to these toxic products. With such a full ban, nobody would be 
exposed legally. However, maintaining a tobacco products prohibition is a political, 
regulatory and societal challenge susceptible for failure3. It might lead to a rise in 
illegal practices) in tobacco products, including illegal production, smuggling or 
growing for personal use. In The Netherlands and many other countries, smokers 
will argue that they will be robbed of their ‘freedom and liberty’ to consume the 
addictive tobacco products. However, ideas have been raised to gradually expand 
regulatory measures with respect to smoking, making it effectively illegal for the 
generation born after 2004 as already proposed in New Zealand.
Besides measures to fully prevent tobacco use, also risk mitigation approaches 
help to fight the smoking pandemic. Such measures are mainly based on taxation, 
de-normalization, cessation-aid, and ‘smoke-free’ legislation focusing on actual 
smokers and potential smokers. These risk mitigation approaches have led to a 
substantially lower prevalence in most countries, but it did, and does, eliminate 
use of cigarettes and other tobacco products. Nevertheless, governments already 
consider experienced smokers switching to Electronic Nicotine Delivery Devices 
(ENDs) such as e-cigarettes, or to dual use, as a successful tobacco policy 4. Even 
though ENDS and other more recently developed tobacco products (such as heated 
tobacco products (HTP)) by tobacco industry may help quitting regular cigarette use, 
the new products are also addictive and harmful 5,6. Although they are less harmful 
with regard to cancer risk, there are disappointing signals with regard to the risk 
of developing cardiovascular diseases and chronic obstructive pulmonary disease. 
Moreover, dual use is not quitting smoking and there are concerns about ENDS and 
HTP as gateway to smoking regular tobacco products. 
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Tobacco policies can be strengthened by regulating the traditional tobacco products 
such as cigarettes, which are still dominantly present on the consumers’ market and 
contribute to the high mortality and morbidity rates. One of the authorities who 
has assembled a harm reduction approach is the World Health Organization (WHO) 
Framework Convention on Tobacco Control (FCTC). Within the FCTC, various 
guidelines have been adopted and implemented in many countries and regions to 
reduce tobacco use. However, little progress has been made concerning Article 9 - 
Regulation of the content of tobacco products. This Article reads “The Conference 
of the Parties, in combination with competent international bodies, should propose 
Guidelines for testing and measuring the contents and emissions of tobacco products, 
and for the regulation of these contents and emissions. Each Party shall, approved 
by competent authorities, adopt and implement, effective legislative, executive and 
administrative or other measures for such testing and measuring, and for such regulation” 
7. Although FCTC went into force in 2005, hitherto no full set of Guidelines for 
Parties have been provided by the Conference of the Parties. In 2010, partial 
Guidelines for the Article 9 and 10 (about the regulation of disclosure of information 
about tobacco products) have been adopted which have been amended in 2014 
and 2016 8. However, in these partial Guidelines paragraph 3.2 about Content and 
3.3 about Emissions anno 2021 still reads “(this section is intentionally left blank 
to indicate that guidance will be proposed at a later stage)”. It illustrates that in the 
political arena no consensus has been found about the scientific foundation for 
guidance about regulation of emissions. In other words, regulators struggle with the 
fact that smoking is still harmful and if they agree on emission regulation, it looks 
like they approve continuing tobacco use. In addition, regulators find the health 
beneficial effects of lowering smoke components unclear. In the 2018 meeting of 
the Conference of the Parties (COP), the concern about filter ventilation has been 
addressed 9. The WHO was tasked to provide “the latest scientific evidence on the 
impact of cigarette ventilation on cigarette use” and to report to the COP before the 
ninth meeting that will be held in The Netherlands in November 2021.
Although no guidance has been provided by FCTC, The European Union (EU) (also 
a Party which adopted FCTC) regulates tar, nicotine and carbon monoxide (CO) 
(TNCO) of cigarettes in the European Tobacco Product Directive (ETPD/2014/40/
EU) 10. The ETPD has limits of respectively 10 mg, 1 mg and 10 mg per cigarette 
set as maximum emissions allowed in cigarettes smoke 10. Interestingly, the 
ETPD/2014/40/EU contains only a reference to the analytical technique of the 
International Organization of Standardization (ISO) method and not to the ISO 3308 
protocol itself that describes the smoke generation. It is known already for decades 
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that cigarette smoke emission is determined by the way the smoke is generated. 
Moreover, emission of toxicants other than TNCO is not regulated at all. Before the 
revision of the ETPD, the ISO 3308 protocol for smoking machines was prescribed 
for the determination of TNCO in the EU. In daily practice, all countries in the EU 
still interpret that this method is the required standardized testing protocol for 
machine smoking experiments. However, setting standards for tobacco smoke 
without indicating how the standard can be endorsed and controlled is questionable. 
Regulating smoke emission based on ISO 3308 alone is not scientifically suitable 
according to WHO Study Group on Tobacco Product Regulation (WHO-TobReg) 
(2008), and could play an important role in what is called ‘a deceptive policy of 
tobacco industry’ to promote highly filter-ventilated cigarettes as ‘light’ or ‘mild’ 
or even ‘healthier’ 11. However, evidence-based tobacco regulation needs to be 
furthered and therefore the following aim was formulated for this thesis.
This thesis aims to:
Relate, for the purpose of risk assessment and cigarette product regulation, the emissions 
of nicotine, carbon monoxide, and volatile organic compounds produced with smoking 
machines to emissions produced during human smoking, as well as to the actual uptake 
of smoke constituents in the body of smokers, taking into account the smokers’ daily use 
of cigarettes and their personal puff topography. 
Methodology
Tobacco smoke contains over 6,000 chemicals with different chemical and 
toxicological properties 12. For obvious reasons not all of these chemicals can be 
studied for the purpose of tobacco smoking related diseases. Furthermore, neither 
all potential variations between exposure of smokers can be taken into account, nor 
the many differences between brands. In this thesis, we used the work of WHO-
TobReg (2008) 13 and focused only on nicotine, CO and aldehydes (Chapter 2) and 
other volatile organic compounds (VOCs) (Chapter 3). A comprehensive discussion 
of tar is intentionally left out, as it is a mixture of thousands of individual and 
potentially toxic chemicals.
Two types of experiments were carried out for this thesis, i.e. smoking studies with 
either machines or volunteers. First, cigarette smoke was generated with smoking 
machines (according to ISO 3308 and Health Canada Intense (HCI)), the smoke 
constituents were quantified and the yields (per cigarette) and concentration (per 
mL) were related to human smoking topography. With smoking machines, cigarettes 
are smoked under controlled conditions with selected and fixed regimes for puff 
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topography, meaning a fixed puff volume, puff duration and inter-puff period. 
Dependent on the specific profile, the smoking machine will ‘consume’ the cigarette 
with a specific number of puffs. The total puff volume of a cigarette depends on the 
number of puffs and the puff volume set at the specific smoking machine regime. 
Second, experiments with volunteers were carried out in order to determine their 
individual smoking topography and to determine the uptake of tobacco smoke 
constituents into the body. Human volunteers usually apply puff topographies that 
are person specific, different from other smokers and which may be brand dependent 
or specific. The rationale behind these experiments is that the human uptake of 
smoke constituents will vary based on the smoker’s topography and the type of 
(filter-ventilated) cigarette. By comparing the smoker’s topography to machine 
smoking settings, human topography standardized machine-smoking settings could 
have the potential to deliver data that aid to set limits for product regulation of 
cigarettes. It is agreed already for decades that machine smoking is different from 
human smoking, but in-depth studies about the nature of the difference has been 
scarce, particularly when it concerns highly filter-ventilated cigarettes testing. 
Chapter 2 is focused on smoking machine data using two types of smoking regimes 
and compares TNCO and aldehydes emissions of various brands of the Dutch 
consumers market. The cigarettes studied are brands with low as well as very high 
filter ventilation levels. In Chapter 4, another approach is presented in which  three 
variants of one brand, i.e. Marlboro, are used to study the influence of variation of 
(human) puffing topography profiles on emissions and uptake. In Chapter 3 and 5, the 
two kinds of experiments are combined in order to study similarities and differences 
between smoking machine emissions and emissions of smoke constituents during 
human smoking as reflected by biomarkers. In Chapter 3, it was investigated whether 
or not exhaled breath can be used as a non-invasive tool to assess exposure of 
constituents by analyzing volatile biomarkers. Additionally, the uptake of  smoke 
constituents in blood was analyzed. 
Summary and answers to the research questions
Research question 1 – Do smokers have characteristic puffing topography profiles?
Volunteers in our study did not increase the number of cigarettes per day (CPD) upon 
switching from Marlboro Red to Marlboro Prime, which is consistent with previous 
findings 14,15. Smoking behavior of smokers is generally studied with a flowmeter 
device, such as the CReSSmicro™ device. Interestingly, in Chapter 4 we describe that 
the use of the CReSSmicro™ device to record smoking behavior may lead to some 
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registration pitfalls, since the method of insertion of the cigarette may influence 
the data collection. Consequently, we concluded that the device is not as robust 
as previously assumed 16-18 and care should be taken when applying it. Differences 
in puffing topography between studies, including ours, may thus be partially the 
result of technical complications of the device, as experienced by us and others, 
particularly when ‘high’ puff numbers and ‘high’ puff volumes are reported 16-18. 
However, because other, more reliable, devices are lacking, and we were able to 
identify an origin for the deviating data (i.e. the way of insertion), it can be concluded 
that the CReSSmicro™ device is useful with the proviso that the raw data need to 
be critically checked for anomalies (e.g. flow-rate dropouts) 16. Furthermore, the 
investigator should correctly insert the cigarette or give detailed instructions to the 
participants in future research. 
In our small prospective observational study, the smoking behavior of Marlboro 
smokers was measured for 36 hours in a home-like atmosphere. Puff volume, 
duration, frequency, flow and inter-puff interval were recorded with the portable 
CReSSmicro™ device. We found significant differences in puffing topography 
between participants, although consistent individual characteristic puffing behavior 
over the course of the day was demonstrated for each participant. In other words, 
smokers did not smoke their first cigarettes of the day, after a night of abstinence, 
significantly different from any other cigarette smoked later on. This observation 
is particularly important for Chapter 5 where the uptake of nicotine and CO 
throughout the day was studied in relationship to smoking topography. In Chapter 4, 
personalized puffing profile characteristics for the individual smokers were created 
based on topographic data of volunteers smoking their usual brand of cigarettes. 
In Chapter 5, we show that most, but not all, smokers maintain this characteristic 
profile when they switch to highly filter-ventilated cigarettes and even to cigarettes 
with completely blocked filter ventilation. That a few smokers do use a different puff 
topography upon switching brands will be discussed later. In conclusion, experienced 
smokers display a characteristic puffing topography per cigarette and do not change 
the number of CPD when they switch to other brands.
Research question 2 – How do the puffing regimes ISO 3308 and HCI used as 
settings for smoking machines relate to puffing topography of human smokers?
The characteristic puffing profiles of the volunteers have been used as settings 
for smoking machine experiments after which TNCO emissions were determined 
and reported in Chapter 4. The application of different human puffing profiles led 
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to a variety of nicotine and CO yields between the different smokers’ profiles. As 
expected, the least intense puffing profile (lowest puff volume and total cigarette 
volume, shortest puff duration and longest inter-puff interval) generated the lowest 
nicotine and CO yields. However, these yields were still higher than those determined 
with the ISO 3308 smoking regime, indicating that even the least intense smoker in 
our study is exposed to higher yields of toxicants as anticipated based upon the ISO 
3308 method. Compared to human smokers, the ISO 3308 regime on a smoking 
machine applies a low puff volume (35 mL), which explains why the generation of 
nicotine and CO was at least two times lower than when human puffing profiles 
were applied on the smoking machine.
Nicotine and CO yields were more in the range of HCI than ISO 3308 generated 
emissions, even though smokers did probably not completely block the filter 
ventilation holes as is done for HCI by taping. Some human smokers use a more 
intense puff topography than HCI, particularly because of higher puffing frequency 
(approximately 3 puffs per minute compared to 2 puffs for HCI and 1 puff for ISO), 
which results in more puffs per cigarette, and consequently more total puff volume 
of the toxic smoke. Besides, also larger puff volumes of approximately 70 mL/puff 
were recorded upon human smoking, compared to the 35 mL and 55 mL per puff 
for ISO 3308 and HCI. These findings are in line with previous studies reporting 
that ISO, and sometimes even HCI, underestimates human smoking behavior 19,20. 
In this thesis, further support is provided that the ISO regime for smoking machines 
generates unrealistically low total puff volumes compared to human smoking. This 
is demonstrated in Figure 1 that shows the frequency distribution of total puffing 
volumes smoking Marlboro, Marlboro Prime and Marlboro Prime taped. Both ISO 
and HCI total puffing volume are left of the peak of distribution. The total puffing 
volumes of Marlboro Prime taped, the not-commercially available variant are closest 
to ISO and HCI. That smokers had smaller total puffing volumes is probably because 
they are less appealing, which was not the scope of our studies. The figure also 
shows a large skew to the right in human total puffing volumes again demonstrating 
the large variability in human smoking behavior and thus that a single smoking 
machine regimes cannot represent all human smokers. HCI may also generate total 
puff volumes that are relatively low compared to humans, but particularly the puff 
frequency applied in HCI is much lower than during human smoking. The lower 
smoking intensity systematically results in lower yields of smoke constituents and 
consequently to an underestimation of human exposure, as was even shown in 
studies from the tobacco industry 21. 
Summary and general discussion | 201
6
As is shown in Chapter 3, uptake of nicotine and other smoke constituents (as 
determined in blood) from highly filter-ventilated cigarettes is only a little lower than 
that from regular king size cigarettes, while most smokers apply their characteristic 
puffing topography that is also used for smoking low-ventilated cigarettes. Both 
cigarette types contain a comparable amount of nicotine in the tobacco filler. The 
little difference in nicotine yields between cigarette types is in contrast to a large 
difference in yields when tested on a smoking machine, illustrating that testing of 
filter-ventilated cigarettes on smoking machine impossibly reflects human smoking 
as filter tip ventilation is not blocked by taping. However, it is also clear from Chapter 
5, that 100% blocking of filter tips is also not a realistic situation reflecting human 
puffing while smoking a commercially available cigarette. Thus, neither unblocked 
nor fully blocked testing of highly filter-ventilated cigarette will generate yields that 
mimic topography of smokers. Even the previously introduced Massachusetts regime 
that consists of testing half-blocked cigarettes with puff parameters between the 
ISO and HCI parameters does not represent human smoking behavior 22. 
In conclusion, machine smoking with ISO 3308 settings generates yields of tobacco 
smoke constituents which cannot reasonably be used for regulatory purposes 
or human risk assessment, as it often underestimates exposure by at least 50% 
compared to human smoking. However, also emissions generated with HCI setting 
of a smoking machine should be used with due restraints, particularly because 
of the low puffing frequency, resulting again in an underestimation of human 
exposure. In addition, testing filter-ventilated cigarettes with ISO 3308 with and 
without blocking the ventilation holes generates unrealistically low yields of smoke 
constituents. Testing only filter-ventilation blocked cigarettes, as is done under HCI 
settings, produces yields that better reflect human smoking. Half-blocked cigarettes 
might better represent the holding of cigarettes between lips and fingers and can 
be achieved by applying special holders within the smoking machine. For risk 
assessment and regulatory purposes both (half-) blocked and unblocked testing with 
a slightly modified testing HCI regime should be further investigated. Suggested 
modifications are a slightly higher puff volume (60-70 mL/puff) and a higher puffing 
frequency (3 puffs per minute rather than 2 puffs per minute) than the current HCI 
regime. 
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Figure 1: Graphs showing the frequency distribution (per 20mL) of the total puff volume per 
cigarette for Marlboro (n=202), Marlboro Prime (n=114) and Marlboro Prime taped (n=117) 
from two human studies (Chapter 4 and 5). ISO total puff volume per cigarette is 277 mL for 
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Marlboro and 273 mL for Marlboro Prime. HCI total puff volume per cigarette is 490 mL for 
Marlboro and 409 mL for Marlboro Prime. ISO and HCI total puff volume per cigarette was 
calculated with the smoking machine data from Chapter 2.
Research question 3 – Is the nicotine delivery of ‘very low yield’ cigarettes above the 
threshold to initiate and sustain nicotine addiction as postulated by Benowitz and 
Henningfield (1994) 23? 
This thesis focused not only on cigarettes with regular yields of TNCO, generated on 
a smoking machine, but also on low-yield products. We take into account that the 
US-regular brands have higher TNCO yields than EU-regular cigarettes. Purposely, 
the brand with the lowest declared nicotine yield in the Dutch consumers’ market 
was subject of the human volunteer study: Marlboro Prime (Chapter 4 and 5), 
previously also named Philip Morris One (Chapter 3), with the declared ISO-nicotine 
yield of 0.1 mg/cig. 
The experimental nicotine yield determined with ISO 3308 was 0.21 mg/cig (Chapter 
2) which is significantly higher than the declared value. However, with HCI, a more 
than 5 times higher yield (0.56 mg/cig) is determined. Smokers in the volunteers’ 
studies described in the Chapters 3, 4 and 5 smoked at maximum 22 CPD. Based 
on 22 CPD, the experimental ISO 3308 yield would lead to a total exposure of ~4.6 
mg maximum per day, which is a value in the range of the threshold proposed by 
Benowitz and Henningfield 23. Because ISO 3308 underestimates real life exposure 
levels it would falsely suggest that by smoking fewer cigarettes, as most smokers do, 
threshold for addiction would not be reached. The nicotine uptake data in Chapter 
5 show the opposite indicating that thresholds are easily reached, and so do the 
calculations based on yields determined with HCI on a smoking machine. Smoking 
Marlboro Prime reduced the cotinine concentrations after a week of smoking with 
approximately 50 µg/mL blood, from an average of 250 µg/mL to 200 µg/mL while the 
CPD did not change. Based on literature data, 200 ug/mL cotinine in blood corresponds 
to a daily nicotine exposure of ~15 mg of nicotine. Hence, it can be concluded that 
highly filter-ventilated cigarettes expose smokers to a sufficient amount of nicotine 
to initiate and sustain nicotine addiction. Based on experimentally determined HCI 
yields, consumption of 15-20 CPD would result in an exposure of 8.4 to 11.2 mg/day. 
Research question 4 – Does the individual’s nicotine uptake change when a different 
type of cigarette is smoked or are smokers adapting their puffing topography to 
(partially) compensate for differences in nicotine yields of the cigarettes?
204 | Chapter 6
In Chapters 4 and 5 it is shown that individuals have a characteristic puffing profile for 
regular cigarette use that is in most cases not altered when the experienced smoker 
switches to highly filter-ventilated products. Total number of CPD, puff volume, 
number of puffs and inter-puff period are person-specific, and brand independent. 
Even when smokers switch to a filter-ventilated blocked cigarette, which has a 
completely different draw resistance, most smokers maintain their characteristic puff 
topography. However, several volunteers smoked fewer filter-ventilation blocked 
cigarettes compared to the usual cigarettes of their own brand. The filter-ventilation 
blocked cigarette (e.g., 100% blocked filter ventilation) was created for this study 
and has not been developed for the consumer’s market by the manufacturer. It may 
have several characteristics that are not appreciated by the smokers, such as mouth-
feel, harshness, taste and smell. Such unpleasant experiences were also reported by 
several of our volunteers but not further investigated as this was out of our scope. 
In general, unblocked highly filter-ventilated cigarettes may also create a different 
sensory sensation during puffing than regular cigarettes as well as a lower draw 
resistance that may facilitate larger puffs. However, in Chapter 5 we observe a non-
significant  average increase of 7% in total puff volume per cigarette. The resulting 
blood nicotine concentration is lower than upon smoking regular cigarettes. After 
smoking the filter-ventilated cigarette for a week, a ~20% reduced cotinine blood 
concentration is found, but the daily cigarette number and puff topography remain 
unaltered. Hence, we conclude that the smokers did not compensate for the switch 
from regular to highly filter-ventilated products by increasing their CPD or smoking 
intensity. However, smokers may use fewer cigarettes when they switch from a 
highly filter-ventilated cigarette to a filter-ventilation-blocked variant, probably 
because they dislike such products that should be investigated in the future.
Research question 5 – Is the uptake of CO or other volatile toxicants in tobacco 
smoke linked to the nicotine uptake during smoking filter-ventilated cigarettes?
The WHO Study Group on Tobacco Product Regulation (TobReg) developed a smoke 
toxicants priority list including several aldehydes, VOCs and polycyclic aromatic 
hydrocarbons (PAHs) 24. In Chapter 2, aldehydes together with nicotine and CO 
were quantified in mainstream cigarette smoke of 11 Dutch cigarette brands and 
two reference cigarettes. The cigarettes of interest differed in (i) design and blend 
characteristics; (ii) TNCO levels; (iii) popularity; and (iv) manufacturer. Variations in 
smoking behavior and cigarette design affecting human exposure to smoke toxicants 
were studied by using four different machine testing protocols based on the ISO 3308 
and HCI regime, both with and without taping the filter vents 25,26. TNCO levels were 
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determined in cigarette smoke according to ISO 8454, ISO 10315 and ISO 4387, as 
used for regulation 27-29. Using an intense smoking regime (increased puff volume, 
shorter puff interval) significantly increased toxicant yields were found, following 
the pattern ISO < ISO-taped < HCI-untaped < HCI for both regular- and highly filter-
ventilated cigarettes. The difference in TNCO and aldehyde levels between regular 
and highly filter-ventilated low-TNCO cigarettes (as measured using ISO) diminished 
when smoking intensely; this effect was stronger when combined with taping filter 
vents. For all of the regimes and for the different cigarette brands, acetaldehyde and 
acrolein yields were strongly and significant correlated with each other  and with the 
other volatile aldehydes. Previously, the WHO suggested that one, but preferably 
more, compounds per chemical class can be used as representative marker(s) for its 
chemical class 24. Indeed, the obtained correlations indicate that in case of volatile 
aldehydes both acetaldehyde and acrolein are suitable representatives. 
In Chapter 3, blood and exhaled breath samples were taken from the participants 
in order to determine VOCs levels directly before and maximally 10 minutes 
after smoking a regular, a highly filter-ventilated, and a filter-ventilation blocked 
Marlboro cigarette. Upon smoking, the levels of toluene, ethylbenzene, m/p-xylene, 
o-xylene, and 2,5-dimethylfuran in both headspace of venous blood and exhaled 
breath increase to a similar extent for all three cigarette types smoked. Generally, 
a correlation between the increase of the concentrations of the various VOCs was 
observed. The increases of VOCs in exhaled breath and in blood samples were not 
different between smoking regular and highly filter-ventilated cigarettes and only 
slightly higher upon smoking the taped variant of the highly filter-ventilated product. 
These results are consistent with the results of Chapter 5 showing a similar nicotine 
uptake in blood upon smoking regular, filter-ventilated and taped cigarettes. CO 
uptake was also similar, except for the taped variant of the highly filter-ventilated 
product after which the CO uptake was statistically higher in accordance with the 
VOC uptake in Chapter 3. The increased filter ventilation in our study did not reduce 
CO and VOC exposure of the smoker, but slightly reduced nicotine intake. The 
consequence of blocking the filter-ventilation is an increased exposure to CO and 
VOCs, even when smokers on average smoke such cigarettes with fewer puffs. In 
conclusion, the uptake of nicotine, CO and VOCs are dependent on the individual 
smoking behavior. 
Research question 6 – Can toxicant yields of cigarettes produced with a smoking 
machine be used for human risk assessment purposes, and are there alternatives 
such as exhaled breath?
206 | Chapter 6
During the human study in Chapter 3, it was aimed to investigate VOCs levels in 
headspace of blood and exhaled breath and their interrelations upon smoking three 
types of cigarettes. For most of the VOCs, concentrations in blood as well as in 
exhaled breath increased 2-3 fold upon smoking a single cigarette. Overall, the VOC 
levels in exhaled breath and blood were not significantly correlated, partly because 
of the large variations observed between the smoking topography of the individual 
volunteers. This lack of correlation may also be due to the moments of sampling 
since sampled exhaled air only at t=10 minutes after smoking, but did not investigate 
the kinetics of the VOCs over an extended period. Therefore, we conclude that 
more research is required in order to use exhaled breath sampling as a non-invasive 
quantitative tool for volatile organic toxicants from cigarette smoke exposure.
Based on the data obtained in Chapter 4 and 5, it can be concluded that the 
currently used ISO regime during machine smoking is insufficiently exemplary for 
human smoking and that the human topography lies closer to the HCI regime and is 
even more intense. However, HCI deals with closed ventilation holes and thus direct 
comparison needs caution. 
In the past, the cigarette product manufacturer positioned the filter vents on the 
filter where they remain open when placed in the smoking machine holder in order 
to mislead the smoking machine and manipulate the cigarette smoke emissions. 
This concept is called the cheating cigarette (‘sjoemelsigaret’ in Dutch) in The 
Netherlands. To improve the relevance of machine smoking measurements for 
regulation, is that either measurement methods are being used that are insensitive 
for filter ventilation (such as HCI, or that filter ventilation as a design feature is 
prohibited. Filter ventilation enhances the palatability of the smoke and is thus an 
attractive design feature for smoker. Also regular brands, such as Marlboro Red 
have some filter ventilation. If filter ventilation is completely blocked, the cigarette 
smoke is less palatable. This is also demonstrated by Figure 1 where can be seen that 
smoking Marlboro Prime taped results in lower total puff volumes; the distribution is 
shifted to the left, compared to Marlboro Prime. Prohibition of filter ventilation will 
end this. Using puffing parameters settings on the smoking machine representative 
for human smoking will lead to a valid exposure estimate and is therefore interesting 
for regulatory purposes. 
Research question 7 – What are the contributions of toxicant smoke yields resulting 
from (the several types of) human puffing topographies to the risk for smokers?
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As expected, levels of nicotine, carboxyhaemoglobin (COHb) and VOCs in blood 
increase after smoking a cigarette with the levels of increase depending on the puffing 
profile of the individual smoker. In Chapter 3, smokers had a similar VOC intake 
for the cigarette types differing in ISO-TNCO yields. In Chapter 5, it is shown that 
COHb levels in smokers are almost similar when volunteers smoke regular or highly 
filter-ventilated cigarettes. This observation indicates that cigarettes with lower 
ISO-declared TNCO levels, such as Marlboro Prime, may expose smokers to similar 
or even higher levels of VOCs and possibly other pyrolysis or combustion-related 
smoke constituents, than regular cigarettes. These observations are consistent 
with literature data of CO uptake  in smokers upon smoking  highly filter-ventilated 
cigarettes. Based on the results of the volunteers’ studies in the Chapters 3 and 5 
it is concluded that a characteristic puffing topography is more important for actual 
exposure to smoke constituents than the brand smoked. However, smoking Marlboro 
Prime taped resulted in higher COHb levels in blood compared to the other cigarette 
types as even when fewer puffs were taken per cigarette and fewer cigarettes were 
smoked, blocking filter ventilation led to significantly higher CO exposure over the 
day compared to non-blocking. An explanation for these higher CO yields might be 
a lower airflow entering the cigarettes via the flank leading to a less complete (e.g. 
more incomplete) combustion. Also during machine smoking experiments (Chapter 
3) higher levels of CO and other volatile organic smoke constituents are generated 
with fewer puffs when cigarettes are taped, showing that pyrolysis and burning 
conditions during puffing substantially influence the concentrations of pyrolysis 
and burning products in the tobacco smoke (Chapter 2). However, the interaction 
between smoking topography and pyrolysis and burning products requires further 
study. In the ‘normally distributed area’ below the 1000mL (Figure 1), the peak of 
total puffing volume lies on 750mL. An individual smoker is able to inhale two to 
three times more volume. The total puffing volume reached by smoking under ISO 
3308 conditions is only a third (277mL) of the 750mL, and for HCI (490mL) this is 
two-third. Fowles and Dybing used ISO data to calculate cancer risk indices (CRI). 
The calculation with ISO resulted in a 4.9 times lower CRI than the observed cancer 
incidence attributable to smoking in the US. The almost five times lower CRI can be 
explained by the underestimation of ISO towards realistic smoking as is shown in 
this thesis. The proposed use of HCI yield data instead of the now used ISO yield 
data by Fowles and Dybing will still not result in a comparable CRI to the observed 
cancer incidence as HCI is still underrepresenting human smoking. Moreover, our 
studies showed that smokers often reach higher total cigarette volumes than the 4.9 
times ISO volume (277 mL x 4.9 = 1.357 mL), as can be seen in Figure 1. The non-
cancer risk indices (NCRI) calculated with ISO yields for some compounds are above 
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1, some even above 100. These will increase up to 1000 if HCI yield or human yields 
are used. Moreover, the NCRI that are below 1 now, and thus not of concern, will be 
above 1 when more representative yields are used for the calculations. The ranking 
of compounds will not change, but the list of compounds of concern will increase. 




Based on the data described in this thesis, several important issues concerning 
cigarette regulation and risk assessment regarding emissions of toxicants are 
addressed (research questions 10, 11 and 12). In our studies, most smokers show 
no, or minimal, characteristic puffing parameter adjustments when switching to 
other brands. Characteristic smoking topography is significantly different between 
smokers, but all smokers still attained comparable nicotine, COHB and VOC blood 
levels independent of the type of cigarette while they smoked a similar number 
of CPD. In studies reported in the literature with Very Low Nicotine Cigarettes 
(VLNC), significantly reduced uptake of nicotine has been observed 30-32 which can 
be explained by the fact that hardly any nicotine is present in the tobacco filler and 
nicotine is not produced during burning and pyrolysis. However, it was unexpected 
that VLNC smokers continued smoking and that only minor changes in puffing 
topography and CPD were observed. These observations are not consistent with 
the hypothesis that experienced habitual smokers only continue smoking to satisfy 
their need of self-administration of nicotine. However, it is consistent with the 
hypothesis that tobacco addiction is only partially a pharmacological addiction and 
more than nicotine addiction. Furthermore, in accordance with our data from the 
volunteers’ experiments, literature also reports that with VLNC puffing topography 
is not controlled by direct nicotine exposure during smoking. Although each 
individual smoker has a characteristic puffing topography, the overall purpose of 
smoking is essentially to experience a brain reward. As uptake of nicotine through 
the lungs and transport to the brain takes more than 10 seconds 33 and the puff 
duration is only 2 seconds or less, it is unlikely that this mechanism plays a critical 
role in puff topography. Nicotine uptake is more likely to be controlled in the buccal 
cavity by the olfactory and trigeminal neural systems 34,35. Brain activity responses 
to exposure in the buccal cavity can be very quick (<4 seconds) and require little 
nicotine. With each puff, a smoker inhales nicotine and other smoke constituents, 
which activate the quick reward response via the olfactory and trigeminal neural 
system. These processes occur independent of the cigarette type (light, heavy, filter-
ventilated, etc.) as each cigarette contains sufficient amount of nicotine (~16 mg 
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in tobacco filler of one cigarette) to deliver the desired amount per puff and per 
cigarette. By doing so, a smoker becomes used to their cigarette brand, and develops 
a characteristic puffing profile. The only aspect the design of the cigarette needs to 
ensure is that there is not too little or too much nicotine per puff delivered, leading 
to respectively too little reward or a trigeminal nerve overreaction. Hence, a smoker 
primarily controls the nicotine intake by its puff-pulse rhythm. In addition, once 
the characteristic puff topography has been developed, the smoker will use this 
topography for other tobacco products as well. Even when nicotine concentrations 
in the smoke are lower, the characteristic smoking behavior will be sustained as long 
as other rewarding sensory elements of the tobacco smoke are delivered by the 
cigarette. Since high filter ventilation, as well as the use of nicotine-free tobacco, may 
influence the overall sensation of puffing, minor changes in puff topography may be 
seen when smokers switch brands. Our study suggested that ‘compensation’ is not 
due to lower nicotine yield and supports the hypothesis that if smokers change their 
puffing when using another brand, they probably do this because of other sensory 
effects in the buccal cavity. 
Upon smoking VLN,C usually no reduced CO levels were found in smokers, 
suggesting that the actual exposure of the smoker to CO, generated during pyrolysis 
and burning, is mainly determined by puffing topography and not necessarily related 
to nicotine exposure and intake. Instead, for CO as well as other smoke constituents 
also produced during burning and pyrolysis, the smoldering and puffing parameters 
such as puff duration, puff volume and puff number, determine the human exposure. 
For nicotine, also the amount present in the tobacco filler plays a role in human 
exposure during smoking, and thus exposure to burning and pyrolysis products in 
tobacco smoke are not always reflected by nicotine exposure. 
Thus, for risk assessment and regulatory purposes, the underlying similarities and 
differences between the processes determining the presence of different classes 
of constituents in the smoke should be taken into account. However, for chemicals 
that are mainly released into the smoke by evaporation such as nicotine, as well as 
constituents that are produced during pyrolysis and burning, puffing topography 
has major impact on the yields. This finding indicates that when risk assessment and 
regulation are based on standardized machine smoking data, the smoking machine 
puffing profile needs to be close to human puffing profiles with regard to puff 
frequency, puff volume, puff duration and puff numbers. However, to use smoke 
toxicant-to-nicotine ratio of the yields may have limitations for low or high nicotine 
content cigarettes. 
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Exposure assessment is an essential aspect of risk assessment as it includes the 
characterization of the magnitude, frequency and duration of exposure to an agent, 
as well as the number and characteristics of the population exposed. In the past, 
TNCO yields have been used as an overarching umbrella term for toxicant yields in 
cigarette smoke. Fortunately, more and more research is performed for chemicals 
with specific characteristics, such as carbonyls and VOCs that are part of cigarette 
smoke emissions. Measurements of different chemicals with similar physicochemical 
characteristics in cigarette smoke emissions produced with the smoking machine 
can be used as exposure estimate of a chemical class in human risk assessments. Our 
research shows that the puffing parameter settings of the smoking machine and the 
cigarette design features (especially filter-ventilation) are important determinants 
for the measured toxicant yields in cigarette smoke. When determining toxicant 
yields it is important to use more than one puffing regime and different cigarette 
types to assure a representative range of toxicant levels in smoke.  As said, a puffing 
regime that requires (half-) blocked and unblocked testing with a slightly higher puff 
volume (60-70 mL/puff) and a higher puffing frequency (3 puffs per minute rather 
than 2 puffs per minute) might be helpful. 
Implications and future research
The methodology (e.g. smoking machine experiments) to determine exposure to 
cigarette smoke toxicants is inadequate and needs improvement to allow for a more 
accurate exposure assessment.
Inhalation measurements
In order to more accurately  assess exposure, more knowledge is needed not only 
about the emission of smoke toxicants, but also about human smoking behavior. 
The dose of toxicants to which smokers are exposed depends on different factors 
such as the cigarette type, the number of cigarettes smoked, the toxicant yields 
delivered per cigarette and lastly the inhalation practice. The inhalation practice is 
defined by the inhalation parameters such as the hold time in the lungs, the in- and 
exhalation volumes, and the depth of inhalation. The inhalation practice, in addition 
to the physicochemical characteristics of the constituents, determines the location 
and amount of smoke constituents in the lung. The majority of the studies indicate 
that approximately 60-80% of particulate matter retains in the lungs after inhalation. 
Similarly, 90-100% of nicotine and nitric oxides, 90% of aldehydes and 55-65% of 
carbon monoxide retain in the lungs of smokers 36-38. Accurate methodology to 
directly measure smoke distribution and retention in the lungs is however lacking. 
To date, computer modeling is used to determine the respiratory region where 
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different smoke toxicants end up. However, this method often uses generalized 
breathing parameters instead of actual human smoking behavior 38. A possible way 
to distinguish breathing from inhaling cigarette smoke is the use of the Respiratory 
Inductance Plethysmography (RIP) technology. With this technology, upper and 
lower respiratory movements are un-invasively measured by the use of sensors 
in comfortable garment such as the Hexoskin. In order to accurately determine 
the internal dose of the smoker, information about the inhalation parameters (by 
Hexoskin) in combination with the smoke toxicants formed (mimicking human 
puffing profile on smoking machine) under certain puffing parameter conditions 
(recorded puffing topography) is needed. In the past, Feng et al., who tested and 
controlled different inhalation patterns in their research, described that using such 
RIP garment is a suitable method for estimation of retention of smoke constituents 
in the lungs 39. With their study design, the hypothesis that larger puff volumes could 
possibly lead to deeper inhalation and development of a specific type of cancer 
tumor in case of highly filter-ventilated cigarettes could be tested 38. The knowledge 
about the inhalation practice of smokers is valuable for the use and optimization of 
computer modeling of respiratory exposure to smoke toxicants.
In vitro systems
An alternative for mixture risk assessment is the use of in vitro cell systems cultured 
in contact with air such as the air-liquid-interface (ALI) models. This cell culture 
system represents the pulmonary epithelial layer as the cells are cultured on air-
liquid inserts, prone to air stream and reacting on exposure by air. A smoking machine 
can be coupled to this system to expose the cells to freshly generated cigarette 
smoke. To specifically estimate individual lung exposure according to actual human 
smoking, the human puff profile of a certain individual can be used as settings to the 
smoking machine coupled to ALI. Parallel, the TNCO and other toxicant yields in the 
smoke generated under the human profile settings can be determined in a smoking 
machine experiment. A similar approach is the combination of a robotic smoking 
machine with a lung-on-a-chip technology. This is a microfluidically coupled, multi-
compartment platform that bidirectionally ‘breathes’ fresh cigarette smoke through 
microchannels of a human lung small airway microfluidic culture device that mimics 
how lung cells may experience smoke in vivo 40. Results of the two described in vitro 
experiments inform on cigarette smoke lung damage according to human smoking 
conditions. A disadvantage of in vitro systems are the many different readouts 
possible and that the human relevance of the results is not that clear yet.
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The study results presented in this thesis help closing the gap in knowledge between 
reduced exposure and reduction of harmful effects. With the rise of new tobacco-
related products such as e-cigarettes and heated tobacco products, closing this gap 
is even more relevant. Using different nicotine delivery systems clearly results in 
different exposure levels, but the (especially non-cancer) effects hereof are unknown.
Limitations
As part of this thesis, two human studies were designed and performed with the 
main aim to study natural smoking behavior. Based on the chosen design, a few 
potential limitations could be raised. It can be argued that the sample size of the 
human studies is small, or that testing only two brands is too little. Another point of 
discussion is that the study population would not be representative for the human 
smoking population. A last debate point is the ad libitum smoking (e.g. natural 
behavior) instead of a controlled number of cigarettes. We are aware of the fact 
that these study design choices are not traditional or regular and are associated 
with disadvantages. Of course, we would have preferred to have an endless number 
of participants and tested more brands, but we had to minimize to such extent for 
practical reasons. From an ethical perspective it is desirable to minimize the number 
of volunteers (n) who are asked to smoke. Moreover, the number of cigarettes 
that individuals are asked to smoke for the experiment should also be minimized. 
Therefore, we chose to study two different types from a cigarette brand, including 
the design feature filter ventilation. The multiple sampling within a participant for 
a single product, and also performed for the different products, is a strength of the 
present study. For labor-intensively reasons, we preferred to have more sampling 
moments per person, to outline the intake over a day, rather than single measures 
for more participants. As described in the introduction, there are many inter-
individual differences in smoking behavior as was tested in heterogenous study 
populations. However, these could not explain why studies find a wide range of 
puffing parameters. Therefore, we decided to study a homogeneous population with 
the hypothesis that the ‘type’ of smoker (male, age range, CPD) would not be the 
possible confounder of the puffing parameter data. The research design aim was to 
study natural smoking behavior, which means that we could not impose to smoke at 
a certain time point. Consequently, we were not able to sample directly before and 
after all cigarettes. The homelike atmosphere environment enabling natural smoking 
behavior and thus a realistic intake of smoke compounds is a strength of the present 
study.
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Concluding remarks
The adverse health impact on individuals and the population of cigarette smoking 
is undisputed. All tobacco smoking increases the health risk and no smoking is the 
only healthy alternative. However, cigarettes are legally available on the consumers’ 
market and health reduction strategies have been chosen by international 
governments in the fight against the tobacco pandemic. Tobacco smoke contains 
thousands of chemicals, many of which are available in toxicologically relevant 
concentrations, and none of which have been regulated so far under the FCTC. In 
order to support future regulation, the aim of this thesis is to
Relate, for the purpose of risk assessment and cigarette regulation, the emissions of 
nicotine, carbon monoxide, and volatile organic compounds produced with smoking 
machines to emissions produced during human smoking, as well as to the actual uptake 
of smoke constituents in the body of smokers, taking into account the smokers’ daily use 
of cigarettes and their personal puff topography. 
I. Experienced smokers expose themselves more than 100 times per day during 
1 or 2 seconds to the chemical mixture by applying their own characteristic 
puffing topography. Actual puffing of experienced smokers is not regulated by 
nicotine uptake by the lungs, but by sensory effects in the buccal and nasal 
cavity, an issue that needs further investigation. Differences between the 
individual smoking behavior (cigarette per day and puffing topography) easily 
leads to a two-to-three-fold different exposure of tobacco smoke when the 
smokers use the same brand (Chapter 3). In risk assessment models variation of 
exposure is usually taken into account, and that this variation is often less than 
factor of 10 between the highest and the lowest exposure. For experienced 
smokers this assumption holds for nicotine, as the variation between nicotine 
concentrations in blood shortly after smoking between users is comparable 
(Chapter 5), irrespective of the brand smoked. It is also shown for carbon 
monoxide in various studies (Chapter 5) other tobacco smoke constituents of 
the gas phase, such as aldehydes and VOCs (Chapter 3 and 4). This is in spite 
of the different puffing topography and differences between brands. This thesis 
generated insufficient data to allow a full statistical analysis of the attribution 
of puffing topography, brand variation and actual exposure. However, based 
on the experiments of human smoking, actual exposure variation between 
individuals is not much more than a factor of 10. Such a limited variation it is 
not completely unexpected, since tobacco industry probably invest much to 
design and manufacture cigarettes to deliver tobacco smoke within a narrow 
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range of nicotine exposure. 
II. A narrow range of emission yields of gas phase constituents is found when tobacco 
smoke yields are determined with standardized smoking machine. However, 
smoking regimes used nowadays underestimate human exposure substantially 
as the puffing volumes and the puffing frequency are too low. In addition, this 
also results in too low puffing numbers compared to human smoking. When ISO 
3308 data are used human exposure may easily be underestimated by a factor 
2-3 for regular cigarettes and even more for highly ventilated products. Taping 
is critical since untaped testing generates unrealistically low yields for highly 
filter filter-ventilated cigarettes. A suggested modification is half-blocking 
with the use of holders that partially cover the filter when used in smoking 
machine experiment. Another option is eliminating filter ventilation to a certain 
extent (e.g. a maximum filter percentage allowed) as design feature. It must be 
noted that puff number per cigarette has major impact on yields, particularly 
since concentrations of smoke constituents can be higher in the last puffs of a 
cigarette compared to the earlier puffs. HCI regiments on a smoking machine 
should actually be modified by applying 3 rather than 2 puff per minute. 
III. Based on this thesis we postulate that such a modified standardized HCI test 
on a smoking machine generates tobacco smoke with smoke constituents in 
concentrations (µg/mL) which can be related to smoke during human smoking, 
under conditions of comparable puffing topography (puff number, puff volume, 
puff frequency, total cigarette volume). However, even a standardized modified 
HCI test will not fully mimic human smoking completely and one testing method 
is prone to (adaptation) design features of products as has been shown with 
ISO 3308 and filter-ventilated products. Therefore, a second testing method is 
always required to be used in tandem with a modified HCI regiment. A modified 
ISO 3308 may be an option as second test when puffing intensity is increased 
with higher puff volume and higher puffing frequency.
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Smoking is still a worldwide problem that should be taken seriously as can also be 
deduced from the World Health Organization (WHO) Framework Convention on 
Tobacco Control (FCTC). The WHO FCTC is a legal framework that entered into 
force in 2005 as a response on the global tobacco epidemic. While all consumer 
products, and especially food and nutraceuticals are tested and rated for their 
potentially safe use, it is known for decades that tobacco products are unsafe but 
allowed. Moreover, while there is all-round legislation for product safety, the unsafe 
tobacco products are not regulated. 
This thesis subject is in agreement with Article 9 and 10 of the WHO FCTC that 
includes regulations of the content and disclosures of tobacco products whereby 
it is unclear whether lowering smoke components has a health beneficial effect. A 
tobacco product may be harm reducing if it lowers total tobacco related mortality 
and morbidity (i.e. on population level) even though the use of that product may 
involve continued exposure to tobacco related chemicals. Toxicity to some extent is 
an inherent aspect of the tobacco product, but less harmful products can still benefit 
the general smokers’ health. 
For example, in the Netherlands yearly 20.000 smokers die because of smoking.1 If this 
number could be halved, this would be a huge health benefit. To reach a less harmful 
product, the WHO Study Group on Tobacco Product Regulation (TobReg) proposed 
mandated lowering of harmful chemicals, or toxicants, in cigarette smoke. Such a 
strategy for regulation is based on product performance measures with the goal to 
reduce toxicant levels in mainstream cigarette smoke measured under standardized 
conditions. This is a challenge for which scientific data based on toxicological testing 
are needed. Currently, smoking machine tests under ‘standardized conditions’ are 
the golden standard to obtain such data although this approach is often criticized. 
No single protocol is able to give a good prediction for every smoker, with every 
brand, but the current International Standardization Organization (ISO) 3308 
protocol definitely fails to link the actual risks for human smokers from a scientific 
and biologically relevant perspective. With this thesis, we aimed to improve this link 
and thereby decrease the gap in current knowledge about smoking topography and 
the assessment of exposure to cigarette smoke compounds. 
Impact on fundamental and applied science
Human studies often show substantially elevated concentrations of (biomarkers 
of) toxicants in smokers’ blood compared to those in the blood of non-smokers, 
indicating an increased health risk. The influence of human smoking behavior on 
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blood concentration of smoke toxicants, in combination with the yields of the used 
products, is scarcely investigated yet. Instead of comparing non-smokers to smokers, 
we investigated how the actual exposure doses depend on individual variations in 
smoking topography. In our studies, we aimed to reflect actual human exposure to 
smoke toxicants, providing insights into the relevance of using machine-smoking 
data in risk assessment and product regulation. 
In this thesis, we show that smokers have a personal smoking profile that is fairly 
stable but varies greatly between smokers. This indicates that personal exposure 
(and therefore risk) vary greatly. Additionally, we show that smokers have a more 
intense smoking profile than even the Health Canada Intense (HCI) protocol. If this 
is taken into account, the calculations of Fowles and Dybing will yield reasonable 
results with epidemiological data. Ergo, the order of compounds as presented by 
Fowles and Dybing stay intact. Reduction of toxicant yields in smoke will therefore 
most likely be associated with less risk of developing smoking related diseases and 
thus lower total tobacco related mortality and morbidity. 
In addition to the regular cigarette Marlboro red, we specifically focused on highly 
ventilated cigarettes of which it is assumed that these cigarettes are less harmful. 
The nicotine exposure of these cigarettes is very low, even below the threshold of 
initiating or sustaining nicotine addiction (daily dose of less than ~5mg). In contrast 
to the established theory, hardly any compensation is found for the highly ventilated 
cigarettes.
We showed that smoke compounds relate to each other, and that a limited set 
of smoke components is therefore sufficient for risk estimation. Hence, the data 
presented in this thesis could be used to improve the current measurement methods 
for toxicant exposure levels and thus consequently contribute to harm reducing 
measures with respect to tobacco smoking. The data presented for the different 
cigarette brands according to different smoking regimes can be used by risk assessors 
as input for their models. In addition, the puffing topography data can be used to 
generate more reliably model human exposure. The information from Chapter 2, 4 
and 5 may lead to more reliable risk assessment models in which health effects are 
related to tobacco smoking. The papers that cited our articles (Chapter 2 and 4) are 
using our data as such. 
The results in this thesis are especially relevant for other scientific researchers 
working in this field, because the list with human studies and the detailed data 
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of puffing parameters presented in Chapter 4 give insight in worldwide puffing 
topography; this is especially informative because it is specified per brand smoked. 
Furthermore, our own puffing topography study included a thorough investigation 
of the CReSSmicro™ device. The data have led to insight about the use of this device 
to measure smoking topography for fellow researchers and future studies. We have 
shown where the anomalies in the raw data possibly come from and how to deal 
with or prevent them. 
Impact on regulation
In Chapter 2, we compared the ISO and Health Canada Intense (HCI) method for 
11 cigarette brands commercially available in The Netherlands. Our data revealed 
that two to three times more TNCO was measured when using HCI compared to 
ISO. This was caused, among other things, by the fact that the measured smoke 
is mixed with air that enters via the ventilation holes in the filter of the cigarette 
during machine smoking of the ISO 3308 method. This means that the current 
measurement method used in the EU (e.g. ISO 3308) is underestimating actual 
exposure levels of smokers to the harmful chemicals in cigarette smoke. Tobacco 
manufacturers manipulated the method by adapting their cigarette design by adding 
filter ventilation holes. This urges for a different measurement method for detecting 
toxicant levels in mainstream cigarette smoke, as for instance the HCI method in 
which the ventilation holes are taped and thus closed. 
In October 2017, the State Secretary sent a letter to Brussels wherein he argued for 
a different measurement method than the prescribed ISO 3308 method to measure 
tar, nicotine and carbon monoxide (TNCO) in the European Tobacco Products 
Directive (EU-TPD). This letter was (partly) based on data from this thesis (Chapter 
2). Subsequently to the letter of the State Secretary, the RIVM was asked to measure 
100 Dutch brands using the HCI method and the obtained results supported our 
outcome that is published in Chapter 2. Despite the recommendation from different 
parties such as the Dutch government, to include an independent measurement 
method, such as the WHO TobLabNet SOP 01, this is not implemented yet in the 
EU-TPD. This is unfortunate because countries cannot implement these SOPs in 
national legislation as they have to adhere to the EU legislation.
Because we used smoking machine settings with and without taping the cigarettes, 
the data for the different brands are also demonstrating the effect of a design feature 
such as filter ventilation on smoke toxicants (and the exposure of the smoker). This 
information adds to the idea of limiting the allowed cigarette design features such 
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as a maximum filter ventilation percentage or no filter at all. 
In conclusion, HCI results in cigarette smoke emission that is too low to represent 
human smoking. In order to give a more accurate reflection of human smoking 
behavior, cigarettes should be machine smoked with a more realistic puffing regime 
that has a higher puff frequency and a higher puff volume, and with and without 
filter ventilation blocking. In addition, two regimes can be used to prevent that 
possible design features manipulate one type of regime and thus the smoke toxicant 
measurements.  
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Wereldwijde tabak pandemie
Wereldwijd worden veel verstrekkende economische en sociale maatregelen 
genomen in de strijd tegen de COVID-19-pandemie. Volgens de Johns Hopkins 
University stierven tijdens de pandemie in 2020 meer dan 1,8 miljoen mensen. 
Volgens de jaarlijkse sterftecijfers stierven in 2020 echter minstens drie keer meer 
wereldburgers (>7 miljoen) als gevolg van tabaksgebruik en dit aantal zal in de nabije 
toekomst blijven groeien. In de strijd tegen COVID-19 hebben regeringen de vrijheid 
van alle burgers drastisch beperkt en dramatische maatregelen genomen om levens 
te redden en virus-gerelateerde morbiditeit te verminderen. Om de tabakspandemie 
op te lossen moet idealiter de productie en verkoop van tabaksproducten worden 
verboden. Naast maatregelen om tabaksgebruik volledig te voorkomen, helpen ook 
risico beperkende benaderingen om de tabakspandemie te bestrijden. Dergelijke 
maatregelen zijn voornamelijk gebaseerd op belastingen, de-normalisatie, hulp bij 
stoppen-met-roken en “rookvrije” wetgeving die gericht is op (potentiële) rokers. 
Deze risico beperkende benaderingen hebben in de meeste landen geleid tot een 
aanzienlijk lagere prevalentie van roken, maar het heeft het gebruik van sigaretten 
en andere tabaksproducten niet geëlimineerd. 
Het tabaksbeleid kan worden verbeterd door regulatie van traditionele 
tabaksproducten, zoals sigaretten, die nog steeds dominant aanwezig zijn op de 
consumentenmarkt en leiden tot hoge sterfte- en morbiditeitspercentages door 
roken. Eén van de autoriteiten die een schadebeperkingsaanpak heeft voorgesteld is 
de Wereldgezondheidsorganisatie (WHO) Kaderverdrag inzake Tabaksontmoediging 
(FCTC). Binnen de FCTC zijn in veel landen en regio’s verschillende richtlijnen 
aangenomen en geïmplementeerd om het tabaksgebruik te verminderen. Er is 
echter weinig vooruitgang geboekt met betrekking tot Artikel 9 - Regulation of the 
content of tobacco products. Dit artikel luidt: De Conferentie van de Partijen doet, 
in overleg met bevoegde internationale instanties, voorstellen voor richtlijnen voor het 
testen en meten van de inhoud en emissies van tabaksproducten, en voor de regulering 
hiervan. Elke Partij neemt, wanneer goedgekeurd door bevoegde nationale autoriteiten, 
doeltreffende wetgevende, uitvoerende en bestuurlijke of andere maatregelen, en 
voert deze uit, ten behoeve van deze tests en metingen, en ten behoeve van genoemde 
regulering. Hoewel de FCTC in 2005 in werking is getreden, heeft de Conferentie 
van de Partijen (COP) tot nu toe geen volledige Richtlijn voor Partijen verstrekt. 
In 2010 zijn gedeeltelijke richtlijnen voor Artikel 9 en 10 (over de verordening 
inzake de openbaarmaking van informatie over tabaksproducten) aangenomen, 
die in 2014 en 2016 zijn gewijzigd. In deze gedeeltelijke richtlijnen staat echter in 
paragraaf 3.2 (“Inhoud”) en 3.3 (“Emissies”) anno 2021 nog steeds “(dit gedeelte is 
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opzettelijk blanco gelaten om aan te geven dat er in een later stadium richtlijnen zullen 
worden voorgesteld)”. Het illustreert dat er op politiek gebied geen consensus is 
gevonden over de wetenschappelijke basis voor richtlijnen betreffende regulering 
van emissies. Met andere woorden, beleidsmakers worstelen met het feit dat 
roken nog steeds schadelijk is en als ze het eens worden over emissieregulering, 
lijkt het erop dat ze doorgaan met tabaksgebruik goedkeuren. Bovendien vinden 
beleidsmakers de effecten die leiden tot voordelen voor de gezondheid door het 
verlagen van rookcomponenten onduidelijk. De bezorgdheid over filterventilatie is 
genoemd in de 2018 COP meeting 2. The WHO kreeg de taak om te voorzien in 
“het recentste wetenschappelijke bewijs over de impact van sigarettenventilatie op het 
gebruik van sigaretten” en dat te rapporteren aan de COP voor de negende meeting 
die gehouden wordt in Nederland in november 2021.
Hoewel de FCTC geen emissierichtlijn heeft verstrekt, regelt de Europese Unie (EU) (ook 
een partij die de FCTC heeft aangenomen) de maximale gehaltes van teer, nicotine en 
koolmonoxide (CO) (TNCO) in sigarettenrook in de Europese tabaksproductenrichtlijn 
(TPD/2014/40/EU). De TPD heeft grenzen van respectievelijk 10 mg, 1 mg en 10 
mg per sigaret gesteld als de maximumemissies die zijn toegestaan in sigarettenrook. 
De ETPD/2014/40/EU bevat alleen een verwijzing naar de analysetechniek van de 
ISO methode (International Organization of Standardization) en niet naar het ISO 
3308-protocol zelf dat de rookmachinemethode beschrijft. Het is al tientallen jaren 
bekend dat de uitstoot van sigarettenrook wordt bepaald door de manier waarop de 
rook wordt gegenereerd. Bovendien is de emissie van andere toxische stoffen dan 
TNCO helemaal niet gereguleerd in de EU. Vóór de herziening van de ETPD werd 
het ISO 3308-protocol voor rookmachines wèl voorgeschreven voor de bepaling van 
TNCO in de EU. In de dagelijkse praktijk gebruiken alle landen in de EU nog steeds 
deze methode als het vereiste gestandaardiseerde testprotocol voor rookmachine-
experimenten. Het is echter twijfelachtig om normen voor tabaksrook vast te stellen 
zonder aan te geven hoe deze norm kan worden goedgekeurd en gecontroleerd. Het 
reguleren van de rookemissie op basis van ISO 3308 alleen is volgens de WHO “Study 
Group on Tobacco Product Regulation” (WHO-TobReg 2008) niet wetenschappelijk 
geschikt en zou een belangrijke rol kunnen spelen in wat wordt genoemd “een 
misleidend beleid van de tabaksindustrie” om filter geventileerde sigaretten te 
promoten als “lichte”, “milde” of zelfs “gezondere” sigaretten. Een wetenschappelijk 
onderbouwde tabaksregulering moet echter nog worden opgesteld en daarom is 
voor dit proefschrift het volgende doel geformuleerd.
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Dit proefschrift heeft als doel om met het oog op risicobeoordeling en regulering van 
sigaretten, de emissies van nicotine, koolmonoxide en vluchtige organische stoffen 
geproduceerd met rookmachines te relateren aan emissies geproduceerd tijdens humaan 
roken, evenals aan de daadwerkelijke opname van rookcomponenten in het lichaam van 
rokers, daarbij rekening houdend met het dagelijks gebruik van sigaretten door rokers en 
hun persoonlijke rooktopografie. 
Methodologie
Tabaksrook bevat meer dan 6000 chemicaliën met verschillende chemische en 
toxicologische eigenschappen. Niet al deze chemische stoffen kunnen worden 
bestudeerd in relatie tot tabaksrook gerelateerde ziekten. Bovendien kan geen 
rekening worden gehouden met alle mogelijke verschillen tussen blootstelling van 
rokers, noch met de vele verschillen tussen sigarettenmerken. In dit proefschrift 
gebruikten we het werk van WHO-TobReg (2008) en richtten we ons alleen op 
nicotine, CO, aldehyden (hoofdstuk 2) en andere vluchtige organische componenten 
(VOCs) (hoofdstuk 3). Een uitgebreide discussie over de effecten van teer wordt 
weloverwogen weggelaten, omdat het een mengsel is van duizenden individuele en 
potentieel giftige chemicaliën. 
Voor dit proefschrift werden twee soorten experimenten uitgevoerd, namelijk 
rookstudies met rookmachines en met rokende vrijwilligers. In de rookstudies 
met de rookmachine werd sigarettenrook gegenereerd (volgens ISO 3308 en 
Health Canada Intense (HCI)), werden de rookcomponenten gekwantificeerd en 
werden de concentraties, per sigaret en per mL, gerelateerd aan de topografie van 
humaan roken. Met de rookmachine worden sigaretten gerookt onder gereguleerde 
omstandigheden met geselecteerde en vaste protocollen voor rooktopografie, 
dat wil zeggen een vast trekvolume, trekduur en trekinterval. Afhankelijk van het 
specifieke profiel zal de rookmachine de sigaret ‘roken’ met een specifiek aantal 
trekjes. Het totale trekvolume van een sigaret is afhankelijk van het aantal trekjes 
en het trekvolume dat is ingesteld bij het specifieke rookmachineprotocol. Ten 
tweede werden metingen bij rokende vrijwilligers uitgevoerd om hun individuele 
rooktopografie en de opname van tabaksrookbestanddelen in het lichaam te bepalen. 
Een roker past meestal een unieke rooktopografie toe die verschilt van die van 
andere rokers en merkafhankelijk of -specifiek kan zijn. De achterliggende gedachte 
bij deze metingen is dat de humane opname van rookcomponenten zal variëren op 
basis van de rooktopografie van de roker en het type (filter geventileerde) sigaret. 
Door de rooktopografie van de roker te vergelijken met de huidige rookprotocollen 
kunnen gestandaardiseerde instellingen geoptimaliseerd worden om gegevens te 
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leveren die helpen bij het vaststellen van limieten voor regulering van sigaretten. 
Hoofdstuk 2 bestudeert twee soorten rookprotocollen en vergelijkt de uitstoot van 
TNCO en aldehyden van verschillende sigarettenmerken verkrijgbaar in Nederland. 
De onderzochte sigaretten zijn merken met zowel lage als zeer hoge filterventilatie. 
In hoofdstuk 4 wordt een andere benadering gepresenteerd waarbij drie varianten 
van één merk, namelijk Marlboro, worden gebruikt om de invloed van variatie 
van (menselijke) rooktopografie profielen op opname en emissies te bestuderen. 
In hoofdstuk 3 en 5 worden de twee soorten experimenten gecombineerd om 
overeenkomsten en verschillen te bestuderen tussen de emissies van de rookmachine 
en het humaan roken op basis van biomarkers. In hoofdstuk 3 wordt onderzocht 
of uitgeademde lucht kan worden gebruikt als een niet-invasief hulpmiddel om 
de blootstelling aan sigarettenrookcomponenten te beoordelen door vluchtige 
biomarkers te analyseren. Bovendien wordt de opname van rookcomponenten in 
bloed geanalyseerd.
Hoofdstuk 2
Aldehyden zijn één van de chemische klassen op de prioriteitenlijst van TobReg 
voor regulatie. Om inzicht te krijgen in factoren die de aldehydeconcentratie in 
sigarettenrook bepalen, zijn de concentraties van 12 aldehyden in sigarettenrook 
van 11 merken verkrijgbaar op de Nederlandse markt gekwantificeerd. Variaties 
in rookgedrag en sigaretontwerp die de humane blootstelling aan aldehyden 
beïnvloeden, werden bestudeerd met behulp van vier verschillende rookmachine 
protocollen. Het machineroken was gebaseerd op het protocol van de ISO en HCI, 
zowel met als zonder afplakken van de filterventilatiegaatjes. De 11 sigarettenmerken 
verschilden in (i) ontwerp- en tabaksamenstellingskenmerken; (ii) TNCO; (iii) 
populariteit; en (iv) fabrikant. Het gebruik van een intensief rookprotocol (verhoogd 
trekvolume, korter trekinterval) verhoogde de aldehyde concentraties aanzienlijk als 
volgt: HCI > HCI niet afgeplakt > ISO afgeplakt > ISO. Voor alle protocollen waren 
de opbrengsten van acetaldehyde en acroleïne sterk gecorreleerd (r = 0,804). Het 
verschil in TNCO- en aldehydegehaltes tussen gewone en sigaretten met hoge 
filterventilatie en een laag TNCO-gehalte (gemeten met ISO) nam af bij intensief 
roken; dit effect is sterker in combinatie met het afplakken van filter ventilatiegaatjes. 
De laag-TNCO-merken met een hoge filterventilatie vertoonden een zes keer 
hogere aldehydeconcentratie per mg nicotine voor de intensieve rookprotocollen. 
Concluderend kan gezegd worden dat acetaldehyde en acroleïne gebruikt kunnen 
worden als vertegenwoordigers voor de klasse van vluchtige aldehyden voor de 
verschillende merken en rookprotocollen. De aldehyde-tot-nicotine-verhouding 
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nam toe wanneer sigaretten met een hoge filterventilatie intens werden gerookt. 
Een roker van sigaretten met een laag TNCO-gehalte en een hoge filterventilatie 
heeft dus een verhoogd risico op hogere blootstelling aan aldehyden in vergelijking 
met een roker van de reguliere sigaretten.
Hoofdstuk 3
Naast de aldehyden worden rokers ook blootgesteld aan VOCs. In hoofdstuk 3 
wordt gefocust op VOCs in rook van drie soorten sigaretten van één merk variërend 
in aangegeven TNCO concentratie; een reguliere (Marlboro red), een laag-TNCO (en 
dus hoog filter geventileerde) (Marlboro Prime) en een laag-TNCO sigaret (Marlboro 
Prime) met afgeplakte filterventilatiegaatjes. De VOC concentraties werden bepaald 
in de lucht boven het bloed en in de uitgeademde lucht van rokers voor en na roken 
van één sigaret. Het doel was om vast te stellen of de VOC concentraties correleren 
met de TNCO concentraties van sigaretten die worden gerookt volgens rookprotocol 
ISO 3308. Uit onze gegevens blijkt dat het roken van reguliere sigaretten en sigaretten 
met een laag TNCO-gehalte vergelijkbare niveaus van VOCs in bloed en uitgeademde 
lucht tot gevolg heeft. Dit is een aanwijzing dat de aangegeven TNCO gehaltes zoals 
bepaald met het rookprotocol ISO 3308 voor machineroken niet relevant zijn voor 
het voorspellen van VOCs uitgescheiden na roken door mensen, omdat je met die 
methode wel verschillen ziet. Veneus bloed en adem werden bemonsterd bij twaalf 
mannelijke rokende vrijwilligers direct voor en tien minuten na het roken van een 
sigaret op drie onderzoeksdagen (dag 1 Marlboro Red, dag 2 Marlboro Prime, dag 
3 Marlboro Prime met afgeplakte filterventilatiegaatjes). Door het roken namen de 
concentraties van tolueen, ethylbenzeen, m/p-xyleen, o-xyleen en 2,5-dimethylfuran 
vergelijkbaar toe in zowel de lucht boven bloed als de uitgeademde lucht voor alle 
drie de typen sigaretten. Er werd echter geen sterke correlatie gevonden tussen 
VOC concentraties in uitgeademde lucht en VOC concentraties in de lucht boven 
bloed, waarschijnlijk vanwege variaties tussen de individuele rokende vrijwilligers. 
Er is meer onderzoek nodig om te bepalen of uitgeademde lucht te gebruiken is 
als een niet-invasieve kwantitatieve marker voor vluchtige toxische stoffen voor 
blootstelling aan sigarettenrook van verschillende merken.
Hoofdstuk 4
Het rookgedrag van mensen beïnvloedt hun blootstelling aan toxische stoffen 
uit rook en dat is belangrijk voor de risicobeoordeling. In een prospectieve 
observationele studie werd het rookgedrag van Marlboro-rokers gedurende 
36 uur gemeten. Het trekvolume, de trekduur, de trekfrequentie, de trekflow 
en het trekinterval werden geregistreerd met het draagbare CReSSmicro™-
234 | 
apparaat, zoals vaak is gedaan door andere wetenschappers. Het gebruik van het 
CReSSmicro™-apparaat kan echter leiden tot problemen met registratie van de 
rooktopografie, aangezien de methode van inbrengen van de sigaret in het apparaat 
de gegevensverzameling kan beïnvloeden. De rokende vrijwilligers vertoonden 
in de loop van de dag een consistent individueel karakteristieke rooktopografie, 
waardoor een gepersonaliseerd rookprofiel kon worden gemodelleerd per roker. 
Deze rookprofielen werden vervolgens gebruikt als instellingen voor experimenten 
met de rookmachine om TNCO-emissies te genereren. De toepassing van humane 
rookprofielen leidde tot TNCO-blootstellingen die meer in het bereik van HCI-
TNCO- dan ISO-TNCO emissies lagen. Vergeleken met het ISO-protocol, dat een 
lager trekvolume toepast ten opzichte van rokers, kan de generatie van TNCO 
minstens twee keer hoger zijn wanneer humane rookprofielen worden toegepast 
op de rookmachine. Rokers vertoonden een hogere trekfrequentie en daarmee een 
hogere trekintensiteit en dus meer trekjes per sigaret dan voor zowel ISO als HCI.
Hoofdstuk 5
Filterventilatiegaatjes hebben invloed op het nicotinegehalte in sigarettenrook. 
De aanwezigheid van filterventilatiegaatjes kan ertoe leiden dat rokers hun 
rooktopografie aanpassen aan de mate van filterventilatie, een fenomeen dat 
compenserend roken wordt genoemd. Er is echter ook gerapporteerd dat rokers 
tijdens het roken een kenmerkende rooktopografie toepassen, ongeacht de nicotine 
concentratie. Bovendien is de hypothese geopperd dat een zeer lage nicotine-
opbrengst van sigaretten met een hoge filterventilatie zelfs onder de drempel kan 
liggen die nodig is om nicotineverslaving in stand te houden. Daarom hebben we het 
effect bestudeerd van filterventilatie op de rooktopografie van rokende vrijwilligers, 
op het aantal sigaretten die door hen per dag worden geconsumeerd en op hun 
nicotinebloedspiegels. Omdat zowel compenserend roken als het kenmerkende 
rookprofiel de blootstelling aan rookcomponenten kan beïnvloeden, hebben we ook 
de blootstelling aan CO bestudeerd door carboxyhemoglobine (COHb) in het bloed te 
meten. In een humane studie met rokende vrijwilligers (leeftijd 25-35 jaar) zijn twaalf 
ervaren Marlboro Red (43% filterventilatie) rokers gedurende een week overgegaan 
op het roken van een laag-TNCO (en dus hoog filtergeventileerde (83%)) sigaret, de 
Marlboro Prime. Ze rookten ad libitum op drie verschillende dagen onder natuurlijke 
omstandigheden (niet in het lab) Marlboro Red, de Marlboro Prime en de Marlboro 
Prime met afgeplakte filterventilatiegaatjes. De meeste rokers veranderden hun 
dagelijkse aantal sigaretten of karakteristieke rooktopografie niet bij het overgaan 
van hun normale Marlboro Red naar Marlboro Prime of de afgeplakte Marlboro 
Prime. We vonden vergelijkbare nicotine- en cotinine-bloedspiegels na het roken 
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van Marlboro Red en de afgeplakte Marlboro Prime gedurende de dag. Er werden 
slechts iets lagere nicotineconcentraties gevonden bij het roken van Marlboro 
Prime. Na een week Marlboro Prime roken, werden lagere concentraties cotinine 
en significant hogere COHb-spiegels gevonden in vergelijking met Marlboro Red. 
Wanneer rokers hun eigen karakteristieke rooktopografie toepassen, extraheren ze 
vergelijkbare hoeveelheden nicotine uit sigaretten met verschillende filterventilatie 
om hun nicotineverslaving in stand te houden en rookt ze een vergelijkbaar aantal 
sigaretten per dag. We concluderen dan ook dat compenserend roken van sigaretten 
met filterventilatie een twijfelachtig concept is, aangezien sigaretten met een ‘lage’ 
en ‘gewone’ opbrengst vergelijkbare hoeveelheden nicotine leveren aan chronische 
rokers met minimale veranderingen in hun rooktopografie.
Discussie
Op basis van de gegevens die in dit proefschrift worden beschreven, worden 
verschillende belangrijke kwesties met betrekking tot sigarettenregulering en 
risicobeoordeling met betrekking tot emissies van giftige stoffen behandeld. In onze 
onderzoeken laten de meeste rokers geen, of minimale, karakteristieke aanpassingen 
van de trekparameters zien bij het overstappen op een ander sigarettenmerk. De 
kenmerkende rooktopografie is significant verschillend tussen rokers, maar alle 
rokers rookten een vergelijkbaar aantal sigaretten per dag van de verschillende 
merken en bereikten hiermee nog steeds vergelijkbare nicotine-, COHB- en VOC-
bloedspiegels, onafhankelijk van het type sigaret. In studies gerapporteerd in de 
literatuur met zeer laag nicotine sigaretten (ZLNS) is een significant verminderde 
opname van nicotine waargenomen wat verklaard kan worden door het feit dat 
er nauwelijks nicotine aanwezig is in de tabak en dat nicotine niet geproduceerd 
wordt tijdens het verbrandingsproces. Het was echter onverwacht dat ZLNS-rokers 
bleven roken en dat er slechts kleine veranderingen in rooktopografie en sigaretten 
per dag werden waargenomen. Deze waarnemingen zijn niet consistent met de 
hypothese dat ervaren rokers van reguliere sigaretten alleen blijven roken om te 
voldoen aan hun nicotinebehoefte. Het is echter consistent met de hypothese dat 
tabaksverslaving slechts gedeeltelijk een farmacologische verslaving is en meer is 
dan een nicotineverslaving. Bovendien, in overeenstemming met onze gegevens 
van de experimenten van de vrijwilligers, meldt de literatuur ook dat met ZLNS 
rooktopografie niet wordt gecontroleerd voor directe blootstelling aan nicotine 
tijdens het roken. Hoewel elke individuele roker een kenmerkende rooktopografie 
heeft, is het algemene doel van roken in wezen het bereiken van een (hersen)
beloning. Aangezien de opname van nicotine door de longen en het transport 
naar de hersenen meer dan 10 seconden duurt en de trekduur maximaal twee 
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seconden is, is het onwaarschijnlijk dat dit mechanisme een cruciale rol speelt bij 
de rooktopografie. Er is een grotere kans dat nicotineopname in de mondholte 
wordt gecontroleerd door de reuk- en trigeminusneuronen. Hersenactiviteit 
reacties op blootstelling in de mondholte kunnen zeer snel zijn (<4 seconden) en 
vereisen weinig tot geen nicotine. Bij elke trek inhaleert een roker nicotine en 
andere rookbestanddelen, die de snelle beloningsreactie activeren via het reuk- en 
trigeminus neurale systeem. Deze processen vinden plaats onafhankelijk van het 
type sigaret (light, regulier, filtergeventileerd, enz.) aangezien elke sigaret voldoende 
nicotine bevat (~16 mg in de tabak van één sigaret) om de gewenste hoeveelheid 
per trekje en per sigaret te leveren. Een roker raakt gewend aan zijn sigarettenmerk 
en ontwikkelt een karakteristiek rookprofiel. Het enige aspect dat het design van de 
sigaret moet waarborgen is dat er niet te weinig of te veel nicotine per trekje wordt 
afgegeven, wat leidt tot respectievelijk te weinig beloning of een overreactie van de 
nervus trigeminus. Vandaar dat een roker voornamelijk de nicotine-inname regelt 
door zijn trek-pulsritme (trekduur en trekinterval). Bovendien zal de roker, zodra 
de karakteristieke rooktopografie is ontwikkeld, deze topografie ook voor andere 
tabaksproducten gebruiken. Zelfs wanneer de nicotineconcentraties in de rook 
lager zijn, blijft het karakteristieke rookgedrag behouden zolang andere belonende 
zintuiglijke elementen van de tabaksrook door de sigaret worden afgegeven. 
Aangezien een hoge filterventilatie, evenals het gebruik van nicotinevrije tabak, het 
algehele gevoel van een trek nemen kan beïnvloeden, kunnen kleine veranderingen 
in de topografie worden waargenomen wanneer rokers van merk veranderen. Onze 
studie suggereert dat ‘compensatie’ niet te wijten is aan een lagere nicotine-opbrengst 
en ondersteunt de hypothese dat als rokers hun rooktopografie veranderen bij het 
gebruik van een ander merk, ze dit waarschijnlijk doen vanwege andere sensorische 
effecten in de mondholte.
Bij het roken van VLNC werden gewoonlijk geen verlaagde CO-niveaus gevonden 
bij rokers, wat suggereert dat de werkelijke blootstelling van de roker aan CO, 
gegenereerd tijdens pyrolyse en verbranding, voornamelijk wordt bepaald door de 
rooktopografie en niet noodzakelijk gerelateerd is aan blootstelling en inname van 
nicotine. In plaats daarvan bepalen CO en andere rookbestanddelen die worden 
geproduceerd tijdens het verbrandingsproces, het smeulen en de trekparameters 
zoals de duur van de trek, het trek volume en het aantal trekjes, de blootstelling 
van de roker. Voor nicotine speelt ook de hoeveelheid die aanwezig is in de tabak 
een rol bij de blootstelling van de roker tijdens het rookproces. Blootstelling aan 
verbrandingsproducten in tabaksrook wordt dus niet altijd weerspiegeld door 
blootstelling aan nicotine. 
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Voor risicobeoordeling en regelgeving moet rekening worden gehouden met 
de onderliggende overeenkomsten en verschillen tussen de processen die de 
aanwezigheid van verschillende klassen van bestanddelen in de rook bepalen. Voor 
chemicaliën die voornamelijk door verdamping in de rook vrijkomen, zoals nicotine, 
evenals bestanddelen die worden geproduceerd tijdens het verbrandingsproces, 
heeft de rooktopografie echter een grote invloed. Deze bevinding geeft aan dat 
wanneer risicobeoordeling en regulering gebaseerd zijn op gestandaardiseerde 
gegevens van rookmachinemetingen, het rookmachine rookprofiel dicht bij de 
humane rookprofielen moet liggen met betrekking tot de trekfrequentie, het 
trekvolume, de trekduur en het aantal trekjes. Het gebruik van de schadelijek stof tot 
nicotine ratio kan echter beperkingen hebben voor sigaretten met een laag of hoog 
nicotinegehalte. De blootstelling is een essentieel aspect van de risicobeoordeling 
omdat het de omvang, frequentie en duur van blootstelling aan een schadelijke 
stof, evenals het aantal en de kenmerken van de blootgestelde populatie bevat. 
In het verleden werden de TNCO-concentraties gebruikt als een overkoepelende 
term voor de opbrengst aan toxische stoffen in sigarettenrook. Gelukkig wordt er 
steeds meer onderzoek gedaan naar componenten met specifieke eigenschappen, 
zoals carbonylen en VOCs die deel uitmaken van de sigarettenrook. Metingen van 
verschillende chemicaliën met vergelijkbare fysisch-chemische kenmerken in de 
sigarettenrook geproduceerd met de rookmachine kunnen worden gebruikt als 
schatting van de blootstelling aan een chemische klasse bij risicobeoordelingen 
voor mensen. Ons onderzoek toont aan dat de trekinstellingen van de rookmachine 
en de kenmerken van het sigarettenontwerp (met name filterventilatie) belangrijke 
determinanten zijn voor de concentraties van schadelijke stoffen in sigarettenrook. 
Bij het bepalen van de concentratie van toxische stoffen is het belangrijk om meer dan 
één rookprofiel en verschillende typen sigaretten te gebruiken om een representatief 
bereik voor humaan roken in sigarettenrook te garanderen. Zoals gezegd zou een 
rookprotocol, met sigaretten in zowel (half)afgeplakte en niet-afgeplakte staat, met 
een iets hoger trekvolume (60-70 ml/trek) en een hogere trekfrequentie (3 trekjes 
per minuut in plaats van 2 trekjes per minuut) nuttig zijn. 
Conclusie
De nadelige gevolgen voor de gezondheid van individuen en hun omgeving 
door het roken van sigaretten is onbetwist. Het roken van tabak verhoogt het 
gezondheidsrisico en niet roken is het enige gezonde alternatief. Sigaretten zijn 
echter legaal verkrijgbaar op de consumentenmarkt en internationale regeringen 
hebben strategieën gekozen die de schadelijkheid van tabaksgebruik verminderen. 
Tabaksrook bevat duizenden chemicaliën, waarvan vele beschikbaar zijn in toxische 
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concentraties, en alleen nicotine en CO zijn daarvan tot nu toe wettelijk gereguleerd. 
Dit proefschrift bevat informatie om toekomstige regelgeving te ondersteunen.
I. Ervaren rokers stellen zich meer dan 100 keer per dag gedurende 1 a 2 
seconden bloot aan het chemische mengsel van sigarettenrook door hun 
eigen karakteristieke rookprofiel toe te passen. De rooktopografie van ervaren 
rokers lijkt niet gereguleerd te worden door de opname van nicotine door de 
longen, maar door sensorische effecten in de mond- en neusholte, een kwestie 
die nader onderzoek behoeft. Verschillen tussen het individuele rookgedrag 
(aantal sigaretten per dag en rooktopografie) leiden al snel tot verschillen van 
twee tot drie keer hogere blootstelling aan sigarettenrook wanneer de rokers 
hetzelfde merk gebruiken (hoofdstuk 3). In risicobeoordelingsmodellen wordt 
meestal rekening gehouden met variatie in blootstelling waarbij deze variatie 
tussen de hoogste en de laagste blootstelling vaak kleiner is dan een factor 10. 
Voor ervaren rokers geldt deze aanname voor nicotine, aangezien de variatie 
tussen nicotineconcentraties in het bloed kort na het roken tussen gebruikers 
vergelijkbaar is (hoofdstuk 5), ongeacht het merk dat gerookt wordt. Dit is ook 
aangetoond voor CO (hoofdstuk 5) en voor andere rookcomponenten in de 
gasfase zoals aldehyden en VOCs (hoofdstuk 3 en 4), ondanks de verschillende 
rooktopografie tussen rokers en verschillen tussen merken. Dit proefschrift 
beschrijft onvoldoende gegevens om een  volledige statistische analyse van de 
invloed van rooktopografie, merkvariatie en werkelijke blootstelling mogelijk te 
maken. Op basis van de experimenten met roken door mensen is de werkelijke 
blootstellingsvariatie tussen individuen echter niet veel meer dan een factor 
10. Een dergelijke beperkte variatie is niet geheel onverwacht, aangezien de 
tabaksindustrie waarschijnlijk veel investeert in het ontwerpen en vervaardigen 
van sigaretten om tabaksrook te produceren binnen een nauw bereik van 
nicotineblootstelling. 
II. Een smal bereik van emissies van gasfase componenten wordt gevonden wanneer 
sigarettenrook wordt geproduceerd met een gestandaardiseerde rookmachine. 
De tegenwoordig gebruikte rookprotocollen onderschatten de blootstelling van 
de mens echter aanzienlijk omdat de trekvolumes en de trekfrequentie te laag 
zijn. Bovendien resulteert dit ook in een te laag aantal trekjes in vergelijking 
met roken door mensen. Wanneer ISO 3308-gegevens worden gebruikt, kan 
de blootstelling van de mens gemakkelijk worden onderschat met een factor 2 
tot 3 voor gewone sigaretten en zelfs meer voor sterk geventileerde sigaretten. 
Afplakken van ventilatiegaatjes tijdens metingen is van cruciaal belang omdat 
testen zonder afplakken onrealistisch lage opbrengsten genereert voor 
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sigaretten met een hoge filterventilatie. Een voorgestelde wijziging is half 
blokkeren met het gebruik van houders die het filter gedeeltelijk afdekken bij 
gebruik in rookmachine-experimenten. Een andere optie is om filterventilatie 
tot op zekere hoogte (bijvoorbeeld een maximaal toegestaan  filterpercentage) 
als ontwerpkenmerk uit te sluiten. Hierbij moet opgemerkt worden dat het 
aantal trekjes per sigaret een grote invloed heeft op de samenstelling van de 
sigarettenrook, vooral omdat de concentraties van rookbestanddelen in de 
laatste trekjes van een sigaret hoger kunnen zijn dan in de eerdere trekjes. Het 
zou nog beter zijn om het HCI-protocol op een rookmachine aan te passen naar 
3 in plaats van 2 trekjes per minuut.
III. Op basis van dit proefschrift stellen we dat een dergelijke gewijzigde 
gestandaardiseerde HCI-test (punt II) op een rookmachine tabaksrook 
produceert met rookbestanddelen in concentraties (µg/mL) die gerelateerd 
kunnen worden aan rook onder omstandigheden van vergelijkbare 
rooktopografie (aantal trekjes, trekvolume, trekfrequentie, totaal rookvolume). 
Maar zelfs een gestandaardiseerd gemodificeerd HCI-protocol zal het roken 
door mensen niet volledig nabootsen en één testmethode is gevoelig voor 
(aanpassings)designkenmerken van producten, zoals is aangetoond met ISO 
3308 en filtergeventileerde producten. Daarom is altijd een tweede testmethode 
vereist om samen met een aangepast HCI-protocol te worden gebruikt. Een 
aangepaste ISO 3308 kan een optie zijn als tweede protocol als de intensiteit 
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